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Condensation: Plasma microRNAs concentrations differ during preeclampsia as compared with 25 
healthy pregnancy. MiR-574-5p and miR-1972, which are both increased during preeclampsia as 26 
compared with healthy pregnancy, affect endothelial cell function in vitro. 27 
Short version of title: Increased plasma microRNAs in early-onset preeclampsia affect endothelial 28 
cell function 29 
 30 
AJOG at a glance: 31 
A. Why was this study conducted? 32 
We investigated if early-onset preeclampsia is characterized with different concentrations of plasma 33 
microRNAs as compared with healthy pregnancy and we studied in vitro if the microRNAs that were 34 
highly different between preeclampsia and healthy pregnancy might be involved in one of the main 35 
features of preeclampsia, endothelial dysfunction. 36 
B: What are the key findings? 37 
We demonstrated that concentrations of 26 plasma (precursor) microRNAs differed in concentration 38 
in early-onset preeclampsia as compared with healthy pregnancy. Furthermore, we showed that miR-39 
574-5p and miR-1972, which showed increased plasma concentrations during preeclampsia as 40 
compared with healthy pregnancy, affect endothelial cell function in vitro. 41 
C: What does the study add to what is already known? 42 
Maternal endothelial cell dysfunction during preeclampsia is one of the underlying 43 
pathophysiological factors of one of the major signs of preeclampsia, hypertension. This study for the 44 
first time showed that 2 of the miRNA that were increased in preeclampsia vs. healthy pregnancy 45 
affected endothelial function in vitro, indicating that in vivo these miRNA may also contribute the 46 
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endothelial dysfunction in preeclampsia. The increased plasma microRNAs might be interesting 47 




Background: Preeclampsia is a hypertensive pregnancy disorder, in which generalized 50 
systemic inflammation and maternal endothelial dysfunction are involved in the pathophysiology. 51 
MiRNAs are small non-coding RNAs responsible for post-transcriptional regulation of gene expression 52 
and involved in many physiological processes. They mainly downregulate translation of their target 53 
genes. 54 
Objective: We aimed to compare the plasma miRNA concentrations in preeclampsia, healthy 55 
pregnancy and non-pregnant women. Furthermore, we aimed to evaluate the effect of three highly 56 
increased plasma miRNAs in preeclampsia on endothelial cell function in vitro. 57 
Study Design: We compared 3,391 (precursor) miRNA concentrations in plasma samples 58 
from early-onset preeclamptic women, gestational age matched healthy pregnant women and non-59 
pregnant women using miRNA 3.1. arrays (Affymetrix) and validated our findings by real-time 60 
quantitative PCR (RT qPCR). Subsequently, endothelial cells (human umbilical vein endothelial cells) 61 
were transfected with microRNA mimics (we choose the three miRNAs with the highest fold change 62 
and lowest false discovery rate in preeclampsia vs. healthy pregnancy). After transfection, functional 63 
assays were performed to evaluate if overexpression of the microRNAs in endothelial cells affected 64 
endothelial cell function in vitro. Functional assays were the wound healing assay (which measures 65 
cell migration and proliferation), the proliferation assay and the tube formation assay (which 66 
assesses formation of endothelial cell tubes during the angiogenic process). To determine if the 67 
miRNAs are able to decrease gene expression of certain genes, RNA was isolated from transfected 68 
endothelial cells and gene expression (by measuring RNA expression) was evaluated by gene 69 
expression microarray (Genechip Human Gene 2.1 ST arrays [Life Technologies]). For the microarray 70 
we used pooled samples, but the differently expressed genes in the microarray were validated by RT 71 
qPCR in individual samples. 72 
Results: No significant differences (fold change < -1.2 or > 1.2 with a false discovery rate < 73 
0.05) were found in miRNA plasma concentrations between healthy pregnant and non-pregnant 74 
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women. The plasma concentrations of 26 (precursor) miRNAs were different between preeclampsia 75 
and healthy pregnancy. The 3 miRNAs which were increased with the highest fold change and lowest 76 
false discovery rate in preeclampsia vs. healthy pregnancy were miR-574-5p, miR-1972, and miR-77 
4793-3p. Transfection of endothelial cells with these miRNAs in showed that miR-574-5p decreased 78 
(p<0.05) the wound healing capacity (i.e. decreased endothelial cell migration and/or proliferation) 79 
and tended (p<0.1) to decrease proliferation, miR-1972 decreased tube formation (p<0.05) and also 80 
tended (p<0.1) to decrease proliferation and miR-4793-3p tended (p<0.1) to decrease both the 81 
wound healing capacity and tube formation in vitro. Gene expression analysis of transfected 82 
endothelial cells revealed that miR-574-5p tended (p<0.1) to decrease the expression of the 83 
proliferation marker MKI67. 84 
Conclusion: We conclude that in the early-onset preeclampsia group in our study different 85 
concentrations of plasma miRNAs are present as compared with healthy pregnancy. Our results 86 
suggest that miR-574-5p and miR-1972 decrease the proliferation (probably via decreasing MKI67) 87 
and/or migration as well as the tube formation capacity of endothelial cells. Therefore, these miRNAs 88 
may be anti-angiogenic factors affecting endothelial cells in preeclampsia.  89 
 90 
Keywords: biomarker, endothelial dysfunction, endothelial cells, epigenetics, HUVEC, microarrays, 91 
microRNAs, miR-1972, miR-4793-3p, miR-574-5p, preeclampsia, proliferation, transfection, tube 92 






Preeclampsia is a hypertensive pregnancy disorder affecting 2-8% of all pregnancies2. The 97 
poorly established3 and/or perfused placenta4 produces pro-inflammatory and anti-angiogenetic 98 
factors which are released into the maternal circulation5–8. These factors induce generalized systemic 99 
inflammation9 and endothelial cell activation10 and dysfunction10,11, resulting in clinical signs of 100 
preeclampsia, such as hypertension and proteinuria5,12. 101 
MiRNAs are small (∼22 nucleotides) non-coding RNAs responsible for post-transcriptional 102 
regulation of gene expression by targeting mRNAs for cleavage or inhibiting their translation13. 103 
MiRNAs play a critical role in many (patho)physiological cell processes, such as cell differentiation 104 
and proliferation14,15. In the circulation, miRNAs are often bound to proteins16 or located inside 105 
microvesicles17 which causes high stability of these small RNAs18. Circulating miRNAs serve as a 106 
communication system between cells19 and circulating miRNAs may be involved in inflammation and 107 
endothelial function20. MiRNAs have been associated with many disorders, including 108 
atherosclerosis21 and chronic kidney disease with proteinuria22. 109 
Other studies showed that the concentrations of certain miRNAs in the circulation before the 110 
onset of preeclampsia or during preeclampsia are different compared to healthy pregnant women23–111 
27. Since miRNAs can target endothelial cells19, we hypothesized that miRNAs which differ in 112 
concentrations during preeclampsia might contribute to maternal endothelial dysfunction. To 113 
examine this, (precursor) miRNA concentrations were measured in plasma samples of pregnant 114 
women with early-onset preeclampsia, healthy pregnant and non-pregnant women by microarray. 115 
Subsequently, endothelial cells were transfected with mimics of the miRNAs which were most highly 116 
elevated in preeclampsia vs. healthy pregnancy and endothelial cell function was evaluated by 117 
wound healing assay (to assess the effects of the miRNAs on endothelial cells migration and 118 
proliferation), cell proliferation assay and tube formation assays (to assess the effects of the miRNAs 119 
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on tube formation properties of endothelial cells) in vitro. Finally we investigated which genes were 120 




Materials and Methods 123 
 124 
For an extensive Materials and Methods please see the online Supplementary File. 125 
 126 
Study design and rational 127 
In the first part of this study, plasma miRNA concentrations of early-onset preeclamptic 128 
patients are compared with plasma microRNA concentrations of healthy pregnant and non-pregnant 129 
women. This was done by miRNA microarray technologies. Three miRNAs with the highest fold 130 
change (fold change > 1.8) and with a false discovery rate < 0.01 in preeclamptic as compared to 131 
healthy pregnant plasma were validated by real-time quantitative PCR. These three miRNAs were 132 
also selected for further investigation in the second part of the study. 133 
 In the second part of the study we examined the effects of increasing the concentrations of 134 
the selected miRNAs in endothelial cells. To increase miRNA concentrations in endothelial cells, 135 
endothelial cells were transfected with miRNA mimics (chemically modified RNAs that mimic 136 
endogenous miRNAs). Subsequently, assays were performed to assess endothelial cell function in 137 
vitro. These assays include a tube formation assay, a wound healing assay and a proliferation assay. 138 
The tube formation assay is a well-established model for measuring formation of endothelial cell 139 
tubes, which is part of the angiogenesis process in vitro28. The other two assays also assess processes 140 
that are important for angiogenesis29. The wound healing assay assesses migration/proliferation of 141 
cells after insertion of a linear scratch in the cell monolayer30. The proliferation assay measures 142 
proliferation of the cells, by measuring metabolic activity of the transfected cells over time.  143 
 Since miRNAs functions by decreasing mRNA expression, in the last part of this study it was 144 
investigated if the miRNAs were able to indeed modify gene expression pattern in the transfected 145 
endothelial cells. To do so, mRNA expression of the endothelial cells was characterized by gene 146 




Patient recruitment and plasma collection 149 
We included healthy non-pregnant women (n=10), healthy pregnant women (n=10) and 150 
women diagnosed with early-onset preeclampsia (PE, n=10). The sample size of 10 subjects in each 151 
group was decided using power calculations described in the article of Liu et al31. Preeclampsia was 152 
defined according to the definition from the Practice Bulletin #203 “Chronic Hypertension in 153 
Pregnancy”: a systolic blood pressure of ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg on 154 
two or more occasions at least 4 h apart after 20 weeks of gestation in women with a previously 155 
normal blood pressure, and proteinuria ≥ 300 mg/24 h32. Samples included in this study were from 156 
early-onset preeclampsia, these women all delivered before week 34 of gestation and did no show 157 
comorbidities, such as autoimmune diseases (i.e. diabetes, antiphospholipid syndrome, SLE) or 158 
chronic hypertension. Healthy pregnant women and PE were matched for gestational age at 159 
sampling. The medical ethical committee of the UMCG approved this study, and informed consent 160 
was signed by all participants. 161 
 162 
MicroRNA array 163 
Total RNA was isolated from the plasma samples and 1 µg was labeled and hybridized to 164 
miRNA 3.1 arrays targeting 3,391 human (precursor) microRNAs ((pre-)miRNAs) (P/N 90215, 165 
Affymetrix). The miRNAs targeted by this array were all (precursor) miRNAs known at that moment 166 
(100% miRBase v17 coverage). 167 
 168 
MicroRNA array quality control and data analysis 169 
Please see the online Supplementary File. The miRNAs with the highest fold change (fold 170 
change > 1.8) and with a false discovery rate < 0.01 in PE vs. healthy pregnant were chosen (miR-574-171 




MicroRNA array validation by real-time quantitative PCR 174 
Validation of the array was done by real-time quantitative PCR (RT qPCR) using miRNAs 175 
which were found to change with the highest fold change and with a false discovery rate < 0.01 in 176 
preeclampsia vs. healthy pregnancy (miR-574-5p, miR-1972 and miR-4793-3p). cDNA was prepared 177 
and RT qPCR was performed on a StepOnePlus™ Real-Time PCR System machine (Applied 178 
Biosystems). Relative expression levels were calculated by the 2-∆CT method and normalized against 179 
expression levels of the relatively stable endogenous control hsa-miR-191-5p. 180 
 181 
Human umbilical vein endothelial cell culturing 182 
Isolation of human umbilical vein endothelial cells was performed in the endothelial cell 183 
facility of the UMCG using umbilical veins from term pregnancies without complications (such as 184 
autoimmune diseases, preeclampsia and intra uterine growth restriction) and cells were pooled from 185 
at least 2 donors and cultured as described before33. Please see the online Supplementary File for 186 
further details. 187 
 188 
Transfection of endothelial cells with miRNA mimics 189 
50% confluent endothelial cells (passage 3) were transfected with mirVana miRNA mimics 190 
(miR-574-5p, miR-1972 or miR-4793-3p) or the mirVana miRNA mimic negative control #1 (Ambion). 191 
Please see the online Supplementary File for further details. 192 
 193 
Tube formation assay 194 
The tube formation assay is a well-established model for measuring tube formation, i.e. the 195 
ability of the endothelial cells to form capillary-like structures in vitro. This is part of the angiogenic 196 
process28. Matrigel basement membrane matrix (Corning) was pipetted into the inner wells of the µ-197 
Slide Angiogenesis (Ibidi). Slides were incubated for 45 min at 37°C. The transfected endothelial cells 198 
were collected after 48 h of incubation and 10,000 endothelial cells were seeded into each well on 199 
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top of the matrigel. After 12h at 37°C, pictures were taken. Tube formation was quantified as total 200 
amount of loops (i.e. numbers of capillaries formed), total tube length (length of the capillaries) and 201 
total branching points (number of interconnections between the tubules, which gives information on 202 
how endothelial cells organize themselves) by using Wimasis, 2017 (n=5). (WimTube: Tube Formation 203 
Assay Image Analysis Solution. Release 4.0. Available from: 204 
https://www.wimasis.com/en/products/13/WimTube). 205 
 206 
Wound healing assay 207 
Endothelial cell migration and/or proliferation potential was assessed by the wound healing 208 
assay of the transfected endothelial cells. A linear scratch was made using a sterile pipet tip. Pictures 209 
were taken of the same area of the scratch after 0, 4, 8, 12, and 24 h of incubation at 37°C. To 210 
measure how long it takes to close the wound, the surface area of the scratch was measured using 211 
ImageJ (n=5). 212 
 213 
WST-1 assay for cell proliferation 214 
Since the wound healing assay evaluates both migration and proliferation, but does not allow 215 
discrimination between these processes, we also performed a proliferation assay, which specifically 216 
measures proliferation of the cells. To do so, the metabolic activity of transfected endothelial cells 217 
was measured by colorimetric WST-1 assays (4-[3-(4-Iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-218 
1,3-benzene disulfonate) (cat. no. 05015944001; Roche Applied Science). 48 hours after transfection, 219 
10 µl WST-1 solution was added to culture medium in all wells and incubated for 2h at 37°C. 220 
Subsequently, absorbance was measured at 450 and 750 (background) nm. The WST-1 assay 221 
measures the number of viable cells. An increase in the number of viable cells indicates proliferation, 222 
a decrease of the number of viable cells indicates cell death (n=5).  223 
 224 
Gene expression microarray of transfected endothelial cells 225 
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To identify miRNAs targets in endothelial cells, total RNA was isolated from transfected 226 
endothelial cells and gene expression was evaluated by microarray. 227 
Gene expression microarray was performed with pooled samples from 6 independent 228 
experiments. Four pooled samples were tested: endothelial cells transfected with the control miRNA 229 
and endothelial cells transfected with the miR-574-5p, miR-1972 or miR-4793-3p mimics. Total RNA 230 
(100 ng) was labeled and hybridized to whole genome Genechip Human Gene 2.1 ST arrays coding 231 
25.088 genes and transcripts (Life Technologies, the Netherlands). For microarray quality control and 232 
data analysis please see the online Supplementary File. 233 
 234 
RT qPCR of potential miRNA targets 235 
To confirm the potential targets of the miRNAs identified by microarray, RT qPCR was used. 236 
Total RNA was reverse transcribed and RT qPCR was performed on a StepOnePlus™ Real-Time PCR 237 
System machine (Applied Biosystems). Relative expression levels were calculated by the 2-∆CT method 238 
and normalized against expression levels of 36B4. 239 
 240 
Statistics 241 
Please see the online Supplementary File. 242 





Patient characteristics 246 
All PE patients included were diagnosed with early-onset preeclampsia, i.e. they all delivered 247 
before 34 weeks of gestation. Since blood sampling of healthy pregnant women was matched for 248 
gestational age with the PE group, there were no differences in gestational age at sampling. There 249 
were also no differences in maternal age, parity and smoking between the pregnant groups (Table 1). 250 
However, the PE patients delivered earlier and the newborns weighed less compared to the healthy 251 
pregnant group (Table 1). The non-pregnant women did not differ in age or smoking from the 252 
pregnant groups (Table 1).  253 
  254 
Differences in microRNA concentrations 255 
No precursor (pre) miRNAs were significantly (fold change < -1.2 or > 1.2 with a false 256 
discovery rate < 0.05) increased in healthy pregnant compared to non-pregnant women. In PE, 26 257 
(pre-)miRNAs were detected in different concentrations compared to healthy pregnant women, 258 
which included an increase in concentrations of six precursor miRNAs and 19 miRNAs and the 259 
decrease in concentrations of one miRNA (Table 2).  260 
 261 
Validation of the three mostly increased microRNAs in PE by RT qPCR 262 
As a microarray may give false positive, we validated the array data with RT qPCR. Expression 263 
levels of the three miRNAs with the highest increase in concentrations (and a false discovery rate < 264 
0.01) in PE vs. healthy pregnant women (miR-574-5p, miR-1972, miR-4793-3p) were evaluated. For 265 
all three miRNAs, a significant linear correlation was found between array and RT qPCR data (Fig. 1A-266 
C). Concentrations of miR-574-5p (Fig. 1D) and miR-1972 (Fig. 1E) were increased compared to both 267 
healthy pregnancy and non-pregnant women. The miR-4793-3p concentrations were increased in 268 




MiR-1972 attenuates tube formation in vitro 271 
Endothelial cells were transfected with miRNA mimics to examine if the miRNAs, with the 272 
biggest change in preeclampsia vs. healthy pregnancy, affected endothelial cell function. Endothelial 273 
cell function was assessed by the tube formation assay (Fig. 2), which assesses the capability of the 274 
endothelial cells to form capillary-like structures. All transfected endothelial cells were able to form 275 
tubes (Fig. 2A). Transfection with miR-1972 significantly (p = 0.049) reduced the amount of loops 276 
formed as compared with the control. Transfection with miR-4793-3p tended (p = 0.068) to reduce 277 
the amount of loops formed as compared with the control, while miR-574-5p did not affect loop 278 
formation (Fig. 2B). No differences were detected in total tube length between the groups (Fig. 2C). 279 
The total branching points were significantly reduced after miR-1972 transfection as compared with 280 
control (p = 0.029) and tended to be reduced after miR-4793-3p transfection as compared with 281 
control (p = 0.085), while miR-574-5 did not affect the total branching points (Fig. 2D) 282 
 283 
MiR-574-5p negatively affects wound healing in vitro 284 
The wound healing assay was used to assess migration and/or proliferation of the 285 
endothelial cells. Therefore, a scratch was made in the wells with transfected endothelial cells and 286 
pictures were taken after 0, 4, 8, 12 and 24 h (Fig. 3A) to evaluate wound healing. Wound healing 287 
was quantified by measuring the percentage of wound closure in time (Fig. 3B). The area under the 288 
curve revealed that miR-574-5p overexpression in endothelial cells significantly reduced wound 289 
closure as compared with control (p = 0.031), while miR-4793-3p overexpression tended to reduce 290 
wound closure as compared with the control (p = 0.062)(Fig. 3C). MiR-1972 did not influence wound 291 
closure. 292 
 293 
MiR-574-5p and miR-4793-3p tend to decrease proliferation of endothelial cells in vitro 294 
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To further examine which factor, decreased proliferation or migration, was responsible for 295 
the reduced wound healing capacity after miR-574-5p transfection, a proliferation assay was 296 
performed. It appeared that miR-574-5p (p = 0.063) and miR-1927 (p = 0.063) tended to reduce 297 
proliferation of endothelial cells as compared with control endothelial cells, while miR-4793-3p did 298 
not affect proliferation in endothelial cells (Fig. 4). 299 
 300 
MiR-574-5p suppresses the proliferation marker MKI67  301 
To investigate which genes in endothelial cells are regulated by the three miRNAs, gene 302 
expression of transfected endothelial cells was evaluated by gene expression array and validated by 303 
RT qPCR. Array data of pooled samples of miR-574-5p transfected endothelial cells showed potential 304 
silencing (a decreased expression > 50%) of 1,034 genes (Supplementary Table 3). SLC31A1 was 305 
downregulated with the highest fold change (fold change = -12.95) and thus this gene was chosen for 306 
validation with RT qPCR in all samples. MKI67 (fold change = -1.51) was also chosen for validation 307 
with RT qPCR since MKI67 is a marker for cell proliferation. For validation, samples were not pooled, 308 
but individual samples were used. RT qPCR validated that miR-574-5p overexpression (n=5) 309 
significantly decreased the expression of SLC31A1 (p = 0.031) and tended to decrease the expression 310 
of MKI67 (p = 0.094) as compared with control endothelial cells (n=5) (Fig. 5). The pooled array data 311 
of miR-1972 (Supplementary Table 4) and miR-4793-3p (Supplementary Table 5) showed potential 312 
silencing of 812 and 840 genes, respectively. The mostly downregulated genes in both cases were 313 
RSAD2 (fold change miR-1972 = -8.33 and fold change miR-4792-3p = -10.20) and CXCL10 (fold 314 
change miR-1972 = -7.94 and fold change miR-4792-3p = -6.69). We validated these genes with RT 315 
qPCR on the individual samples. This RT qPCR revealed, however, that these were not significantly 316 
decreased as compared with the control sample (data not shown). The genes encoding ICAM-1, 317 
VCAM-1 or other pro-inflammatory factors were not altered in expression. It seems therefore that 318 
these miRNAs do not affect endothelial cell activation and we decided not to focus on genes involved 319 






Principal findings  324 
In this study we identified (pre-)miRNAs with different plasma concentrations in early-onset 325 
preeclamptic women as compared with healthy pregnant women. We demonstrated that 326 
preeclampsia is characterized by changes in plasma levels of 26 (pre-)miRNAs as compared with 327 
healthy pregnancy. Subsequently, we studied the influence of the three miRNAs which were 328 
increased with the highest fold change (and a false discovery rate < 0.01) in preeclampsia vs. healthy 329 
pregnancy on angiogenic function of endothelial cells. This was done by transfecting endothelial cells 330 
with miRNA mimics of these miRNAs followed by assays evaluating processes involved in 331 
angiogenesis, i.e. the a wound healing assay, a proliferation assay and a tube formation assay. We 332 
showed that miR-574-5p negatively affected wound healing and tended to reduce proliferation of 333 
endothelial cells in vitro. MiR-1972 negatively affected tube formation and also tended to reduce 334 
proliferation of endothelial cells in vitro. MiR-4793-3p tended to decrease tube formation and tended 335 
to negatively affect wound healing. Thus, the early-onset preeclampsia group in our study is 336 
characterized with differences in plasma miRNA concentrations as compared to healthy pregnancy. 337 
We demonstrated that increased miR-574-5p and miR-1972 showed anti-angiogenic affects.  338 
 339 
Comparison with existing literature 340 
Our study revealed differences in plasma levels of miRNAs in early-onset preeclamptic vs. 341 
healthy pregnant women, which is in line with various previous studies23–27. Details about these 342 
studies are presented in Table 3. We found that the concentrations of 26 (pre-)miRNAs were 343 
different in preeclampsia vs. healthy pregnancy, the miRNAs which were mostly increased in 344 
concentrations being miR-1972, miR-574-5p and miR-4793-3p. However, our study differs from other 345 
studies: For example, miR-1972 and miR-4793-3p were not mentioned in any of the other studies 346 
evaluating miRNA expression in preeclampsia vs. healthy pregnancy and which also performed 347 
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genome-wide miRNA profiling23,25–27. Differences between studies might be explained by differences 348 
in sample collection (serum instead of plasma)26,34, inclusion of early- or late-onset 349 
preeclampsia23,24,26, gestational age at sampling25,26, profiling methods25 and/or ethnicity of 350 
patients34,35. MiR-574-5p, which was increased in PE in our study, was also found to be increased 351 
during or before preeclampsia in two other studies23,24. The fact that we are the third study to link 352 
this specific miRNA with preeclampsia, may indicate an important role of miR-574-5p in the 353 
development and/or the pathogenesis of preeclampsia. There are several miRNAs predominantly 354 
expressed in the placenta, including miRNAs located at the chromosome 19 microRNA cluster 355 
(C19MC), C14MC and the miR-371-3 cluster36. The 26 (pre-)miRNAs did not include any members of 356 
the C19MC, C14MC or the miR-371-3 cluster. This does not automatically imply that the placenta was 357 
not the source of the miRNAs. However, the miRNA could also arise from other sources, such as 358 
activated immune cells or maybe even activated endothelial cells themselves. 359 
 360 
Overexpression of miR-574-5p in preeclampsia 361 
We found that overexpression of miR-574-5p in endothelial cells resulted in a decreased 362 
endothelial wound healing capacity, i.e. a decreased capacity of migration and/or proliferation of 363 
endothelial cells. The strength of the wound healing assay is that it actively measures cell activity in 364 
vitro. However, the specific factors involved (migration or proliferation) cannot be addressed. In our 365 
study, the decreased wound healing capacity is probably (partly) induced by decreased proliferation 366 
since subsequent experiments revealed that miR-574-5p overexpression tended to inhibit 367 
proliferation of endothelial cells in vitro. Inhibited migration of endothelial cells probably also plays 368 
an important role. Furthermore, we also found that miR-574-5p overexpression tended to decrease 369 
the expression of MKI67, which encodes the well-known proliferation marker Ki-6737. Our data of the 370 
effect of miR-574-5p on proliferation are in accordance with two other studies38,39. MiR-574-5p 371 
overexpression in our study significantly reduced the expression of SLC31A1. This gene encodes for a 372 
high affinity copper transporter in the cell membrane. Copper transport is essential for cell function, 373 
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including proliferation40. The decreased expression of SLC31A1 in our study might contribute to 374 
decreased proliferation of endothelial cells after miR-574-5p overexpression by limiting copper entry 375 
into the cells. Since both endothelial cell migration and proliferation are processes involved in 376 
angiogenesis29, this miR-574-5p has anti-angiogenic properties, and this miRNA may contribute to the 377 
anti-angiogenic environment in preeclampsia.  378 
 379 
Overexpression of miR-1972 in preeclampsia 380 
Overexpression of miR-1972 in endothelial cells resulted in attenuated tube formation and 381 
tended to reduce proliferation. The tube formation assay is a well-established in vitro model for 382 
formation of endothelial cell tubes, a process important in the angiogenic process28. Preeclampsia is 383 
characterized with increased levels of circulating anti-angiogenic factors like soluble fms-like tyrosine 384 
kinase 1 (sFlt-1)5 and soluble endoglin (sEng)41. Our data show that miR-1972, like miR574-5p, may 385 
also contribute to the anti-angiogenic environment in preeclampsia. However, as compared with 386 
miR574-5p, miR1972 seems to affect a different part of the angiogenic process, i.e. endothelial cell 387 
tube formation. Another study showed that overexpression of miR-1972 in chronic myelogenous 388 
leukemia cells inhibited cell division42. This might be in line with our results, since miR-1972 389 
overexpression also tended to reduce endothelial cell proliferation. Since to our knowledge no 390 
previous research mentioned miR-1972 in relation with preeclampsia, further research is necessary 391 
to determine the exact role of miR-1972 during preeclampsia. 392 
 393 
Overexpression of miR-4793-3p in preeclampsia 394 
The third miRNA, which was increased during preeclampsia vs. healthy pregnancy was miR-395 
4793-3p. Previous studies showed that miR-4793-3p concentrations were increased in un-ruptured 396 
cerebral aneurysm tissues43 and decreased in the circulation during chronic thromboembolic 397 
pulmonary hypertension44. However, on a functional level not much is known about this particular 398 
microRNA. In our study, miR-4793-3p overexpression in endothelial cells tended to reduce tube 399 
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formation and tended to negatively affect wound healing in vitro, suggesting that this miRNA may 400 
potentially reduce angiogenesis in preeclampsia 401 
 402 
Strengths and limitations 403 
We extended our observational study on plasma miRNAs in preeclampsia with a mechanistic 404 
study in which we pinpointed the effects of the increased plasma miRNAs in preeclampsia on 405 
endothelial cell function in vitro. Using various techniques, we demonstrated that preeclampsia-406 
specific miRNAs affected endothelial cell function, especially angiogenic function, in vitro. We note 407 
that the in vivo miRNA uptake mechanically differs from the in vitro transfection method used in this 408 
study. However, the transfection method, we used, is generally accepted45–47 to enable investigating 409 
the effect of increased concentrations of specific miRNAs on cells. Moreover, the observed cellular 410 
effects are biologically plausible in the context of preeclampsia. Although we included non-pregnant, 411 
pregnant and preeclamptic patients, our study was a relatively small study, with 10 individuals in 412 
each group. However, we included a relatively homogeneous group of preeclamptic women, which 413 
were all early onset and gestational age at sampling was perfectly matched with healthy pregnant 414 
women. 415 
 416 
Clinical implications 417 
The miRNAs which differed in concentrations during preeclampsia maybe modulators of 418 
endothelial function in preeclampsia. Our findings fit into the current understanding of the 419 
pathophysiology of preeclampsia. The poorly established placenta in early-onset preeclampsia 420 
produces many proinflammatory8 and anti-angiogenic factors (which may include the miRNAs found 421 
in our study)5,7 into the maternal circulation inducing generalized systemic inflammation9 and 422 
endothelial cell activation and dysfunction10,11. If the inflammatory cells or endothelial cells also 423 
produce the miRNAs identified in our study, then these miRNA may also target the endothelial cells, 424 
with anti-angiogenic effects.  425 
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If these microRNAs are already present early in pregnancy, these microRNAs may contribute 426 
to a better biomarker profile for early preeclampsia diagnostics. Existing circulating biomarkers 427 
profiles (including placental growth factor, sFlt-1 and sEng) are at the moment still limited for 428 
prediction of preeclampsia48 and would therefore benefit with additional early biomarkers.  429 
The miRNAs might also be interesting future targets for reducing endothelial dysfunction 430 
during preeclampsia. Endogenous miRNAs can for example be inhibited using synthetic antisense 431 
microRNAs which are complimentary to the endogenous miRNA49. At this moment the possibilities of 432 
such microRNA therapeutics are under extensive investigation and a small number of microRNA 433 
therapeutics are already at the stage of clinical trials49,50. 434 
 435 
Research implications 436 
Future research should demonstrate if the effects of the miRNAs on endothelial cell function 437 
in vitro also take place in vivo. This could first be tested in animal experiments, in which the effects of 438 
overexpression of the miRNA in animals could be tested. For example, transgenic mice could be 439 
developed to overexpress the miRNA of interest by incorporating a transgene51. To investigate the 440 
effect of the miRNA specifically in the endothelium, expression of the transgene could be made 441 
tissue specific (e.g. using the Cre-LoxP system)51. Furthermore, miRNA concentrations could be 442 
examined in preeclamptic animal models to detect if these miRNAs are also elevated in these 443 
models. If so, these animals could be treated to reduce these miRNA levels (by microRNA 444 




In conclusion, we demonstrated that early-onset preeclampsia is associated with changes in 449 
plasma miRNAs compared to healthy pregnancy. If this is also the case for late-onset preeclampsia, 450 
needs to be further investigated. Two of the most highly elevated miRNAs (miR-574-5p and miR-451 
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1972) significantly influenced endothelial angiogenic function in our in vitro assays. We postulate 452 
that, besides the well-established pathways contributing to this multifactorial disease (e.g. signaling 453 
of sFlt-1, VEGF, inflammatory cytokines such as TNFα and the renin-angiotensin system) miRNAs may 454 
also contribute to the pathogenesis of preeclampsia, by affecting endothelial angiogenic cell 455 
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Age (years) 27.6 ± 4.5 28.0 ± 4.4 31.5 ± 5.7 
Smoker (n) 0 (0%) 0 (0%) 1 (10%) 
Nulliparous (n)  NA 8 (80%) 8 (80%) 
Systolic blood 
pressure (mmHg) 
NA NR 168.0 ± 19.52 
Diastolic blood 
pressure (mmHg) 
NA NR 104.3 ± 10.72 
Urinary protein 
excretion (g/24h) 
NA NR 1.32 ± 1.71 
Gestational age at 
sampling (weeks) 
NA 29.8 ± 1.2 29.7 ± 2.8 
Gestational age at 
delivery (weeks) 
NA 40.3 ± 1.0 30.5 ± 2.6 *** 
Newborn weight (g) NA 3586 ± 291.6 1098 ± 368.0 *** 
Perinatal mortality (n)  NA 0 (0%) 1 (10%) 
Data are shown as mean ± SD or numbers (percentages). *** p < 0.0001 compared to healthy 601 
pregnancy  with unpaired t-statistics. NA = not applicable; NR = within normal ranges but not 602 










Table 2. Differentially expressed (precursor) miRNAs in early-onset preeclampsia vs. healthy 609 
pregnancy. 610 
 Fold change False Discovery Rate 
hsa-miR-1972_st 2.821007 1.58E-09 
hsa-miR-574-5p_st 2.327063 6.99E-06 
hsa-miR-1246_st 1.961194 0.048174 
hsa-miR-4793-3p_st 1.860032 7.95E-05 
hsa-miR-574-3p_st 1.761949 0.012838 
hsa-miR-4745-5p_st 1.719226 0.019111 
hsa-miR-4484_st 1.692787 0.036335 
hsa-miR-1290_st 1.683642 0.036335 
hsa-miR-1268_st 1.654545 0.012838 
hsa-miR-3665_st 1.641798 0.0241 
hsa-miR-4787-5p_st 1.600838 0.029235 
hsa-miR-4436b-5p_st 1.494193 0.009999 
hsa-miR-4440_st 1.431718 1.77E-05 
hsa-miR-1910_st 1.417769 0.012838 
hp_hsa-mir-1299_st 1.390918 3.13E-06 
hsa-miR-4767_st 1.382612 0.024187 
hsa-miR-1268b_st 1.366834 1.16E-05 
hsa-miR-1207-5p_st 1.326744 0.02257 
hp_hsa-mir-5095_st 1.303841 0.002187 
hp_hsa-mir-4730_st 1.2653 0.0003 
hsa-miR-4734_st 1.255385 0.040037 
hp_hsa-mir-550b-2_s_st 1.250968 0.003634 
hp_hsa-mir-4525_st 1.221849 0.003239 
hsa-miR-3935_st 1.221763 0.030878 
hp_hsa-mir-550b-1_s_st 1.206412 0.004849 
   
hsa-miR-548a-3p_st -1.32324 0.024187 




Table 3. Summary of studies investigating circulating miRNA concentrations before the onset of 613 
preeclampsia or during preeclampsia as compared to healthy pregnancy 614 







Matrix Type of 
preeclampsia 
Main results in 




























by RT qPCR 





























29a in mild PE 
and decreased 
miR-144 in both 
































PE and 8 
severe 
PE 











  616 
33 
 
Figure legends 617 
Figure 1. Validation of the miRNA microarray. Real time quantitative PCR (RT qPCR) was performed to 618 
validate the miRNA expression values of the array data. Expression values of the three miRNAs which 619 
were mostly increased in concentrations were evaluated and the correlation between array and RT 620 
qPCR data was determined by Pearson correlation (A-C). Additionally, relative expression values of 621 
the miRNAs by RT qPCR were compared between PE (n=10), Pr (n=10) and NPr (n=10) groups (D-F). 622 
PE = early-onset preeclampsia; Pr = healthy pregnant; NPr = non-pregnant women. Data are 623 
presented as scatterplots including all data points. * p < 0.05, ** p < 0.01, *** p < 0.001 by the Mann 624 
Whitney test.  625 
 626 
Figure 2. Tube formation was assessed of endothelial cells transfected with miRNA mimics. Light 627 
microscopy pictures were taken after 12 h. Tube formation was quantified in the amount of loops 628 
formed (A), the total tube length (B) and total branching points (C). N=5. Data are presented as 629 
scatterplots including all data points. * p < 0.05 as compared with the control determined by one-630 
sided Wilcoxon statistics. 631 
 632 
Figure 3. Wound healing was assessed of endothelial cells transfected with miRNA mimics. Light 633 
microscopy pictures were taken after 0, 4, 8, 12, and 24 h after the monolayer of cells had been 634 
scratched. Lines were drawn at the border of the scratch to clearly distinguish the wound area. 635 
Wound healing was quantified by the percentage of surface area closure (A) and the area under the 636 
curve (AUC) was calculated (B). N=5. Surface area closure is presented as median and interquartile 637 
range and the AUC is presented as a scatterplot including all data points. * p < 0.05 as compared with 638 
the control determined by one-sided Wilcoxon statistics. 639 
 640 
Figure 4. Proliferation was assessed of endothelial cells transfected with miRNA mimics by the WST-1 641 
assay.  642 
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N=5. Data are presented as scatterplots including all data points. Significance was determined by 643 
one-sided Wilcoxon statistics. 644 
 645 
Figure 5. Targets of miR-574-5p were examined by real time quantitative PCR. Relative gene 646 
expression of MKI67 (A) and SLC31A1 (B) in endothelial cells transfected with the miR-574-5p mimic 647 
were evaluated. N=5. Data are presented as scatterplots including all data points. * p < 0.05 as 648 
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Supplemental Materials and Methods 
 
Study design and rational 
In the first part of this study, plasma miRNA concentrations of early-onset preeclamptic 
patients are compared with plasma microRNA concentrations of healthy pregnant and non-pregnant 
women. This was done by miRNA microarray technologies. Three miRNAs with the highest fold 
change (fold change > 1.8) and with a false discovery rate < 0.01 in preeclamptic as compared to 
healthy pregnant plasma were validated by real-time quantitative PCR. These three miRNAs were 
also selected for further investigation in the second part of the study. 
 In the second part of the study we examined the effects of increasing the concentrations of 
the selected miRNAs in endothelial cells. To increase miRNA concentrations in endothelial cells, 
endothelial cells were transfected with miRNA mimics (chemically modified RNAs that mimic 
endogenous miRNAs). Subsequently, assays were performed to assess endothelial cell function in 
vitro. These assays include a tube formation assay, a wound healing assay and a proliferation assay. 
The tube formation assay is a well-established model for measuring formation of endothelial cell 
tubes, which is part of the angiogenesis process in vitro1. The other two assays also assess processes 
that are important for angiogenesis2. The wound healing assay assesses migration/proliferation of 
cells after insertion of a linear scratch in the cell monolayer3. The proliferation assay measures 
proliferation of the cells, by measuring metabolic activity of the transfected cells over time.  
 Since miRNAs functions by decreasing mRNA expression, in the last part of this study it was 
investigated if the miRNAs were able to indeed modify gene expression pattern in the transfected 
endothelial cells. To do so, mRNA expression of the endothelial cells was characterized by gene 
expression microarray and validated by real-time quantitative PCR.  
 
Patient recruitment and plasma collection 
The sample size of 10 subjects in each group was decided using power calculations described 
in the article of Liu et al4. Preeclampsia was defined according to the definition from the Practice 
Bulletin #203 “Chronic Hypertension in Pregnancy”: a systolic blood pressure of ≥ 140 mmHg or a 
diastolic blood pressure ≥ 90 mmHg on two or more occasions at least 4 h apart after 20 weeks of 
gestation in women with a previously normal blood pressure, and proteinuria ≥ 300 mg/24 h5. 
Samples included in this study were from early-onset preeclampsia, these women all delivered 
before week 34 of gestation and did no show comorbidities, such as autoimmune diseases (i.e. 
diabetes, antiphospholipid syndrome, SLE) or chronic hypertension. Non-pregnant women included 
were personnel at the UMCG, and healthy pregnant women were recruited from the midwifery 
antenatal clinics at the UMCG. PE patients were recruited from patients admitted in the UMCG. 
Blood was drawn from the antecubital vein into tubes containing EDTA (BD Biosciences). healthy 
pregnant women and PE were matched for gestational age at sampling. For non-pregnant women, 
samples were obtained within 10 days from the start of last menstruation. Within 1 h, samples were 
centrifuged at 4°C, 130 g for 10 min followed by 700 g for 10 min. Plasma was stored at -80°C until 
further use. The medical ethical committee of the UMCG approved this study, and informed consent 
was signed by all participants. 
 
RNA isolation 
Total RNA was isolated from the plasma samples with TRIzol reagent (Invitrogen), followed 
by RNA purification with the miRNeasy Serum/plasma kit (Qiagen) according to manufacturer’s 




Total RNA (1 µg) was labelled with the use of the Affymetrix FlashTag Biotin HSR RNA 
Labeling kit (P/N 901911, Affymetrix) and hybridized to miRNA 3.1 arrays targeting 3,391 human 
(precursor) microRNAs ((pre-)miRNAs) (P/N 90215, Affymetrix). The miRNAs targeted by this array 
were all (precursor) miRNAs known at that moment (100% miRBase v17 coverage). Sample labelling, 
hybridization to chips and image scanning was performed according to the manufacturer's 
instructions (for detailed protocols: Affymetrix FlashTag Biotin HSR RNA Labeling Kit User Manual 
(P/N 703095, Revision 2)). 
 Before statistical analysis, the quality of the datasets obtained from the scanned Affymetrix 
arrays was determined. Quality control of the data was performed using Bioconductor packages6 
integrated in an on-line pipeline7. Various advanced quality metrics, diagnostic plots, pseudo-images 
and classification methods were applied8. Background correction, normalization and summation of 
the miRNA arrays was performed as described before9 with minor modifications. In brief: background 
was corrected by a robust normal-exponential convolution model that takes into account the 
intensities of the negative control probes present on the array. This was followed by weighted cyclic 
loss normalization for all probes. To this end, all control probes (except the negative controls) were 
assigned weight 100, and all other probes, including those detecting (pre-)miRNAs, 5.8 rRNA and 
small nucleolar RNAs (including small Cajal body-specific RNAs and C/D box and H/ACA box small 
RNAs) were attributed a weight of 0.001. Finally, probes were summarized into probe set expression 
estimates9. 
 
MicroRNA array data analysis 
The differentially expressed probe sets were identified using linear models, applying 
moderated t-statistics that implemented intensity-dependent empirical Bayes regularization of 
standard errors10,11. The moderated t-test statistic has the same interpretation as an ordinary t-test 
statistic, except that the standard errors have been moderated across genes, i.e. shrunk to an 
intensity-dependent common value, using a Bayesian model. P-values were corrected for multiple 
testing using a false discovery rate method12. Probe sets with a fold change of > 1.2 or < -1.2 and a 
false discovery rate < 0.05 were considered significantly different. For further analysis, the miRNAs 
with the highest fold change (fold change > 1.8 with a false discovery rate < 0.01) in PE vs. healthy 
pregnant women were chosen (miR-574-5p, miR-1972 and miR-4793-3p).  
 
MicroRNA array validation by real-time quantitative PCR 
Validation of the array was done by real-time quantitative PCR (RT qPCR) using miRNAs 
which were found to change with the highest fold change and with tha false discovery rate < 0.01 in 
preeclampsia (miR-574-5p, miR-1972 and miR-4793-3p). From total RNA, which was also used on the 
miRNA array, cDNA was prepared with the TaqMan Advanced miRNA cDNA synthesis Kit (Applied 
Biosystems) following manufacturer’s instructions. To measure miRNA expression, TaqMan advanced 
miRNA assays (Applied Biosystems) were used (Supplementary Table 1). RT qPCR was performed 
using 2.5 µL of 10x diluted cDNA, 2 µL RNase-free water, 0.5 µL TaqMan Advanced miRNA assay, and 
5 µL TaqMan Fast Advanced Master Mix (Applied Biosystems). Samples were run in triplicates on a 
StepOnePlus™ Real-Time PCR System machine (Applied Biosystems) with the following protocol: 20 s 
95°C, followed by 40 cycles of 3 s 95°C and 30 s 60°C. Relative expression levels were calculated by 
the 2-∆CT method and normalized against expression levels of the relatively stable endogenous control 
hsa-miR-191-5p. 
 
Human umbilical vein endothelial cell culturing  
Isolation of human umbilical vein endothelial cells was performed in the endothelial cell 
facility of the UMCG using umbilical veins from term pregnancies without complications (such as 
autoimmune diseases, preeclampsia and intra uterine growth restriction) and cells were pooled from 
at least 2 donors and cultured as described before13. The cells were cultured on 1% gelatin coated 
flasks at 37°C, 5% CO2 in endothelial cell medium (ECM). ECM consisted of RPMI 1640 (Lonza) 
supplemented with 20% heat inactivated fetal calf serum (Sigma), 2 mM L-glutamine (Lonza), 1% 
gentamicin (Lonza), 5 U/mL heparin (Leo Pharma), and 50 µg/mL endothelial cell growth factors 
supplement extracted from bovine brain (which was prepared using the method of Maciag et al.14). 
endothelial cells were used at passage 3. 
 
Transfection of endothelial cells with miRNA mimics 
50% confluent endothelial cells (passage 3) were transfected with mirVana miRNA mimics 
(miR-574-5p, miR-1972 or miR-4793-3p) or the mirVana miRNA mimic negative control #1 (Ambion) 
in 12-wells and 96-wells plates. Transfected endothelial cells in 12-wells plates were used for the 
tube formation assays,  the wound healing assays and RNA isolation, and transfected endothelial 
cells in 96-wells plates were used for the proliferation assays.  
For 12-wells plates: 9 µL Lipofectamine RNAiMAX transfection reagent (Invitrogen) was 
diluted in 150 µL Opti-MEM Medium (Life Technologies) and 30 pmol miRNA mimic was diluted in 
150 µL Opti-MEM medium. The two solutions were mixed and incubated for 5 min. Then, 100 µL 
miRNA-lipid mixture was added (dropwise) to each well. Cells were incubated for 48 hours at 37°C, 
5% CO2. 
For 96-wells plates: 1.5 µL Lipofectamine was diluted in 25 µL Opti-MEM medium and 5 pmol 
miRNA mimic was diluted in 25 µL Opti-MEM medium. The two solutions were mixed and incubated 
for 5 min. Then, 10 µL miRNA-lipid mixture was added to each well. Cells were incubated for 48 hours 
at 37°C, 5% CO2.  
  
Tube formation assay 
The tube formation assay is a well-established model for measuring tube formation, i.e. the 
ability of the endothelial cells to form capillary-like structures in vitro. This is part of the angiogenic 
process1. Matrigel basement membrane matrix (Corning) was defrosted at 4°C overnight. 10 µL of 
matrigel was pipetted with precooled pipet tips into the inner wells of the µ-Slide Angiogenesis 
(Ibidi). Slides were incubated for 45 min at 37°C. The transfected endothelial cells were collected 
after 48 h of incubation following trypsin (Gibco) treatment. 10,000 endothelial cells dissolved in 50 
µL ECM were seeded into each well of the µ-Slide Angiogenesis on top of the matrigel. After 12h of 
incubation at 37°C, 5% CO2, pictures were taken with the Leica MC120 HD (Leica Microsystems). Tube 
formation was quantified as total amount of loops (i.e. numbers of capillaries formed), total tube 
length (length of the capillaries) and total branching points (number of interconnections between the 
tubules, which gives information on how endothelial cells organize themselves) by using Wimasis, 
2017 (n=5). (WimTube: Tube Formation Assay Image Analysis Solution. Release 4.0. Available from: 
https://www.wimasis.com/en/products/13/WimTube). 
 
Wound healing assay 
Endothelial cell migration and/or proliferation potential was assessed by the wound healing 
assay of the transfected endothelial cells in a 12-wells plate. A linear scratch was made using a sterile 
200 µL pipet tip. The wells were washed twice with PBS to remove debris followed by ECM 
replacement. The microscope was used to confirm scratches were comparable in all groups and wells 
did not contain cell debris. Pictures were taken with the Leica MC120 HD (Leica Microsystems) of the 
same area of the scratch after 0, 4, 8, 12, and 24 h of incubation at 37°C, 5% CO2. To measure how 
long it takes to close the wound, the surface area of the scratch was measured using ImageJ (n=5). 
 
WST-1 assay for cell proliferation 
Since the wound healing assay evaluates both migration and proliferation, but does not allow 
discrimination between these processes, we also performed a proliferation assay, which 
specificallymeasures proliferation of the cells. To do so, the metabolic activity of transfected 
endothelial cells was measured by colorimetric WST-1 assays (4-[3-(4-Iodophenyl)-2-(4-nitrophenyl)-
2H-5-tetrazolio]-1,3-benzene disulfonate) (cat. no. 05015944001; Roche Applied Science). 50% 
confluent endothelial cells in a 96-wells plate were transfected in triplicates as described above. 48 
hours after transfection, 10 µl WST-1 solution was added to culture medium in all wells. As a blank, 
culture medium (without cells) was incubated with WST-1 solution. The samples were incubated for 
2h at 37°C. Subsequently, the plate was thoroughly shaken for 1 min and absorbance was measured 
at 450 and 750 (background) nm. The WST-1 assay measures the number of viable cells. An increase 
in the number of viable cells indicates proliferation, a decrease of the number of viable cells indicates 
cell death. This was calculated with the use of the following formula: (Absorbance 450 nm – 
Absorbance 750)/(Absorbance control 450 nm – Absorbance control 750 nm)*100. N=5 
 
RNA isolation and gene expression microarray of transfected endothelial cells 
To identify miRNAs targets in endothelial cells, total RNA was isolated from transfected 
endothelial cells and gene expression was evaluated by microarray. Total RNA was isolated with the 
use of AllPrep DNA/RNA Mini Kit (Qiagen) according to manufacturer’s instructions. RNA quality was 
assessed using RNA 6000 nanochips on the Agilent 2100 bioanalyzer (Agilent Technologies, 
Amstelveen, the Netherlands). 
Gene expression microarray was performed with pooled samples from 6 independent 
experiments. Four pooled samples were tested: endothelial cells transfected with the control miRNA 
and endothelial cells transfected with the miR-574-5p, miR-1972 or miR-4793-3p mimics. Total RNA 
(100 ng) was labelled using an Affymetrix WT plus reagent kit and hybridized to whole genome 
Genechip Human Gene 2.1 ST arrays coding 25.088 genes and transcripts, (Life Technologies, the 
Netherlands). Sample labelling, hybridization to chips and image scanning was performed according 
manufacturer's instructions. Microarray analysis was performed using MADMAX pipeline for 
statistical analysis of microarray data6. Quality control was performed and all arrays met our criteria. 
For further analysis a custom annotation was used based on reorganized oligonucleotide probes, 
which combines all individual probes for a gene15. Expression values were calculated using robust 
multichip average (RMA) method, which includes quantile normalisation16. Since the array was 
performed with one pooled sample per group, no further statistics were performed. 
 
RT qPCR of potential miRNA targets 
To confirm the potential targets of the miRNAs identified by microarray, RT qPCR was used. 
Total RNA (up to 1 µg in 10 µL) was reverse transcribed using M-MLV Reverse Transcriptase 
(Invitrogen) and random nonamers (Sigma), following manufacturer’s instructions. cDNA was diluted 
1:10 and stored at -20°C until further use. RT qPCR was performed using 2 µL cDNA, 5 µL PowerUpTM 
SYBRTM Green Master Mix (Life Technologies), 0.125 µL µL (10 µM) forward and reverse primer mix, 
and 2.875 µL RNAse free water. Samples were run in triplicates on a StepOnePlus™ Real-Time PCR 
System machine (Applied Biosystems) with the following protocol: 2 min 50°C, 2 min 95°C, followed 
by 40 cycles of 3 sec 95°C, 30 sec 60°C. Primers (Invitrogen) were designed using Primer3 and BLAST 
(Supplementary Table 2). Relative expression levels were calculated by the 2-∆CT method and 
normalized against expression levels of 36B4. 
 
Statistics 
The data were analyzed with Graphpad Prism 5.0. Normality of the data was examined by 
the D’Agostino-Pearson normality test. Patient information analysis of continuous variables are 
presented as mean ± SD and significance was determined by unpaired t-statistics, and analysis of 
categorical variables were presented as numbers (percentages) and significance was determined by 
chi-square and Fisher’s exact test. Correlations between microRNA array and RT qPCR expression 
values were determined by Pearson correlation. RT qPCR data of microRNA array data validation are 
presented as scatterplots including all data points and significance was determined by the one-tailed 
Mann Whitney test. Tube formation, the AUC of the wound healing, WST-1 and RT qPCR data of 
transfected endothelial cells are presented as scatterplots including all data points and significance 
was determined by one-tailed Wilcoxon statistics. P < 0.05 was considered significant and p < 0.1 was 




1.  Khoo CP, Micklem K, Watt SM. A comparison of methods for quantifying angiogenesis in the 
Matrigel assay in vitro. Tissue Eng Part C Methods. 2011;17(9):895-906. 
doi:10.1089/ten.TEC.2011.0150 
2.  Norton K-A, Popel AS. Effects of endothelial cell proliferation and migration rates in a 
computational model of sprouting angiogenesis. Sci Rep. 2016;6:36992. 
doi:10.1038/srep36992 
3.  Jonkman JEN, Cathcart JA, Xu F, et al. An introduction to the wound healing assay using live-
cell microscopy. Cell Adh Migr. 2014;8(5):440-451. doi:10.4161/cam.36224 
4.  Liu P, Hwang JTG. Quick calculation for sample size while controlling false discovery rate with 
application to microarray analysis. Bioinformatics. 2007;23(6):739-746. 
doi:10.1093/bioinformatics/btl664 
5.  ACOG Practice Bulletin No. 203. Obstet Gynecol. 2019;133(1):e26-e50. 
doi:10.1097/AOG.0000000000003020 
6.  Lin K, Kools H, de Groot PJ, et al. MADMAX - Management and analysis database for multiple 
~omics experiments. J Integr Bioinform. 2011;8(2):160. doi:10.2390/biecoll-jib-2011-160 
7.  Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for 
computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi:10.1186/gb-
2004-5-10-r80 
8.  Brettschneider J, Collin F, Bolstad BM, Speed TP. Quality Assessment for Short Oligonucleotide 
Microarray Data. Technometrics. 2008;50(3):241-264. doi:10.1198/004017008000000334 
9.  Wu D, Hu Y, Tong S, Williams BRG, Smyth GK, Gantier MP. The use of miRNA microarrays for 
the analysis of cancer samples with global miRNA decrease. RNA. 2013;19(7):876-888. 
doi:10.1261/rna.035055.112 
10.  Smyth GK. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in 
Microarray Experiments. Stat Appl Genet Mol Biol. 2004;3(1):1-25. doi:10.2202/1544-
6115.1027 
11.  Sartor MA, Tomlinson CR, Wesselkamper SC, Sivaganesan S, Leikauf GD, Medvedovic M. 
Intensity-based hierarchical Bayes method improves testing for differentially expressed genes 
in microarray experiments. BMC Bioinformatics. 2006;7(1):538. doi:10.1186/1471-2105-7-538 
12.  Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S 
A. 2003;100(16):9440-9445. doi:10.1073/pnas.1530509100 
13.  Donker RB, Ásgeirsdóttir SA, Gerbens F, et al. Plasma Factors in Severe Early-Onset 
Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro. J Soc Gynecol 
Investig. 2005;12(2):98-106. doi:10.1016/j.jsgi.2004.10.014 
14.  Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from 
bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci U S A. 
1979;76(11):5674-5678. http://www.ncbi.nlm.nih.gov/pubmed/293671. Accessed April 20, 
2018. 
15.  Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the 
interpretation of GeneChip data. Nucleic Acids Res. 2005;33(20):e175. doi:10.1093/nar/gni179 
16.  Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for 
high density oligonucleotide array data based on variance and bias. Bioinformatics. 
2003;19(2):185-193. 
 
Supplementary Tables 1 and 2 
 
Early-onset preeclampsia, plasma microRNAs and endothelial cell function 
 
Simone V. LIP, MSc, Mark V. BOEKSCHOTEN, PhD, Guido J. HOOIVELD, PhD, Mariëlle G. VAN PAMPUS, 
MD, PhD, Sicco A. SCHERJON, MD, PhD, Torsten PLÖSCH, PhD, Marijke M. FAAS, PhD 
 
 
Supplementary Table 1. TaqMan Advanced miRNA assays (Applied Biosystems) 






Supplementary Table 2. RT qPCR Primers 
 Forward primer Reverse primer 
36B4 GCTTCATTGTGGGAGCAGACA CATGGTGTTCTTGCCCATCAG 
MKI67 GACTTTGGGTGCGACTTGAC ACAACTCTTCCACTGGGACG 
SLC31A1 ACCATCACCCAACCACTTCA AAAAGCTCCAGCCATTTCTCC 
 
 
Supplementary tables 3 through 5 
 
Early-onset preeclampsia, plasma microRNAs and endothelial cell function 
 
Simone V. LIP, MSc, Mark V. BOEKSCHOTEN, PhD, Guido J. HOOIVELD, PhD, Mariëlle G. VAN PAMPUS, MD, PhD, Sicco A. SCHERJON, MD, PhD, Torsten PLÖSCH, PhD, Marijke M. FAAS, PhD 
 
Supplementary table 3     
 
Supplementary table 4     
 
Supplementary table 5     
Gene Control miR-574-5p Fold change 
 
Gene Control miR-1972 Fold change 
 
Gene Control miR-4792-3p Fold change 
SLC31A1 899.49823 69.45847676 -12.95015766 
 
RSAD2 87.232357 10.4733628 -8.328973071 
 
RSAD2 87.232357 8.556116505 -10.1953213 
DCAKD 461.58199 55.04372557 -8.385733146 
 
CXCL10 76.013852 9.56796814 -7.944618026 
 
CXCL10 76.013852 11.35855176 -6.692213393 
GLYR1 1078.3701 128.8975559 -8.366101782 
 
PPP3CB-AS1 27.810221 4.47922747 -6.208709294 
 
IFI44L 181.84091 30.31751532 -5.997882856 
BMP4 1630.8149 205.2963157 -7.943712687 
 
MIR548AL 18.951217 3.05522005 -6.202897499 
 
MX2 37.871554 6.366703933 -5.948376854 
SIGMAR1 1504.1313 198.3874051 -7.581788087 
 
MIR1254-1 17.193305 2.90227128 -5.924085987 
 
OASL 48.895642 9.63893179 -5.072724127 
PORCN 203.22358 27.05365032 -7.511872677 
 
IFI44L 181.84091 33.0556447 -5.501054569 
 
LOC100996713 11.926805 2.372280512 -5.027569257 
ESCO2 193.07599 28.71375495 -6.72416365 
 
LOC100506113 17.535078 3.31088732 -5.296186942 
 
MX1 334.73261 69.03828458 -4.848507118 
KIAA0895L 115.04248 17.413865 -6.606372771 
 
OR4N2 15.507999 2.96043059 -5.238426825 
 
IFIT1 29.641818 6.669024176 -4.444700961 
MIR4653 27.636899 4.192818114 -6.591485368 
 
MX2 37.871554 8.17292792 -4.633780534 
 
RRN3P2 16.248763 4.148192414 -3.917070598 
MCM8 417.68586 65.52715183 -6.374241035 
 
MX1 334.73261 79.6641826 -4.20179563 
 
OR4N2 15.507999 4.067342069 -3.812809144 
CALCOCO1 145.69318 25.47558657 -5.718933239 
 
IFIT1 29.641818 7.08253608 -4.185198331 
 
GOLGA8R 24.619413 6.57016392 -3.747153549 
ZNF774 44.77574 8.104864742 -5.524551172 
 
IGHV3-16 24.882514 6.10911403 -4.073015118 
 
LOC101928160 14.153222 3.80042909 -3.724111605 
SCARA3 316.09452 61.64403208 -5.127739151 
 
SLC22A1 106.34636 26.8411744 -3.962060516 
 
PRRX2 31.033179 8.764420814 -3.540813443 
EHD3 68.983271 13.55810492 -5.087972969 
 
HS3ST2 28.864616 7.48206536 -3.857840634 
 
EPSTI1 27.372585 7.746830566 -3.533391515 
XRCC1 560.68105 110.4487965 -5.076388929 
 
NA 14.532512 3.82406615 -3.800277323 
 
CGB1 16.057483 4.568679989 -3.514687717 
SNX2 882.44662 176.2003376 -5.008200505 
 
GOLGA6A 25.396446 6.80025542 -3.734631127 
 
IFITM1 611.07204 184.8602771 -3.305588686 
LHFP 295.09312 61.71754131 -4.781349235 
 
LINC01260 9.4270466 2.53968394 -3.711897537 
 
FAM47B 15.210835 4.651187936 -3.270311809 
MIR3127 15.376813 3.234001074 -4.754733494 
 
PPIAL4C 9.0359666 2.44901409 -3.689634382 
 
SLC22A1 106.34636 32.78994514 -3.243261213 
OR4N2 15.507999 3.271322692 -4.740589814 
 
RAET1G 27.577317 7.79961655 -3.535727312 
 
FDPSP2 11.420594 3.571584422 -3.197626855 
LOC101927093 12.016116 2.674727534 -4.492463551 
 
LOC400743 26.780546 7.58494542 -3.530750054 
 
LOC101927762 22.714008 7.152978454 -3.175461509 
CTSD 2175.8256 493.9523125 -4.404930517 
 
NA 10.814676 3.18423614 -3.396317061 
 
NA 21.947702 7.024515415 -3.124443521 
TRIOBP 55.070719 12.50717907 -4.403128704 
 
OAS2 95.583231 28.6991887 -3.330520304 
 
KRTAP20-2 29.285164 9.407116652 -3.113086108 
CLEC18B 34.608425 7.935935743 -4.36097598 
 
PRAMEF7 13.846143 4.16422751 -3.325020854 
 
NA 15.617896 5.050272526 -3.092485837 
Supplementary table 3     
 
Supplementary table 4     
 
Supplementary table 5     
Gene Control miR-574-5p Fold change 
 
Gene Control miR-1972 Fold change 
 
Gene Control miR-4792-3p Fold change 
NCK2 506.24467 117.1353184 -4.321878944 
 
LOC101927762 22.714008 6.83984866 -3.320834842 
 
RSPH10B 7.4606891 2.422810944 -3.079352568 
TMEM150C 57.003504 13.34414954 -4.271797452 
 
SNRPE 16.478113 4.96397653 -3.319538801 
 
TRAF1 220.12821 71.59448765 -3.074653024 
SPTLC3 36.287062 8.585133369 -4.226732474 
 
OAS1 156.23063 48.7231262 -3.206498467 
 
LOC100506113 17.535078 5.734615504 -3.057760054 
SNAI2 65.446929 15.50225602 -4.221768021 
 
EPSTI1 27.372585 8.56251927 -3.1967911 
 
VTRNA2-1 31.880586 10.43953574 -3.05383176 
FAM117B 322.83775 78.81760835 -4.096010456 
 
IFITM1 611.07204 191.233018 -3.195431656 
 
LOC101928716 13.791835 4.52391271 -3.048651785 
SLC43A3 1533.7455 382.6967687 -4.007730544 
 
LOC101927093 12.016116 3.85417925 -3.117684772 
 
IFI6 738.78338 244.1768013 -3.025608405 
EDA2R 132.49263 33.50626944 -3.954263808 
 
LOC101928219 12.797946 4.10758559 -3.115685838 
 
TRBV7-6 18.564897 6.162802398 -3.012411565 
PPP1R16B 505.55973 131.8694098 -3.833790816 
 
LOC286297 18.557671 5.9886268 -3.098819131 
 
IFIT3 69.103881 23.01589632 -3.002441437 
RAET1G 27.577317 7.376570217 -3.738501289 
 
IL12A 13.322684 4.36347451 -3.053228444 
 
OAS2 95.583231 32.34486893 -2.955128085 
LOC101929380 12.992967 3.508208088 -3.703590714 
 
LOC101927751 38.62771 12.689797 -3.043997494 
 
MRGPRD 23.46354 7.96204312 -2.946924448 
ZSWIM1 76.957672 21.05383646 -3.655280237 
 
DEFB4B 9.423337 3.12702978 -3.013510473 
 
PSG4 11.156337 3.786009139 -2.946727479 
HPS3 765.60496 211.2813123 -3.623628397 
 
NA 21.947702 7.31334771 -3.001047201 
 
MIR548AL 18.951217 6.47672684 -2.926048493 
NA 15.617896 4.349743407 -3.590532774 
 
LOC100288798 23.588847 7.86617374 -2.998770204 
 
SPX 53.909972 18.77317317 -2.871649425 
SERPINB9P1 138.37636 39.64631799 -3.490270071 
 
FAM47B 15.210835 5.07619927 -2.996500733 
 
NA 14.532512 5.06139225 -2.871247899 
PTPLAD1 1488.6247 428.9483349 -3.470405489 
 
LOC101929236 27.750622 9.36962962 -2.961762989 
 
TTTY20 11.532613 4.096326454 -2.815354852 
LOC101928160 14.153222 4.093040962 -3.457874527 
 
FCN2 7.0788299 2.43301978 -2.9094831 
 
CCL20 550.19478 199.4021336 -2.759222146 
NA 21.947702 6.428630225 -3.414055702 
 
IFI6 738.78338 257.257814 -2.871762649 
 
LOC100506217 14.174572 5.238748097 -2.705717431 
BTN3A3 10.992588 3.231265398 -3.401945233 
 
MIR4689 15.271899 5.35900587 -2.849763434 
 
LINC00937 14.096305 5.25277164 -2.683593721 
EFNB1 210.44441 61.86728806 -3.401545718 
 
OASL 48.895642 17.2516165 -2.834264366 
 
SPATA31C1 15.987191 5.990012838 -2.668974427 
MIR486-1 26.263357 7.732655566 -3.396421364 
 
MFI2 32.289194 11.4614748 -2.817193682 
 
LOC645513 21.94902 8.228457757 -2.667452441 
ZNF449 77.667366 22.95056775 -3.384115253 
 
LOC101927614 28.168854 10.3139568 -2.731139477 
 
REG1A 7.1451142 2.683534409 -2.662575947 
FAM47B 15.210835 4.506569428 -3.375258071 
 
IFIT3 69.103881 25.3052095 -2.73081639 
 
LOC101928859 10.40721 3.914013283 -2.658961407 
FAM86C1 71.744202 21.28216871 -3.371094515 
 
BMP8B 11.195419 4.12330367 -2.715157647 
 
LOC389705 11.593037 4.373967738 -2.650462368 
MIR1238 22.187246 6.668705734 -3.327069313 
 
TRBV7-6 18.564897 6.89653195 -2.691917813 
 
HS3ST2 28.864616 10.90031459 -2.648053459 
TRBV7-6 18.564897 5.594803746 -3.318239219 
 
FAM106B 45.828554 17.1468881 -2.672703834 
 
PYGM 13.541365 5.13659898 -2.636251206 
PTTG1 50.47561 15.23519831 -3.313091759 
 
AKR7A2 41.303951 15.5124341 -2.662635075 
 
LOC101927300 13.206683 5.03964344 -2.62055896 
KLF7 794.41648 244.577569 -3.248116663 
 
LOC254896 51.921316 19.5662682 -2.653613621 
 
LOC101927144 11.880177 4.571753657 -2.598604028 
SKA2 80.570813 25.42606769 -3.168827137 
 
RSPH10B 7.4606891 2.81673287 -2.648703105 
 
RAB3IL1 79.178687 30.48705529 -2.597124788 
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Gene Control miR-1972 Fold change 
 
Gene Control miR-4792-3p Fold change 
LOC400743 26.780546 8.532649199 -3.138596915 
 
ALPP 9.8710223 3.74173012 -2.638090396 
 
LINC01491 8.4059163 3.242125567 -2.592717682 
MIR548AL 18.951217 6.095993045 -3.108798956 
 
MIR519A1 7.9139383 3.00015261 -2.637845253 
 
UGT2A1 8.3758392 3.233123057 -2.590634219 
LINC00937 14.096305 4.611086836 -3.057046092 
 
CSRP2BP 17.688123 6.71994044 -2.632184505 
 
LINC01260 9.4270466 3.641924529 -2.588479386 
UBLCP1 608.9842 200.1592195 -3.042498873 
 
LINC01180 10.114726 3.8611913 -2.619586873 
 
OAS1 156.23063 60.78200405 -2.570343505 
KRTAP20-2 29.285164 9.798382446 -2.988775374 
 
POM121L10P 22.869521 8.75178993 -2.613125047 
 
LINC01180 10.114726 3.946072876 -2.563238532 
MYZAP 33.903223 11.38710451 -2.977334834 
 
HIST1H2BH 22.896161 8.84449647 -2.588746658 
 
CTC-338M12.4 37.366622 14.65615633 -2.549551254 
HAGLR 47.807018 16.10406336 -2.968630757 
 
TCEB3CL2 15.498478 6.0149609 -2.576654838 
 
MIR3163 24.962528 9.820578689 -2.541859216 
ANG 77.250331 26.07516135 -2.962602219 
 
CLEC18B 34.608425 13.4878136 -2.565903278 
 
CCL5 48.886391 19.3307745 -2.528941138 
OR10S1 10.080532 3.409606714 -2.956508735 
 
C8orf88 26.138486 10.2967997 -2.538505856 
 
CSF2 24.659026 9.754471078 -2.52797164 
LCE3B 29.609679 10.05948094 -2.943459912 
 
MAGEA4 10.062814 3.98288013 -2.526516947 
 
LOC101927614 28.168854 11.15204931 -2.525890415 
RPL23AP7 10.111639 3.441351147 -2.938275955 
 
IFNA4 6.7784289 2.68473112 -2.524807346 
 
LOC101929380 12.992967 5.172236065 -2.512059916 
HOXA2 51.407804 17.65206883 -2.912282122 
 
ZNF324 23.956015 9.51219591 -2.518452681 
 
NA 15.493125 6.196815862 -2.500175222 
NA 77.459186 26.92001183 -2.877383062 
 
LOC100289061 34.271702 13.6148896 -2.517222153 
 
ALG10B 11.202913 4.484961776 -2.497883686 
GSTM2 12.356682 4.305218494 -2.870163643 
 
ZP3 15.782153 6.35708632 -2.48260801 
 
BOLA3-AS1 42.085855 16.85882224 -2.496369825 
LINC01260 9.4270466 3.314637454 -2.844065664 
 
LOC101928716 13.791835 5.56878391 -2.476633098 
 
LINC00702 36.317201 14.55117281 -2.495826384 
AQP1 28.656526 10.14265431 -2.82534782 
 
ZNF90 38.766252 15.6637141 -2.474908054 
 
MIR486-1 26.263357 10.53246907 -2.493561234 
LOC101929432 13.784772 4.891967184 -2.817838175 
 
ZNF506 10.630432 4.32971433 -2.455227185 
 
MYHAS 13.270634 5.362987117 -2.47448561 
MIR520F 9.5227824 3.402136435 -2.799059539 
 
SNORD115-24 8.0006711 3.26052291 -2.453800001 
 
SRP54-AS1 19.60325 7.946566041 -2.466883221 
LOC100288798 23.588847 8.537143173 -2.763084438 
 
IGKV3D-11 9.6125009 3.938251 -2.440804543 
 
LOC100996671 7.4291028 3.021553118 -2.458703351 
RPS10 28.597101 10.53143614 -2.715403707 
 
C8orf31 12.22449 5.04858295 -2.421370616 
 
KRT33B 9.7461771 3.972692468 -2.453292607 
FAXDC2 108.79567 40.06746878 -2.715311664 
 
ATP1A3 13.273697 5.50810277 -2.409849212 
 
LOC101926893 8.6738539 3.538372512 -2.451368201 
GOLGA6A 25.396446 9.390491847 -2.704485129 
 
FOS 36.085853 14.9797056 -2.408982816 
 
KCNK15 8.1159598 3.320847684 -2.443942211 
MARCH3 707.35591 262.330525 -2.69643005 
 
PYGM 13.541365 5.63276117 -2.404036821 
 
EBI3 22.105568 9.06051256 -2.439770189 
LINC01197 206.29273 76.72874826 -2.688597596 
 
LOC101929463 9.9281657 4.1376526 -2.399468177 
 
CCDC144CP 12.791317 5.246921821 -2.4378707 
SLC10A5 14.215453 5.295706027 -2.684335682 
 
TRAJ59 12.598117 5.25077756 -2.399286058 
 
LOC101927307 11.172323 4.583127807 -2.437707131 
LOC101928859 10.40721 3.87708654 -2.684286296 
 
LOC100507334 14.335607 5.9986639 -2.389800065 
 
C2orf70 18.304238 7.510438829 -2.43717295 
GPBP1L1 381.74035 142.5044375 -2.678796247 
 
MIR4292 16.460554 6.93373041 -2.37398246 
 
CNR1 20.289823 8.366271914 -2.425192906 
CAMK2N1 158.13998 59.27865739 -2.667738963 
 
MIR4674HG 17.479948 7.43246062 -2.351838592 
 
CTU1 40.877987 16.86416519 -2.423955591 
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FGFRL1 87.340343 32.76716725 -2.665483467 
 
NA 13.477512 5.73097703 -2.351695341 
 
LOC101927093 12.016116 4.982594548 -2.411618252 
OSBPL9 812.54631 305.0994924 -2.663217515 
 
WNT7A 15.447567 6.5959604 -2.341973866 
 
WASH2P 48.972445 20.55269743 -2.382774566 
C10orf10 638.34631 240.4534957 -2.654759938 
 
MYZAP 33.903223 14.4923365 -2.339389707 
 
FAM86C1 71.744202 30.31385909 -2.366712928 
LOC101928219 12.797946 4.834366532 -2.64728505 
 
OR56B4 9.7229856 4.19337858 -2.318651993 
 
MFI2 32.289194 13.65048454 -2.365424773 
TP53I11 60.772083 23.00256046 -2.641970359 
 
OR9A2 8.0653226 3.48323729 -2.315467465 
 
GTF2H2C 31.198201 13.21211303 -2.361333219 
GCNT3 10.917253 4.149315101 -2.631097492 
 
LOC101927787 7.9913701 3.45831331 -2.310771005 
 
TCEB3C 20.505798 8.691924948 -2.359177942 
MIR519A1 7.9139383 3.025533277 -2.615716836 
 
CHGB 8.1681129 3.54332916 -2.305208606 
 
ULBP1 138.74051 59.33106971 -2.338412419 
PPIAL4C 9.0359666 3.454746489 -2.615522331 
 
KRTAP20-2 29.285164 12.7081072 -2.304447358 
 
SEMA3C 17.762638 7.615096925 -2.332555725 
SEPT6 215.41051 83.22804726 -2.58819608 
 
PRAP1 33.56208 14.5760592 -2.302548266 
 
OR52B2 10.268392 4.432985624 -2.316360322 
MIR196B 54.487592 21.05419869 -2.587967998 
 
NA 100.72619 43.896318 -2.294638731 
 
LOC392196 8.4948031 3.681833929 -2.307220609 
SENP1 702.83381 271.5797778 -2.587946039 
 
SNORD116-23 16.303739 7.1392755 -2.283668505 
 
MS4A6A 8.0245038 3.47994983 -2.30592515 
SELENBP1 68.453233 26.51502921 -2.58167668 
 
MRGPRD 23.46354 10.2975709 -2.278550903 
 
MIR3922 12.334941 5.349264878 -2.305913318 
CCDC88C 107.90656 41.82270461 -2.580095289 
 
OTX2-AS1 9.2428404 4.06542234 -2.273525255 
 
OR1I1 16.742456 7.293838349 -2.295424664 
LOC100653133 21.809327 8.522237032 -2.559108236 
 
VCX2 24.73997 10.8904474 -2.271712887 
 
OR9A2 8.0653226 3.531263202 -2.283976625 
E2F8 147.53756 58.03560045 -2.542190555 
 
CCL20 550.19478 243.761831 -2.257099817 
 
BCRP3 5.6755798 2.490815925 -2.278602672 
GJA4 33.09791 13.11817547 -2.523057426 
 
HERC5 54.595001 24.3127344 -2.245531103 
 
ATAD3B 20.682 9.079103596 -2.277978153 
ANO8 33.075704 13.11274623 -2.522408592 
 
NUDT6 30.722716 13.70904 -2.241055275 
 
MPV17L 20.474956 8.992153076 -2.276980387 
OR10G8 12.742403 5.056019041 -2.520244314 
 
MIR486-1 26.263357 11.7336137 -2.238300767 
 
SCARNA20 32.691326 14.36285606 -2.276102014 
DKFZp779M0652 20.45614 8.170782165 -2.503571846 
 
PPP1R2 18.843284 8.47145656 -2.224326393 
 
SNORA37 70.881215 31.16321208 -2.2745157 
CD93 1581.7864 632.0408767 -2.502664724 
 
KLRC4 7.2162493 3.25578343 -2.21644021 
 
DKFZp779M0652 20.45614 8.993667459 -2.274504843 
FLJ20021 48.804657 19.62879293 -2.486380955 
 
WASH2P 48.972445 22.1530804 -2.210638155 
 
LTB4R 15.754141 6.938430161 -2.270562674 
SNORD114-14 39.890121 16.06297751 -2.483357801 
 
LOC101929432 13.784772 6.25262569 -2.204637308 
 
MCTP2 20.801869 9.170499711 -2.26834625 
PRAMEF7 13.846143 5.593566117 -2.475369561 
 
MT1DP 11.026036 5.00357406 -2.203632098 
 
GOLGA6A 25.396446 11.21270782 -2.264969885 
MAL2 200.09982 80.8818977 -2.473975319 
 
LOC146880 66.648582 30.2481215 -2.203395757 
 
PTTG1 50.47561 22.44730792 -2.248626434 
AR 55.412469 22.50949525 -2.461737516 
 
MEIS3P1 35.028675 15.9062215 -2.202199599 
 
RAG1 7.3748208 3.280277804 -2.248230555 
LOC100653005 8.2475975 3.350998508 -2.461235807 
 
MPV17L 20.474956 9.30900528 -2.199478415 
 
MAL2 200.09982 89.18767198 -2.243581587 
HOXB4 105.34739 43.27851816 -2.434172848 
 
FAM90A10P 45.71649 20.8937526 -2.188045906 
 
MC5R 59.506186 26.69199241 -2.22936472 
ADAMTS18 434.70468 179.1417361 -2.426596316 
 
LINC01194 12.772876 5.83887873 -2.187556361 
 
C8orf88 26.138486 11.75296048 -2.223991677 
Supplementary table 3     
 
Supplementary table 4     
 
Supplementary table 5     
Gene Control miR-574-5p Fold change 
 
Gene Control miR-1972 Fold change 
 
Gene Control miR-4792-3p Fold change 
MIR222 30.777858 12.71403111 -2.420778916 
 
TMEM120B 40.896928 18.7024388 -2.186716307 
 
ATF3 119.71539 53.83813817 -2.22361675 
SPX 53.909972 22.28490621 -2.41912492 
 
SPIN2B 122.95207 56.2344589 -2.186418619 
 
LOC100499484 5.0876713 2.292114628 -2.219640885 
ART4 181.22422 75.26874347 -2.407695623 
 
MORN4 56.727548 25.9538053 -2.185712154 
 
ZRSR2 48.892934 22.02924829 -2.219455404 
NA 19.527281 8.110974246 -2.407513622 
 
LOC100653133 21.809327 9.99432321 -2.182171471 
 
NA 23.946665 10.82826084 -2.21149683 
SNAP29 709.03274 295.3831966 -2.400382782 
 
CCDC144CP 12.791317 5.86362469 -2.181469254 
 
OAS3 143.5634 65.00314073 -2.208560999 
LOC101927614 28.168854 11.7726251 -2.392741995 
 
IFI44 133.41588 61.2161764 -2.179421934 
 
NA 13.477512 6.13233477 -2.19777825 
MIR4778 17.514362 7.328019487 -2.390053987 
 
LOC101927476 26.184076 12.0161407 -2.179075374 
 
ISG15 86.138685 39.21879092 -2.19636258 
INHBA 198.31501 83.17164041 -2.384406562 
 
NA 23.946665 10.992191 -2.178516046 
 
PHOSPHO2 10.563336 4.810446588 -2.195915958 
MBL1P 20.287732 8.508703231 -2.384350636 
 
SNORA31 8.2621694 3.79922543 -2.174698393 
 
FAP 24.910904 11.38944806 -2.187191463 
MARCH4 130.2773 55.04379546 -2.366793606 
 
OR11H4 7.6838275 3.54096059 -2.169983911 
 
MIR4421 7.1796704 3.295669203 -2.178516695 
SNORD114-17 17.246776 7.305854876 -2.360678707 
 
LOC100499484 5.0876713 2.34969305 -2.165249343 
 
CRHR1-IT1 20.089424 9.241534006 -2.173819199 
PSG4 11.156337 4.746644615 -2.35036285 
 
WNT5A 16.249095 7.51389847 -2.162538528 
 
LOC101929224 10.432801 4.830613552 -2.15972591 
TNFRSF10C 1118.0527 475.8910307 -2.349388044 
 
FAM24B 15.749133 7.28712969 -2.161225844 
 
WNK3 13.693084 6.35384315 -2.155086943 
RSPH10B 7.4606891 3.177986958 -2.347614764 
 
IL23A 13.682207 6.34478798 -2.156448298 
 
LOC101929018 15.302488 7.104013479 -2.154062345 
IGHV3-15 20.674388 8.812356875 -2.346067918 
 
PARP9 139.17353 64.6018083 -2.154328677 
 
KRT7 157.59504 73.17646006 -2.153630266 
MAGEA4 10.062814 4.2910535 -2.345068442 
 
LOC101928208 7.5076719 3.49124833 -2.150426206 
 
MIR103A2 15.848983 7.371462432 -2.15004592 
SPATA31C1 15.987191 6.855096433 -2.332161369 
 
GAL3ST4 27.671338 12.9157916 -2.142442282 
 
SNORD90 13.086034 6.089325173 -2.149012233 
NEIL1 55.108704 23.66023875 -2.329169396 
 
GPM6A 12.320204 5.75809051 -2.139633549 
 
CSF3 231.59642 107.7857809 -2.148673181 
LOC101927762 22.714008 9.77657232 -2.32330995 
 
SNORA14A 8.7032152 4.07995563 -2.133164172 
 
MIR4691 17.690165 8.236357638 -2.147814135 
PLAC8 127.6167 55.19549704 -2.312085389 
 
LOC100132077 15.376462 7.23064779 -2.126567702 
 
HMGN3-AS1 27.493646 12.83082317 -2.142781123 
APOB 15.872648 6.872589606 -2.30955853 
 
LOC101805491 9.9547948 4.7102028 -2.113453534 
 
BHLHA15 33.310407 15.57093173 -2.139268727 
SRD5A3 239.66342 103.9993315 -2.304470737 
 
LOC101928758 14.345728 6.79132824 -2.112359701 
 
LOC101927787 7.9913701 3.740624581 -2.136373208 
LOC101927963 28.95375 12.5833578 -2.300955793 
 
ANKRD20A19P 20.000796 9.48037042 -2.109706125 
 
MIRLET7D 30.336448 14.20402136 -2.135764708 
LOC728739 12.868266 5.593566117 -2.300547692 
 
NA 19.527281 9.27122546 -2.106224368 
 
NUPR1 256.21149 120.4115772 -2.127797781 
KCNIP3 68.335323 29.7675687 -2.295629983 
 
LGALS2 11.306289 5.38049408 -2.101347697 
 
FAM106B 45.828554 21.54747363 -2.126864352 
BVES 176.25385 77.03322443 -2.288023812 
 
SNTA1 26.647823 12.6826642 -2.101121854 
 
FAHD2CP 36.300657 17.12179759 -2.120142849 
MIR635 13.630017 5.971990277 -2.282324127 
 
LOC648691 8.1109742 3.8611913 -2.10064035 
 
BHLHB9 80.141889 37.94302461 -2.112163968 
APOC4-APOC2 7.9134985 3.470484769 -2.280228551 
 
FAHD2CP 36.300657 17.3065321 -2.097511883 
 
TNFRSF9 257.13256 122.0000847 -2.107642481 
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TNFSF10 557.85291 244.910234 -2.277785195 
 
SPX 53.909972 25.7059981 -2.09717482 
 
LOC101929236 27.750622 13.2206688 -2.099033161 
ELFN1 18.797539 8.290007295 -2.267493711 
 
LOC100507033 7.975731 3.8099579 -2.093390841 
 
TCF7 15.881922 7.57254749 -2.097302401 
PCDHB14 14.096632 6.216949227 -2.267451635 
 
PRICKLE2-AS3 8.5089313 4.07272833 -2.089245979 
 
LINC00520 94.107114 44.94599662 -2.093781894 
WNT4 16.200032 7.203803003 -2.24881658 
 
RASD1 34.696317 16.6503001 -2.083825336 
 
XAF1 278.50109 133.0669731 -2.092939205 
OR1L8 15.80286 7.030291468 -2.247824256 
 
LOC101927307 11.172323 5.37029784 -2.080391755 
 
KCNG1 39.316069 18.79975779 -2.091307219 
MIR99B 38.934152 17.35779107 -2.243036094 
 
LINC00314 7.2696764 3.50126947 -2.076297304 
 
CLDN4 8.3219056 3.984351073 -2.088647675 
FAM90A25P 18.293829 8.18466969 -2.23513349 
 
KIR3DL3 10.644604 5.12673268 -2.076294016 
 
AQP12B 16.478113 7.902736018 -2.08511491 
ARHGEF9 66.718517 29.88183714 -2.232744811 
 
LTB4R 15.754141 7.59882365 -2.07323413 
 
FUK 23.044978 11.06946454 -2.081851159 
CCDC170 12.507065 5.605656207 -2.231150879 
 
URAHP 24.201609 11.6736665 -2.073179785 
 
ACSL5 46.477792 22.34686234 -2.079835256 
FOXN3 267.67543 120.7219284 -2.217289194 
 
TNC 58.996173 28.48733 -2.070961812 
 
TCEB1 17.570283 8.471456565 -2.074056878 
SPATA31D4 52.537002 23.77881235 -2.209403945 
 
BEAN1 16.271324 7.86168148 -2.069700184 
 
TRAJ59 12.598117 6.08730084 -2.069573648 
SSR4P1 15.9149 7.227865271 -2.201881152 
 
OR4D5 12.497601 6.04888012 -2.066101657 
 
MIR519A1 7.9139383 3.828504813 -2.067109411 
RPP21 65.510013 29.8588172 -2.193992216 
 
MIR4655 13.114765 6.35305261 -2.064324892 
 
IGHV1-2 14.146971 6.852068907 -2.064627703 
SNORD116-23 16.303739 7.472983552 -2.181690685 
 
KCNK15 8.1159598 3.93897205 -2.060425851 
 
RRN3P3 48.374306 23.47948573 -2.060279627 
EOGT 1182.6323 543.6556148 -2.175333613 
 
LOC101929128 59.847605 29.0713246 -2.058647355 
 
FBXO4 19.426092 9.443845215 -2.057010793 
ZRANB3 41.99037 19.35195525 -2.169825727 
 
NA 13.635816 6.64484074 -2.052090767 
 
SEC14L1P1 34.924125 17.00567329 -2.053674946 
KRT8 94.071317 43.38959574 -2.16806162 
 
ISM1 13.625324 6.65669694 -2.046859564 
 
CD69 29.630785 14.44838181 -2.050802988 
CSF2RB 181.21089 83.66057466 -2.166024969 
 
TRAV8-4 9.7831196 4.78080476 -2.046333229 
 
NSUN5 71.939982 35.16759761 -2.045632529 
ZNF135 43.033387 19.89423413 -2.163108504 
 
MIR4766 6.6366593 3.24326777 -2.046287814 
 
IGHV1-58 8.0111623 3.917879294 -2.044770066 
PRKCQ-AS1 18.682672 8.637431222 -2.162989379 
 
MIR1236 9.1810725 4.49104638 -2.044305886 
 
BIRC3 444.32443 218.3262653 -2.035139587 
FBXL20 169.44632 78.63957116 -2.154720769 
 
CMPK2 21.920706 10.7273069 -2.04344909 
 
ZNF571-AS1 19.890106 9.794031025 -2.030839643 
FAM183CP 9.659383 4.483245283 -2.154551529 
 
MIR3620 18.914185 9.27596693 -2.039052642 
 
PPP3CB-AS1 27.810221 13.69887966 -2.030109169 
LIMD1 120.04327 55.8711176 -2.148574652 
 
TRIM61 10.564267 5.22672983 -2.021200055 
 
LOC400743 26.780546 13.195121 -2.029579453 
KCNK15 8.1159598 3.782414389 -2.145708798 
 
C1orf56 32.546316 16.2239558 -2.00606538 
 
IGHJ2 17.117605 8.462056752 -2.022865738 
LOC100505767 14.36804 6.71036365 -2.141171644 
 
NDNF 6.7388105 3.36171983 -2.004572323 
 
ZNF594 24.824052 12.27555396 -2.022234731 
C15orf41 160.87271 75.19278445 -2.139470081 
 
LENG9 36.130355 18.0370361 -2.003120412 
 
GATM 12.987931 6.427932114 -2.020545807 
LINC00968 5.7392353 2.684156344 -2.138189644 
 
FAM184A 23.698537 11.8357157 -2.002290184 
 
FOS 36.085853 17.87232121 -2.019091581 
NCDN 61.103322 28.60006544 -2.136474895 
 
SNORD90 13.086034 6.53663591 -2.001952452 
 
SNORD116-23 16.303739 8.077362048 -2.018448413 
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THAP3 32.610594 15.26622004 -2.136127598 
 
BIRC3 444.32443 222.02669 -2.001220779 
 
G0S2 25.557311 12.66451248 -2.01802564 
LOC101928758 14.345728 6.721165165 -2.134410887 
 
TRBJ2-6 43.896318 21.9796293 -1.997136416 
 
PPIAL4C 9.0359666 4.477907614 -2.017899289 
SLC46A1 32.538247 15.25109587 -2.133502227 
 
HOXB-AS1 52.908532 26.5293663 -1.99433834 
 
LOC101060400 8.6568048 4.296303749 -2.014942452 
LOC101929295 10.141599 4.757493376 -2.131710667 
 
RNF207 29.201578 14.6559018 -1.992479101 
 
BOP1 537.44534 266.772529 -2.014620268 
CYP4V2 55.975956 26.26421885 -2.13126294 
 
DPY19L2P3 6.9522645 3.49000333 -1.99205098 
 
SLC10A5 14.215453 7.065516628 -2.011948085 
HIST1H2BE 22.4107 10.54582793 -2.125077348 
 
FGFR2 8.3530441 4.20697833 -1.985521067 
 
POMZP3 73.756933 36.70048366 -2.009699221 
IGHV3-16 24.882514 11.71450997 -2.124076371 
 
SKP1 17.720618 8.95072008 -1.97979808 
 
ZNF540 6.1819329 3.077381727 -2.008828762 
OR9A2 8.0653226 3.798950104 -2.12303989 
 
CRHR1-IT1 20.089424 10.1482559 -1.979593766 
 
ZNF561 71.928955 35.8278012 -2.00762961 
MIR4421 7.1796704 3.388884712 -2.118593871 
 
FLJ13224 19.363927 9.79080216 -1.977767184 
 
AFF3 66.179731 33.01176564 -2.004731643 
RAB3B 341.44394 161.6020153 -2.112869315 
 
LOC391322 15.791748 7.99218757 -1.975898112 
 
LOC101928126 6.922708 3.454421236 -2.004013857 
C15orf57 60.485308 28.82517649 -2.098349958 
 
ZNF774 44.77574 22.6956726 -1.972875659 
 
ANKRD20A19P 20.000796 9.994907009 -2.001098713 
LOC391322 15.791748 7.526398724 -2.098181202 
 
C19orf44 41.826858 21.2181981 -1.971272873 
 
PCDHA6 10.661301 5.331118885 -1.99982432 
HNF4A 14.313027 6.824117665 -2.097417978 
 
NA 15.617896 7.93620622 -1.967929742 
 
CIR1 83.639268 41.91981535 -1.995220323 
LOC100288814 8.2888215 3.964398532 -2.090814389 
 
IRAK2 399.68252 203.1746 -1.967187419 
 
HIF1A-AS2 72.609086 36.42915489 -1.993158679 
LOC100379224 67.265598 32.27005962 -2.084458439 
 
CASC1 7.4049598 3.7706284 -1.963852981 
 
MIR99B 38.934152 19.54327805 -1.992201706 
LINC00265 87.955491 42.34777111 -2.076980421 
 
MIR4532 8.2429232 4.19856437 -1.963271832 
 
FHL1 10.532043 5.294150286 -1.989373553 
MIR103A2 15.848983 7.648810955 -2.072084513 
 
TSACC 12.236244 6.23602582 -1.962186308 
 
BCL2A1 135.68444 68.34073181 -1.985410929 
UBA7 55.463365 26.77271235 -2.071637883 
 
MYHAS 13.270634 6.77113413 -1.959883557 
 
MSC 118.64386 59.94277936 -1.979285213 
MAPK8IP1 8.6663537 4.183652986 -2.071480042 
 
IDO1 7.6409024 3.9046947 -1.956850138 
 
LOC101928595 8.7097008 4.404105756 -1.977632085 
ZNF816 22.672142 10.976142 -2.065583893 
 
LOC101928800 5.2658414 2.69916935 -1.950911827 
 
SCARNA5 73.963345 37.40252924 -1.977495821 
SYNPO 227.79118 110.3204067 -2.064814534 
 
ZNF140 55.718749 28.6023686 -1.948046689 
 
SLC12A7 447.34108 226.653451 -1.973678659 
LOC101928323 55.989253 27.12333933 -2.064246309 
 
MTRNR2L2 14.850906 7.63831935 -1.944263516 
 
CCNT2-AS1 27.436378 13.91017789 -1.972395896 
MIR105-1 8.827525 4.279532776 -2.062731012 
 
CNR1 20.289823 10.4393769 -1.943585674 
 
ZNF667 37.301925 18.91210769 -1.972383275 
NA 9.9308643 4.815821867 -2.062132811 
 
LINC00702 36.317201 18.688022 -1.943341092 
 
RPP21 65.510013 33.21706702 -1.972179316 
MIR3939 21.431411 10.40480975 -2.059760043 
 
ZNF322 35.645737 18.3900592 -1.938315536 
 
LPAL2 7.2598486 3.692447558 -1.966134518 
ZNF826P 11.24268 5.464149113 -2.057535353 
 
NTNG2 18.045358 9.31296135 -1.937660569 
 
FAM226A 4.3046828 2.190131544 -1.965490525 
POP5 71.108726 34.64638723 -2.05241387 
 
LINC00906 5.9607095 3.07748899 -1.936874339 
 
OR2B11 12.49946 6.372554927 -1.961451913 
IFNA4 6.7784289 3.302769798 -2.05234675 
 
MDGA1 18.568745 9.60420722 -1.933397005 
 
RGPD4-AS1 6.7100241 3.422496493 -1.960564207 
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FOSL1 1498.9588 730.4984805 -2.051967079 
 
LOC101929356 13.179781 6.82009677 -1.932491744 
 
PCOLCE-AS1 11.41161 5.824840749 -1.959128308 
RNASE3 6.6439513 3.243974808 -2.048089685 
 
LOC100507373 26.924937 13.952683 -1.929731865 
 
AHRR 61.652453 31.48904178 -1.957901834 
TNNC1 10.773936 5.26130354 -2.047769298 
 
KCNG1 39.316069 20.3870765 -1.928479994 
 
NA 11.182511 5.715979183 -1.956359588 
C8orf88 26.138486 12.80228048 -2.041705486 
 
FAM46C 18.232446 9.46034117 -1.927250366 
 
MIR4674HG 17.479948 8.953300746 -1.952346764 
PLXDC2 186.74643 91.51945584 -2.040510743 
 
LOC100132731 10.057052 5.23097066 -1.922597684 
 
SIX1 12.039749 6.179216302 -1.948426598 
INVS 128.12996 62.87458082 -2.03786585 
 
KRTAP1-5 9.8503901 5.12473535 -1.922126585 
 
CXCL5 175.23017 90.03911249 -1.946156122 
LGALS2 11.306289 5.554698791 -2.035445895 
 
ULBP1 138.74051 72.2086302 -1.921384049 
 
PSMB8-AS1 17.871672 9.183944036 -1.94596913 
SLC9A9 38.729645 19.05145334 -2.032897124 
 
ZNF17 10.735423 5.58879789 -1.920882339 
 
MT1DP 11.026036 5.667546052 -1.945469221 
FCN2 7.0788299 3.487952775 -2.02950854 
 
AADACP1 22.855167 11.899648 -1.920659075 
 
LILRA6 6.6836709 3.436215452 -1.945067474 
MIR3134 6.1515221 3.034256748 -2.027357142 
 
HIST1H2BE 22.4107 11.6783169 -1.919000847 
 
IL6 236.85212 121.7802056 -1.944914771 
ZBTB16 6.9431067 3.42915235 -2.024729727 
 
GGTLC1 10.499565 5.47410432 -1.918042475 
 
HERC5 54.595001 28.09146887 -1.943472644 
CMA1 10.484304 5.187244078 -2.021170289 
 
PTCHD1 7.7425401 4.04569639 -1.913771908 
 
WNT5A 16.249095 8.373526989 -1.940531746 
NA 13.477512 6.673153082 -2.019661742 
 
SUGT1P3 5.5935661 2.92561512 -1.911928222 
 
LOC101927881 9.2529391 4.76985743 -1.939877497 
TECPR2 53.195373 26.34241221 -2.019381255 
 
DLX2 22.947021 12.0155573 -1.909775832 
 
OR5M10 10.777497 5.556372013 -1.939664374 
LOC101927881 9.2529391 4.587866547 -2.016828301 
 
OAS3 143.5634 75.3454185 -1.9054032 
 
C11orf96 35.819422 18.4734293 -1.938969808 
UGT1A10 17.01861 8.445339053 -2.015148224 
 
LOC101928227 5.8825058 3.08935408 -1.904121594 
 
LOC283683 5.9040635 3.04513397 -1.938851792 
LOC101929187 6.2764561 3.117437405 -2.013338287 
 
TRAV38-1 32.499471 17.0913157 -1.901519543 
 
LOC101927685 13.020529 6.715654968 -1.938832355 
OR1B1 7.4548818 3.704677695 -2.012288897 
 
NA 15.493125 8.14932862 -1.901153604 
 
NNT-AS1 94.813182 48.92289711 -1.938012415 
C11orf96 35.819422 17.80951824 -2.011251577 
 
LOC101927617 5.077336 2.67472753 -1.898262888 
 
OR52N2 7.1830612 3.708603554 -1.936864131 
LOC101805491 9.9547948 4.96609919 -2.004550125 
 
GPNMB 12.868266 6.78688655 -1.896048434 
 
NA 12.364946 6.384264946 -1.936784595 
MAP7D1 247.84328 123.8010358 -2.001948368 
 
LOC100134368 12.110026 6.38823628 -1.895675921 
 
CBX8 26.661145 13.77173435 -1.935932297 
BCRP3 5.6755798 2.835744829 -2.00144236 
 
ARHGEF25 34.176077 18.0579624 -1.892576595 
 
FAM69C 8.4916604 4.393342789 -1.932847213 
ADAM28 8.4714608 4.23790071 -1.998975755 
 
IFIT5 83.269499 44.0047661 -1.892283642 
 
CCL18 19.072468 9.870641571 -1.932241993 
FBXL14 59.47654 29.80801461 -1.995320422 
 
MIR1296 11.267197 5.95793532 -1.891124464 
 
DLX2 22.947021 11.88017747 -1.931538565 
LOC101929356 13.179781 6.612532414 -1.993151773 
 
LOC101927318 13.137545 6.95161436 -1.88985523 
 
SSR4P1 15.9149 8.252688715 -1.928450334 
MIR539 20.944025 10.51977999 -1.99091855 
 
ZNF30 24.107179 12.764887 -1.888554043 
 
SNHG7 57.041024 29.62115147 -1.925685564 
C8orf31 12.22449 6.16185356 -1.983898236 
 
MIR3675 5.9886268 3.17491528 -1.886231999 
 
MIR2861 11.204021 5.819429362 -1.925278282 
KRT7 157.59504 79.44563235 -1.983684118 
 
LOC101927676 5.6647494 3.00704753 -1.883824372 
 
TCF15 13.881516 7.213061679 -1.924497065 
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OLFML2A 9.0526005 4.572023741 -1.979998583 
 
IGLL3P 11.004432 5.84669487 -1.882162855 
 
IGKV3-11 12.5196 6.507798904 -1.923784116 
FHL1 10.532043 5.326488373 -1.977295702 
 
OR3A2 8.3961204 4.46139367 -1.881950136 
 
LOC642441 38.897501 20.22087903 -1.923630565 
CYP2S1 45.632817 23.0788406 -1.977257753 
 
TMEM52 17.949784 9.55682439 -1.878216376 
 
ZDHHC11 9.1561359 4.760522714 -1.923346757 
C5orf56 25.252187 12.77600175 -1.976532817 
 
FOLR3 12.056291 6.42906001 -1.875280591 
 
RCSD1 17.906593 9.34091215 -1.917006934 
REG1A 7.1451142 3.615908931 -1.976021605 
 
NUPR1 256.21149 136.84608 -1.872260332 
 
LOC101928219 12.797946 6.683993916 -1.914715424 
LOC101929637 6.4286302 3.254265263 -1.975447515 
 
CYB561D1 30.52403 16.3150016 -1.87091797 
 
ARPIN 58.985348 30.86451275 -1.911105768 
RUNX1T1 262.91543 133.2095742 -1.973697723 
 
MIR593 39.96878 21.3636283 -1.870879782 
 
FAM205A 8.6669624 4.535934044 -1.910733779 
LOC101928548 8.2900073 4.200715973 -1.973474843 
 
TRBV27 9.279098 4.96276208 -1.869744676 
 
MYH6 7.5979304 3.977267202 -1.910339445 
PURA 178.2647 90.52889844 -1.969146877 
 
MYH1 7.7542564 4.14912051 -1.86889158 
 
LAMC2 245.05584 128.3521686 -1.909245844 
OR2A12 4.3721576 2.221454367 -1.968150996 
 
LOC100507191 4.8699013 2.60794233 -1.867334741 
 
CFL1P1 7.6705451 4.021498432 -1.907384818 
MIR4717 9.3590275 4.757493376 -1.967218189 
 
HERC6 143.12542 76.6595904 -1.867025608 
 
LOC728739 12.868266 6.74660733 -1.907368399 
RGPD4 8.8829211 4.525452832 -1.962880047 
 
SLC46A1 32.538247 17.4368454 -1.866062714 
 
ASB16 19.519411 10.24665684 -1.904954115 
IQCG 22.797354 11.61658481 -1.962483341 
 
CD164L2 14.386944 7.72502425 -1.862381735 
 
PI3 24.05144 12.64867949 -1.901498109 
POM121L10P 22.869521 11.65604624 -1.962030777 
 
SMARCD3 36.227587 19.4614793 -1.861502203 
 
GPR135 24.556708 12.91556244 -1.901327046 
SNORD116-26 24.756867 12.62236863 -1.961348777 
 
AGMAT 16.41605 8.81961055 -1.861312336 
 
LGALS2 11.306289 5.951453434 -1.899752553 
POU2F1 194.73156 99.29722427 -1.961097733 
 
LOC101927685 13.020529 6.99782848 -1.860652798 
 
LURAP1L-AS1 197.06642 103.7855616 -1.898784507 
LINC00202-1 7.6694861 3.915180538 -1.958909956 
 
CLEC18C 24.896504 13.3841814 -1.860143924 
 
FOXF1 213.31025 112.7329128 -1.89217369 
GRM2 7.6544346 3.911442022 -1.956934187 
 
NA 34.806005 18.711929 -1.860097079 
 
HMSD 8.04396 4.252003265 -1.891804758 
SPATA24 18.067345 9.260520659 -1.95100746 
 
FDPSP2 11.420594 6.14253669 -1.859263499 
 
MIR1238 22.187246 11.72903106 -1.891652098 
TENC1 137.34608 70.61756154 -1.944928047 
 
OR5AR1 12.000451 6.46691368 -1.855668917 
 
TAS2R4 12.403021 6.559160335 -1.890946524 
SLC40A1 157.61093 81.20832284 -1.940822397 
 
SUMO1 8.2937031 4.47134789 -1.854855246 
 
TRAJ58 5.6882874 3.009111943 -1.890354189 
PCDHA6 10.661301 5.494497966 -1.940359477 
 
ATG10 30.533421 16.4843338 -1.852269059 
 
EPHB3 13.844984 7.326665646 -1.889670514 
MIR1290 4.6830927 2.415843801 -1.93849149 
 
SSBP2 143.99452 77.8049216 -1.850712175 
 
CTD-2337A12.1 23.980523 12.7024499 -1.887865983 
OR2Y1 7.729245 3.988034249 -1.938108979 
 
SOWAHC 18.856718 10.191137 -1.850305644 
 
LOC101928917 8.5080213 4.512383059 -1.885482941 
ZNF707 27.110236 13.99170329 -1.937593666 
 
AJUBA 94.311506 51.0580424 -1.847143013 
 
CYP2D7P 16.948262 8.991055384 -1.885013654 
NLK 289.92268 149.6889423 -1.936834335 
 
NA 121.65274 65.9588161 -1.844374212 
 
TNC 58.996173 31.30294242 -1.884684572 
TEAD1 187.18104 96.64703224 -1.936748944 
 
SPATA3-AS1 8.4756234 4.5962336 -1.844036691 
 
IGHV3-15 20.674388 10.98236654 -1.882507533 
ASNA1 309.68768 159.9317588 -1.936373851 
 
LOC101060153 11.987916 6.5106873 -1.841267364 
 
CDCP2 7.3877689 3.927751972 -1.880915321 
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LOC101928117 9.8939649 5.109866018 -1.936247423 
 
LINC01491 8.4059163 4.56629039 -1.840863276 
 
PDYN 7.7628947 4.127836988 -1.880620463 
KIF9-AS1 9.0359666 4.672331361 -1.933931027 
 
MAFA 18.810741 10.2369497 -1.837533766 
 
RRAD 24.935128 13.27856604 -1.877847939 
LINC00997 26.093375 13.50595871 -1.931989869 
 
LOC101928796 10.0652 5.48034427 -1.836599867 
 
FBF1 35.135003 18.71727328 -1.877143216 
ARL11 8.7718139 4.540811967 -1.931772103 
 
NPIPB6 70.754882 38.5412708 -1.835821197 
 
UTS2 6.8898436 3.671248463 -1.876703164 
ZNF525 17.375198 9.02259898 -1.925742004 
 
LOC283070 30.162809 16.433859 -1.835406318 
 
LOC101928208 7.5076719 4.002797968 -1.875606003 
MXD3 11.896776 6.197842392 -1.919502775 
 
LOC101929715 11.456978 6.24282024 -1.835224733 
 
LOC101927759 14.263708 7.605978569 -1.875328452 
ADAM19 140.32055 73.13233369 -1.91872111 
 
LOC390937 11.762824 6.41877336 -1.832565763 
 
TCEB3CL2 15.498478 8.308153557 -1.865453978 
IL3RA 68.483305 35.7058074 -1.917987855 
 
MC5R 59.506186 32.5022919 -1.830830466 
 
PRR4 34.046316 18.26278007 -1.864246061 
AQP12A 14.345191 7.489275027 -1.915431258 
 
TTLL3 15.637419 8.54816113 -1.829331376 
 
LINC01097 9.0382227 4.849058941 -1.863912731 
ZNF134 278.00817 145.2108416 -1.914513856 
 
ST7-OT4 10.542052 5.76734333 -1.82788704 
 
LOC100506753 20.704179 11.1116432 -1.863286845 
MYL10 10.777894 5.635658463 -1.912446272 
 
KRTAP19-5 24.896504 13.6205338 -1.82786549 
 
MIR151A 8.4684755 4.548786216 -1.861700037 
CDON 19.351556 10.13577276 -1.909233406 
 
FAM205A 8.6669624 4.75048058 -1.824439077 
 
RGPD4 8.8829211 4.772284834 -1.861356012 
TTTY20 11.532613 6.04298735 -1.908429041 
 
MIR524 5.5958141 3.07679863 -1.818713137 
 
IDO1 7.6409024 4.107818395 -1.860087674 
KLRC4 7.2162493 3.784102294 -1.906991077 
 
CTC-338M12.4 37.366622 20.5938454 -1.814455773 
 
LOC286297 18.557671 9.976954577 -1.860053701 
ZNF709 31.16079 16.366191 -1.903973281 
 
LOC100996713 11.926805 6.57711248 -1.813380051 
 
CXCL12 9.2597031 4.979083719 -1.859720299 
IL33 10.022993 5.27326071 -1.900720081 
 
DUSP2 26.899397 14.8389196 -1.812759806 
 
RNASE3 6.6439513 3.574223396 -1.85885173 
FAM111B 183.34957 96.49773333 -1.900040186 
 
NDUFB9 161.00095 88.829287 -1.81247604 
 
MIR1296 11.267197 6.063173509 -1.858300314 
MIR574 94.941875 49.99631646 -1.898977402 
 
PLAC8 127.6167 70.4779659 -1.810731917 
 
MIR4451 5.6808649 3.057432883 -1.858050551 
OTX2-AS1 9.2428404 4.876291049 -1.895465278 
 
FLCN 177.78955 98.23397 -1.80985817 
 
IFIH1 117.03465 63.12842467 -1.853913756 
TUBA4A 21.496473 11.35223142 -1.89359012 
 
CECR2 28.51924 15.7666223 -1.808836384 
 
LOC391322 15.791748 8.526591864 -1.852058663 
CDCP2 7.3877689 3.904084133 -1.892318047 
 
IFIH1 117.03465 64.7110649 -1.808572539 
 
PPIP5K1 31.090369 16.79737333 -1.850906605 
MIR4500HG 7.6862242 4.062739123 -1.891882299 
 
LOC101929125 12.260144 6.7790903 -1.80852347 
 
KIF27 34.246602 18.50759133 -1.850408361 
HNRNPA1L2 9.7129412 5.137439173 -1.890619213 
 
BRSK1 12.424559 6.87478222 -1.807265858 
 
ZNF322 35.645737 19.28920054 -1.847963439 
POM121L8P 69.141378 36.61612453 -1.888276799 
 
HOXB9 96.074611 53.167437 -1.807019793 
 
IFNA4 6.7784289 3.670366856 -1.846798733 
LOC101928923 6.8081471 3.606499323 -1.887743907 
 
UNCX 15.720183 8.70789206 -1.805279963 
 
SNAPC1 529.56051 286.9654263 -1.845380879 
MIR32 12.805488 6.78691594 -1.886790383 
 
LOC283278 6.7006213 3.71296661 -1.804654349 
 
PRAMEF25 17.980091 9.74557507 -1.844949173 
LOC101927787 7.9913701 4.237186214 -1.886008717 
 
SLC38A5 21.147007 11.7212963 -1.804152575 
 
SNORA80A 55.246316 29.96118282 -1.843929754 
MAF 35.989853 19.10596072 -1.883697653 
 
IGLV1-36 60.171316 33.3867506 -1.802251329 
 
AWAT2 8.6892611 4.71422607 -1.843199924 
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ZNF860 27.446344 14.58819571 -1.881407689 
 
LOC101929709 30.700212 17.0663779 -1.798870961 
 
CLK2 23.902474 12.98446783 -1.840851244 
ACCS 22.472411 11.95897609 -1.879124977 
 
SNORD111 72.030327 40.1018619 -1.796184097 
 
SLC23A3 17.222448 9.356099673 -1.840772168 
PIK3C2B 140.87825 75.00386114 -1.878280032 
 
FAM215A 26.465601 14.7353617 -1.796060479 
 
CKLF 64.724861 35.18351272 -1.839636111 
MGRN1 886.03432 471.9657396 -1.877327627 
 
LOC100130899 8.1781793 4.55468446 -1.795553423 
 
LOC101929453 6.3219487 3.438264999 -1.838703168 
TMEM176B 15.360378 8.214402309 -1.869932578 
 
MIR4663 12.367659 6.89694648 -1.79320786 
 
SLC6A9 200.60425 109.1182998 -1.838410714 
MIR4793 10.168901 5.440508378 -1.86910861 
 
BHLHE40-AS1 7.8336264 4.36869984 -1.793125333 
 
SFTA1P 19.49458 10.60735593 -1.8378359 
AKR7A2 41.303951 22.10361154 -1.868651688 
 
ICAM4 10.148237 5.67035666 -1.789699985 
 
DDIT4 746.55359 406.3861528 -1.837054685 
OR2B11 12.49946 6.690115175 -1.868347513 
 
FSTL5 13.349232 7.46157872 -1.789062627 
 
KRTAP5-2 13.336989 7.26434906 -1.835950958 
BCL7B 308.62994 165.2285794 -1.86789684 
 
USP27X 39.179744 21.9050443 -1.788617426 
 
LINC00899 32.677301 17.80452346 -1.835337042 
IGHV1-58 8.0111623 4.29016125 -1.867333612 
 
PMEL 10.094079 5.64398218 -1.788467588 
 
SH2D6 13.544248 7.384436578 -1.834161348 
TAS2R9 5.4146905 2.901022105 -1.866476808 
 
LINC00937 14.096305 7.88438382 -1.787876556 
 
CMA1 10.484304 5.720318831 -1.832818051 
HOXB-AS1 52.908532 28.37009542 -1.86494023 
 
HIST3H2BB 87.460429 48.9581422 -1.786432757 
 
OR2T11 5.730977 3.127029783 -1.83272224 
WNK3 13.693084 7.343879894 -1.864557238 
 
LOC101928595 8.7097008 4.88048057 -1.784599021 
 
OR1B1 7.4548818 4.069346713 -1.831960341 
LOC284632 11.825297 6.347225219 -1.863065564 
 
MIR4520-2 4.984266 2.7930445 -1.784527958 
 
SPATA24 18.067345 9.870387963 -1.830459447 
GDPD1 43.552197 23.39532333 -1.861577049 
 
PLCE1-AS2 18.655915 10.462838 -1.783064534 
 
IPO5P1 24.559373 13.41806811 -1.830321079 
NA 11.182511 6.011274966 -1.860256059 
 
NA 8.2091373 4.60445122 -1.782869849 
 
RGPD3 171.01405 93.55552072 -1.827941823 
LINC00278 10.329464 5.554209423 -1.859754196 
 
LINC00942 7.5652236 4.24583979 -1.78179677 
 
MIR3939 21.431411 11.73252876 -1.826666 
S100A2 25.760926 13.85328546 -1.859553543 
 
SLC15A3 32.001739 17.9715694 -1.780686969 
 
KIF9-AS1 9.0359666 4.951000993 -1.825078727 
PKNOX2 21.101446 11.36013671 -1.857499265 
 
ZNF836 57.583461 32.3710829 -1.778854954 
 
PRICKLE2-AS3 8.5089313 4.664507484 -1.824186435 
MIR139 15.672838 8.438073258 -1.857395351 
 
LILRA6 6.6836709 3.75827022 -1.778390195 
 
APTR 70.296316 38.57335415 -1.822406095 
PBLD 36.659114 19.73716016 -1.857365198 
 
BHLHA15 33.310407 18.7321139 -1.778251374 
 
SNORD114-3 73.620186 40.43767276 -1.820584144 
CIB2 39.897261 21.48408078 -1.857061573 
 
FAM86C1 71.744202 40.360381 -1.777589814 
 
SKP1 17.720618 9.756691295 -1.816252856 
MIR500A 12.095387 6.514714732 -1.856625705 
 
RTN4RL1 10.589059 5.95829666 -1.777195642 
 
ADM2 28.029784 15.44532234 -1.814774977 
LOC283070 30.162809 16.26275013 -1.854717586 
 
TAC1 8.3454718 4.70044891 -1.775462721 
 
TTLL10-AS1 8.5534472 4.715711877 -1.813818876 
EHD2 1806.1213 974.0958657 -1.85415153 
 
SNORD115-2 5.6093418 3.16144916 -1.774294497 
 
LOC100289061 34.271702 18.90135704 -1.813187366 
UQCC3 80.083816 43.2163498 -1.853090703 
 
GUSBP1 15.816466 8.91598706 -1.773944443 
 
TNFAIP3 550.12826 303.6206977 -1.811893137 
TRIM61 10.564267 5.703137641 -1.852360452 
 
OR52B2 10.268392 5.79318235 -1.772495908 
 
IL20RB 52.219605 28.83840441 -1.810766095 
HOXA-AS2 13.514191 7.30518015 -1.849946289 
 
MIR1185-2 8.6446336 4.88830077 -1.768433244 
 
KIF1A 38.73679 21.4018687 -1.809972311 
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C8orf74 18.003256 9.732267744 -1.849852123 
 
ZFP2 10.930867 6.18372521 -1.767683143 
 
RERG 8.1924957 4.530171159 -1.808429622 
KAL1 51.488726 27.84815364 -1.848909863 
 
FAM115C 71.334332 40.359071 -1.767491918 
 
CCDC166 10.815661 5.983464143 -1.80759189 
PLBD1 11.904838 6.439003375 -1.848863395 
 
LCP1 48.009553 27.1713493 -1.766918245 
 
IGKV3-15 7.8440704 4.345254287 -1.805204006 
CBLN3 40.035027 21.67091604 -1.847408158 
 
SLC13A3 9.6588367 5.46715218 -1.766703457 
 
C1orf140 9.0456887 5.014676328 -1.803842978 
FAM124B 906.7558 490.8287756 -1.8473974 
 
MIR3191 19.708338 11.1577154 -1.76634171 
 
LOC390937 11.762824 6.521223067 -1.803775793 
TMEM198B 44.795716 24.26930083 -1.845776934 
 
TOB1-AS1 7.9196131 4.48598744 -1.765411337 
 
LOC101927257 8.9728071 4.978961039 -1.802144467 
ALDH1A1 767.16764 415.8237686 -1.84493456 
 
LOC100996348 10.441854 5.91620297 -1.764958663 
 
OTX2-AS1 9.2428404 5.13387162 -1.800364531 
MIR4658 14.605297 7.925988567 -1.842709816 
 
KIAA1804 15.405794 8.73196361 -1.764298904 
 
FAM86C2P 41.377083 22.99701732 -1.799236929 
DPY19L2P3 6.9522645 3.77315932 -1.842557908 
 
SPATA31D4 52.537002 29.7963197 -1.763204396 
 
TESC 12.066715 6.706884188 -1.799153651 
ZNF585A 36.317585 19.710554 -1.842545138 
 
GOLGA8A 146.57132 83.1461323 -1.762815818 
 
EML2 60.205322 33.48704628 -1.797868975 
TARS2 76.384908 41.49631646 -1.840763577 
 
NNT-AS1 94.813182 53.8713165 -1.759993782 
 
APOC4-APOC2 7.9134985 4.404938078 -1.796506174 
LOC101927307 11.172323 6.073819278 -1.839423076 
 
EBI3 22.105568 12.56566 -1.759204724 
 
OR3A2 8.3961204 4.676860546 -1.795247121 
KIAA1377 66.603737 36.23337906 -1.838187281 
 
EML2 60.205322 34.2466205 -1.757993074 
 
SELE 1899.9443 1058.771763 -1.79447959 
IGLV1-36 60.171316 32.73944375 -1.837884484 
 
LOC100507642 10.042328 5.71267618 -1.757902591 
 
LAIR2 5.8951982 3.285216616 -1.794462565 
ZSWIM5 21.709748 11.83400034 -1.83452319 
 
PCDHGC5 7.2662213 4.13479846 -1.757333841 
 
LOC100506047 14.0145 7.817404674 -1.792730533 
IFFO2 122.0324 66.5720761 -1.833086864 
 
ZNF135 43.033387 24.4981982 -1.756593959 
 
ISM1 13.625324 7.601706158 -1.792403378 
THSD7A 29.294608 15.98743442 -1.832352033 
 
CSF3 231.59642 131.936573 -1.755361777 
 
FCGR2A 7.3911952 4.124019443 -1.792230939 
ZNF382 30.858356 16.85353192 -1.830972633 
 
KRT14 6.480772 3.69469056 -1.754077057 
 
FGF13-AS1 5.0381385 2.812857974 -1.791110167 
MEIS1 62.386327 34.08055327 -1.830554985 
 
CCNB3 10.959646 6.24969813 -1.753628095 
 
ZNF383 62.528599 34.91565903 -1.79084687 
LOC101928227 5.8825058 3.213812386 -1.830382458 
 
RRAD 24.935128 14.2248097 -1.75293226 
 
GCNT3 10.917253 6.101226713 -1.789353694 
CTRB1 7.7567282 4.237897294 -1.830324714 
 
CBX8 26.661145 15.2168427 -1.752081286 
 
LOC100507144 10.020866 5.60148407 -1.788966276 
TMSB4Y 6.4359201 3.516784374 -1.830058205 
 
AFF3 66.179731 37.8080712 -1.750412782 
 
HIRIP3 25.683499 14.3804016 -1.786007108 
LYRM7 87.571636 47.87712431 -1.829091401 
 
FAM86JP 10.16794 5.81071523 -1.749860258 
 
AZIN2 15.009807 8.417434218 -1.783180766 
RNASE4 129.6185 70.91543338 -1.827789779 
 
BATF 10.986332 6.28208341 -1.74883582 
 
SLC46A1 32.538247 18.27214933 -1.780756407 
FLJ44635 97.429616 53.44493765 -1.822990538 
 
NA 9.2250896 5.27504352 -1.748817731 
 
ASIC2 7.189953 4.039360613 -1.779973035 
B4GALNT1 11.566087 6.347433069 -1.822167644 
 
RPS6KA1 47.796316 27.3387325 -1.748300351 
 
GGT7 16.904424 9.505925453 -1.778303876 
CDNF 12.34904 6.778110307 -1.821900183 
 
MIR320D2 4.8950297 2.80257898 -1.746616158 
 
LOC283070 30.162809 16.97516579 -1.77687859 
TUB 31.412779 17.25246967 -1.820769996 
 
POTEF 4.7549989 2.72383452 -1.745700377 
 
WFDC21P 7.2162493 4.064718572 -1.775337992 
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LOC101928360 9.1218145 5.010179486 -1.820656222 
 
RRNAD1 25.357458 14.5274941 -1.745480539 
 
WNT3 8.3200062 4.690749669 -1.773705021 
LINC00472 59.726735 32.84456033 -1.818466584 
 
LOC642934 5.8932063 3.37647259 -1.745373642 
 
HLA-G 27.671251 15.61146142 -1.772495908 
LOC100132731 10.057052 5.537244386 -1.81625577 
 
DUPD1 7.988711 4.57995671 -1.744276536 
 
NHLH2 8.2748781 4.675895567 -1.769688395 
KIR3DL3 10.644604 5.870523195 -1.813229253 
 
FAM155B 10.825691 6.20828337 -1.743749493 
 
KYNU 18.572886 10.49507531 -1.769676341 
C4orf27 118.82869 65.54071304 -1.813051536 
 
MND1 26.478172 15.2182489 -1.739896105 
 
ST6GALNAC2 19.208279 10.86042759 -1.768648539 
SFTA1P 19.49458 10.75443482 -1.812701445 
 
LOC100506753 20.704179 11.9023046 -1.739510067 
 
ST3GAL5-AS1 10.855012 6.144015763 -1.766761809 
MKLN1-AS 13.478691 7.436891835 -1.812409116 
 
MESP1 47.092045 27.0727149 -1.739465183 
 
SMARCD3 36.227587 20.50702182 -1.766594237 
NA 15.493125 8.555967727 -1.810797559 
 
LOC100506123 24.377362 14.0260843 -1.738001946 
 
KRTAP19-5 24.896504 14.11271202 -1.764119016 
OR56B4 9.7229856 5.372153227 -1.80988613 
 
PDXDC2P 33.66315 19.3982529 -1.735370194 
 
CDNF 12.34904 7.000676534 -1.763978145 
CELP 8.7666139 4.847758691 -1.80838496 
 
ELAVL3 19.486017 11.2293045 -1.735282658 
 
NA 6.0194912 3.413398767 -1.763489017 
NACC1 319.51242 176.7270789 -1.807942603 
 
LRRC3-AS1 7.0145211 4.04316297 -1.734909307 
 
LPHN3-AS1 7.1244157 4.042374209 -1.762433505 
KLRG1 95.037983 52.57856137 -1.807542473 
 
TSLP 8.6705621 5.00128828 -1.733665726 
 
BEX2 14.94441 8.480097419 -1.762292248 
MIR4451 5.6808649 3.144023157 -1.806877548 
 
IGLV6-57 4.9087794 2.83153056 -1.733613446 
 
NA 29.788762 16.92749204 -1.759785929 
NRGN 161.83432 89.56877621 -1.806816261 
 
RNASE3 6.6439513 3.83736119 -1.731385456 
 
LAT 25.656487 14.5976602 -1.757575291 
LOC100507334 14.335607 7.935935743 -1.806416767 
 
LOC101928322 6.7878849 3.92188545 -1.73077082 
 
LINC01208 6.4286302 3.659116657 -1.75688037 
FGFR2 8.3530441 4.627229505 -1.805193387 
 
LOC400736 14.221742 8.22416126 -1.729263543 
 
HTR1F 6.9598382 3.96340336 -1.756025705 
HOXD1 80.457465 44.57635612 -1.804935893 
 
LOC101928917 8.5080213 4.92186321 -1.728617986 
 
WRAP53 70.136821 39.94210714 -1.755961956 
MEOX2 34.218431 18.96081251 -1.804692228 
 
SLC32A1 13.883544 8.03637399 -1.727588047 
 
ZNF558 24.188611 13.77797773 -1.755599536 
MTRNR2L2 14.850906 8.241979991 -1.801861403 
 
CST2 10.11589 5.85964927 -1.726364354 
 
CLEC18B 34.608425 19.72660302 -1.754403691 
SOX9-AS1 8.5702118 4.756740237 -1.801698509 
 
DDIT4L 50.892764 29.4927888 -1.725600263 
 
EGOT 13.366956 7.622413258 -1.75363834 
KIF21B 20.903314 11.60328505 -1.801499665 
 
LOC101927372 5.658053 3.28052373 -1.724740768 
 
MYH1 7.7542564 4.423368897 -1.753020508 
MIR548AB 18.273363 10.14733096 -1.800804833 
 
LINC00520 94.107114 54.5921198 -1.723822309 
 
LAMB3 38.860184 22.17307099 -1.752584639 
GP9 10.49286 5.828670451 -1.800215041 
 
TCF15 13.881516 8.05323586 -1.723719046 
 
VILL 13.160789 7.513763417 -1.751557507 
SCARNA5 73.963345 41.09265458 -1.799916458 
 
GRK7 8.9020853 5.16931045 -1.72210305 
 
SP140L 432.79631 247.2582647 -1.750381579 
GALM 26.222445 14.57151148 -1.799569297 
 
MTMR9LP 17.80459 10.3398024 -1.721946852 
 
NXF3 6.3832574 3.650836213 -1.74843708 
LOC100506217 14.174572 7.877565628 -1.799359436 
 
PCOLCE-AS1 11.41161 6.6284959 -1.721598771 
 
LOC101927221 12.608166 7.213260425 -1.747914988 
CCNJ 236.61986 131.5083637 -1.799276155 
 
AP1S3 18.415184 10.7055913 -1.72014635 
 
LOC100506999 16.652735 9.52743 -1.747872739 
LOC100506113 17.535078 9.745811064 -1.799242577 
 
MDFIC 46.56503 27.0931472 -1.718701403 
 
TBC1D26 13.75616 7.878240327 -1.746095472 
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RASGEF1C 7.5489161 4.197614196 -1.798382536 
 
MFSD4 10.80009 6.28828088 -1.717494892 
 
TAP1 174.54908 99.99607464 -1.745559293 
C9orf16 35.309815 19.64893651 -1.797034421 
 
RPL13A 40.346315 23.4968108 -1.717097497 
 
MIR219A2 12.300864 7.055335992 -1.743483831 
KRTAP5-AS1 11.142772 6.201229314 -1.796864996 
 
LOC101927958 9.4476677 5.50600427 -1.715884563 
 
LOC100507175 6.1707782 3.545049747 -1.740674647 
LINC01491 8.4059163 4.679483009 -1.796334396 
 
MBL1P 20.287732 11.8343149 -1.714314015 
 
SPATA3-AS1 8.4756234 4.871292749 -1.739912552 
PLA2R1 88.783173 49.44257831 -1.795682516 
 
SNORD116-13 7.0645466 4.12113984 -1.714221509 
 
FLJ44511 12.115975 6.96575749 -1.739362179 
ZNF540 6.1819329 3.445581449 -1.794162471 
 
NA 12.364946 7.22023671 -1.712540253 
 
NEK11 42.585154 24.48722627 -1.739076279 
LOC100996263 11.501867 6.411805565 -1.79385773 
 
ZNF585A 36.317585 21.224851 -1.711087884 
 
CCDC169 23.955826 13.80369586 -1.735464622 
GALNT16 9.2479929 5.15731297 -1.793180475 
 
ARAP2 11.561943 6.75727363 -1.711036669 
 
CD164L2 14.386944 8.290007295 -1.735456141 
LUM 61.760587 34.44309074 -1.793119785 
 
CETP 15.266766 8.9357273 -1.708508442 
 
LOC642934 5.8932063 3.395885531 -1.735396028 
ZNF561 71.928955 40.13419385 -1.79221127 
 
PDYN 7.7628947 4.54437704 -1.708241776 
 
SNORD115-2 5.6093418 3.233221806 -1.734907835 
PRR4 34.046316 19.0015149 -1.791768497 
 
CRYAA 12.109796 7.09154831 -1.7076378 
 
AP1S3 18.415184 10.62400379 -1.733356289 
MPV17L 20.474956 11.42731499 -1.791755649 
 
ACCS 22.472411 13.1679353 -1.706600936 
 
ZNF860 27.446344 15.84204044 -1.732500538 
MIR205HG 8.057605 4.499843204 -1.790641289 
 
LOC101929767 29.364096 17.214511 -1.705775785 
 
STAG3 7.1102213 4.109958561 -1.729998283 
ST7-OT3 26.453595 14.77591164 -1.790318993 
 
TUBB2A 44.062647 25.835448 -1.705511232 
 
SULT1E1 21.684808 12.54423921 -1.728666624 
CDKN2C 29.218446 16.33562719 -1.78863323 
 
FAM183CP 9.659383 5.66384897 -1.705445014 
 
MAGEA12 5.8002235 3.359509731 -1.726508927 
NUF2 145.65839 81.44200602 -1.788492117 
 
C8orf74 18.003256 10.5633364 -1.704315325 
 
PRKY 20.001295 11.58684723 -1.726206841 
RNF217-AS1 7.8931247 4.414272054 -1.788092037 
 
MIR4717 9.3590275 5.49138083 -1.70431223 
 
ZNF578 7.3379769 4.251781938 -1.725859186 
SLC30A10 6.3791496 3.570753789 -1.786499432 
 
MRPL23-AS1 14.560925 8.54691939 -1.703645983 
 
IGLV1-36 60.171316 34.92648755 -1.722798939 
BTK 11.421436 6.39540285 -1.785882171 
 
PRR34 11.827098 6.94243173 -1.70359589 
 
ADORA1 20.282599 11.77728304 -1.722179813 
MNT 88.704485 49.68058835 -1.785495857 
 
CT47B1 9.932488 5.83330161 -1.702721496 
 
TRAV13-2 14.772022 8.581337547 -1.721412536 
DISP2 8.2575897 4.628199167 -1.784190652 
 
TRBV4-1 7.8426232 4.60676563 -1.702414188 
 
SYP 7.4736669 4.342118705 -1.721202795 
SULF1 491.23332 275.5514461 -1.782728149 
 
TAS2R4 12.403021 7.28630843 -1.702236676 
 
MORN4 56.727548 32.95892491 -1.721158923 
SULT1E1 21.684808 12.17067293 -1.781726268 
 
TRBV4-2 5.7727271 3.39185702 -1.701937043 
 
KLF4 46.48123 27.03686018 -1.719180008 
ZNF204P 8.0758177 4.533561086 -1.781340877 
 
RGPD4-AS1 6.7100241 3.94386195 -1.701384127 
 
CXCL3 129.44355 75.29555482 -1.719139332 
PDYN 7.7628947 4.35850639 -1.781090588 
 
RPL23AP53 69.549186 40.8862168 -1.701042348 
 
TARID 8.2101722 4.78100492 -1.717248224 
MRGPRD 23.46354 13.18044211 -1.780178489 
 
C6orf147 9.669139 5.68635054 -1.700412054 
 
LOC101927391 4.895287 2.850841351 -1.717137643 
CCDC92 500.59194 281.2335486 -1.77998657 
 
DOK3 21.791259 12.8343838 -1.697881162 
 
SUMO1 8.2937031 4.830409692 -1.716977155 
CFP 13.926674 7.829722621 -1.778693133 
 
C5orf63 8.4070337 4.95331926 -1.697252542 
 
BTN2A3P 24.335084 14.1784148 -1.716347321 
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ST6GALNAC4 339.90262 191.1367339 -1.778321821 
 
IGFN1 8.4476536 4.98109265 -1.695943888 
 
POTEH 7.6814684 4.477266045 -1.715660475 
LOC389705 11.593037 6.52021205 -1.778015316 
 
MCTS1 14.813145 8.7348968 -1.695857987 
 
LOC100653005 8.2475975 4.807507701 -1.715566158 
CD164L2 14.386944 8.091955095 -1.777931773 
 
ZNF525 17.375198 10.2548594 -1.694337989 
 
PLAC8 127.6167 74.42260827 -1.714757185 
UBQLN2 316.18551 177.9668888 -1.776653587 
 
SNORD114-31 6.5876822 3.89007265 -1.693459943 
 
LOC101929432 13.784772 8.048481311 -1.712717138 
HTR2B 42.732444 24.05533109 -1.776423026 
 
MIR4421 7.1796704 4.24155625 -1.692697198 
 
MCTS1 14.813145 8.649291965 -1.712642441 
PAIP2B 17.005702 9.581171652 -1.774908388 
 
MIR548I1 6.6196186 3.91733769 -1.689825874 
 
SCG3 6.7917452 3.968567132 -1.711384744 
NA 12.364946 6.96849141 -1.77440787 
 
REP15 14.844854 8.79406152 -1.688054411 
 
LOC101929679 7.4733866 4.367671161 -1.711068973 
MYHAS 13.270634 7.481936295 -1.773689848 
 
BAG2 61.856752 36.7168099 -1.684698426 
 
THAP10 55.660558 32.53037184 -1.711033547 
PEX12 67.840146 38.28499267 -1.771977504 
 
DIO1 6.7677849 4.01768229 -1.68449977 
 
PRDM5 26.556197 15.52990659 -1.710003636 
CPSF4L 16.832085 9.501383683 -1.771540357 
 
LOC100996404 7.8801547 4.67947442 -1.683982852 
 
SNORD111 72.030327 42.15860081 -1.708555909 
ADH1C 17.75652 10.02593654 -1.771058519 
 
LPHN3-AS1 7.1244157 4.23285413 -1.68312338 
 
SNORD101 20.04459 11.73598579 -1.707959606 
ABHD12B 6.543118 3.698687443 -1.769037828 
 
OR52E6 7.0815048 4.20875364 -1.682565773 
 
NA 6.1594589 3.607288636 -1.707503765 
TUBA3D 7.4007802 4.18545958 -1.768212076 
 
CROCCP3 9.4084979 5.59356612 -1.68202139 
 
A4GALT 22.52112 13.19596229 -1.706667487 
RNF144A 190.43918 107.7554575 -1.767327508 
 
LINC00998 36.516673 21.7106665 -1.681969233 
 
IGFBP6 12.201261 7.150635989 -1.706318249 
LOC101927734 6.2900968 3.560232702 -1.766765643 
 
FHL1 10.532043 6.26242238 -1.681784127 
 
LINC01194 12.772876 7.487501393 -1.705893012 
LOC101928387 8.6766623 4.911939596 -1.766443208 
 
LOC284454 184.54259 109.780915 -1.68100793 
 
GGTA1P 5.691148 3.337367229 -1.705280726 
LINC00998 36.516673 20.67647834 -1.766097325 
 
NA 9.9308643 5.90807358 -1.68089719 
 
FAM46A 16.559799 9.713659145 -1.704795111 
LENG9 36.130355 20.46082309 -1.765830971 
 
SNHG20 42.503124 25.2963556 -1.680207389 
 
MED4-AS1 10.944799 6.428630225 -1.702508718 
LOC101928917 8.5080213 4.819023167 -1.765507445 
 
ZFP3 52.773315 31.4261037 -1.679282784 
 
NKAIN1 21.055153 12.38007987 -1.70072837 
TULP3 462.40976 261.9728854 -1.765105433 
 
COL4A6 9.1911727 5.47389933 -1.679090566 
 
CIDECP 53.371316 31.38366217 -1.700608303 
ROR2 7.966991 4.515647407 -1.764307594 
 
KRT42P 9.8574159 5.87183969 -1.678761081 
 
LOC101927497 37.474272 22.06217195 -1.698575813 
LINC01208 6.4286302 3.645486324 -1.763449277 
 
AMT 16.000817 9.5333688 -1.678401165 
 
LOC101928658 5.5818446 3.288982193 -1.697134326 
IGLV6-57 4.9087794 2.784582333 -1.762842271 
 
FAM155A-IT1 14.209848 8.47145656 -1.677379602 
 
LINC00472 59.726735 35.19296312 -1.69712153 
ATP8B1 387.15306 219.7050842 -1.762148827 
 
DKFZp779M0652 20.45614 12.1976208 -1.677059856 
 
LOC101059976 8.9313489 5.263639095 -1.696801164 
EFHC1 52.499981 29.80607581 -1.761385213 
 
KLF15 5.9794557 3.56552448 -1.677019958 
 
ZFP2 10.930867 6.445113847 -1.695992822 
EFCAB5 7.3943981 4.200715973 -1.760270913 
 
LOC101927507 16.627679 9.91704733 -1.676676411 
 
MAPK8IP1 8.6663537 5.11582179 -1.694029624 
TTLL10-AS1 8.5534472 4.85962372 -1.760104837 
 
LOC101928464 27.203323 16.2250523 -1.676624671 
 
ZNF816 22.672142 13.38418136 -1.693950606 
OR52N2 7.1830612 4.081309965 -1.759989137 
 
DPY19L2 5.0528574 3.01531338 -1.675732084 
 
ZNF561-AS1 17.479123 10.32003809 -1.693707183 
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PTP4A2 348.97662 198.4460988 -1.758546145 
 
NA 8.5552278 5.1054848 -1.675693514 
 
GBP1 306.90235 181.262853 -1.69313427 
MIR3621 20.276513 11.53947187 -1.757143919 
 
APOL1 47.203826 28.1700235 -1.675675768 
 
DPY19L2P3 6.9522645 4.106184153 -1.693120495 
CD82 123.05928 70.03433475 -1.75712781 
 
MIR1323 6.2131111 3.70799479 -1.675598671 
 
LINC00276 6.0537091 3.578136804 -1.691860718 
LOC100134368 12.110026 6.892304575 -1.757035772 
 
SIRT4 9.9367275 5.93034471 -1.675573337 
 
LENG9 36.130355 21.36438165 -1.691149115 
IGLV3-9 23.84603 13.57250128 -1.756937002 
 
ATF3 119.71539 71.4577169 -1.675331806 
 
MT4 18.284515 10.81811048 -1.69017639 
ELOVL6 167.2797 95.23387113 -1.756514795 
 
LINC00862 5.5562696 3.31792436 -1.674622133 
 
LINC00052 5.7708688 3.414799752 -1.689958196 
KCNIP2-AS1 8.5528727 4.875149353 -1.754381684 
 
LINC00463 12.776857 7.63886333 -1.67261237 
 
TAC1 8.3454718 4.939215142 -1.689635209 
SYP 7.4736669 4.26179335 -1.753643652 
 
LOC101927144 11.880177 7.10308544 -1.672537598 
 
IL23A 13.682207 8.100337261 -1.689091058 
SPATA31D3 10.421931 5.947410978 -1.752347487 
 
PGBD2 21.552058 12.8892139 -1.672100295 
 
LINC01343 6.1677696 3.651879907 -1.688930007 
SNORD115-2 5.6093418 3.202574953 -1.751509934 
 
PWAR4 6.3381577 3.79073022 -1.672014969 
 
SIGLEC5 8.7456201 5.178627143 -1.688791228 
LEPREL1 25.230808 14.40523496 -1.751502701 
 
LOC101928162 13.777018 8.23991423 -1.671985581 
 
LOC101927888 13.782619 8.171713615 -1.686625287 
NA 9.4270466 5.392323859 -1.748234494 
 
MIR28 10.111839 6.04983642 -1.671423508 
 
RRNAD1 25.357458 15.03953068 -1.686053826 
NOX5 9.0679554 5.19115428 -1.746809078 
 
OR1S2 8.8921839 5.32616631 -1.66952803 
 
HCRTR1 15.346346 9.103438173 -1.685774731 
GUCY1A3 21.236166 12.15753352 -1.746749565 
 
LOC90246 19.510682 11.6867506 -1.669470188 
 
MIR1236 9.1810725 5.44691818 -1.685553598 
SERPINA10 8.7054741 4.986291991 -1.745881328 
 
PRIMPOL 69.223126 41.4941807 -1.668261071 
 
SPIN2B 122.95207 73.01200639 -1.683997936 
HMHB1 6.9345143 3.973586643 -1.745152402 
 
LINC01350 4.8780558 2.92874171 -1.665580746 
 
ZP3 15.782153 9.373327249 -1.683730119 
AADACP1 22.855167 13.10345467 -1.744209263 
 
TRAJ5 8.7613765 5.26187993 -1.665065832 
 
INA 57.051799 33.90452558 -1.682719283 
CHGB 8.1681129 4.682999802 -1.744205259 
 
PAQR5 27.273715 16.3906847 -1.663976541 
 
LOC101926966 15.67297 9.31732949 -1.68213109 
NA 23.000105 13.18913631 -1.743867407 
 
KCTD6 11.58359 6.96576128 -1.662932423 
 
MIR943 63.962851 38.03106314 -1.681858071 
CCND1 1328.9519 762.3157299 -1.743309017 
 
ADORA1 20.282599 12.1991491 -1.66262408 
 
LINC00314 7.2696764 4.323108499 -1.681585452 
GPR126 459.78029 263.9128545 -1.742167099 
 
CDKN2A 10.811222 6.50584048 -1.661771759 
 
IFIT5 83.269499 49.54411852 -1.680714109 
IL12A 13.322684 7.652155146 -1.741036901 
 
FBLN7 12.23395 7.36518337 -1.66105163 
 
FOXE3 7.0113906 4.174720729 -1.679487333 
DACH1 108.60191 62.38868489 -1.740730879 
 
TUBA3C 13.07791 7.87560913 -1.660558479 
 
SNORD114-4 17.276567 10.2962692 -1.677944342 
SNORD113-7 7.6202703 4.37802606 -1.740572164 
 
COX6A2 20.813442 12.5392541 -1.659862859 
 
MIR1273F 6.2925792 3.752439748 -1.676930102 
NT5C3A 27.88769 16.02991109 -1.739728314 
 
MTMR7 9.6935322 5.84243593 -1.659159345 
 
KCNG3 11.172878 6.665422889 -1.676244444 
HDAC10 62.26814 35.81193924 -1.738753658 
 
SHISA9 8.1109742 4.89033904 -1.658570946 
 
USP17L10 18.66616 11.13907512 -1.675736953 
IRF2 431.11491 248.0241965 -1.738196963 
 
LOC101929058 9.0359666 5.44815936 -1.658535661 
 
CPXM2 125.91009 75.16779947 -1.675053553 
LOC100130700 15.817066 9.099962305 -1.738146326 
 
OR8H3 5.9725127 3.60121053 -1.658473626 
 
SNORD41 634.13301 378.6760416 -1.674605577 
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LOC101927206 8.6047277 4.953003931 -1.737274549 
 
CISD3 86.507251 52.1630779 -1.658400047 
 
BMP8B 11.195419 6.687592857 -1.674058175 
GAB1 222.20647 128.0611098 -1.735159648 
 
ISG15 86.138685 51.9846078 -1.65700365 
 
LOC101926895 10.957284 6.545366159 -1.674052152 
ACE 153.04931 88.21936142 -1.734872146 
 
CHRNG 9.9579896 6.01103542 -1.656618019 
 
ATP6V0CP3 38.038193 22.72347987 -1.673959865 
LRRC16A 107.6031 62.03593708 -1.734528427 
 
MIR325HG 14.560617 8.79088024 -1.656332088 
 
LINC01187 9.9033835 5.916698996 -1.673802155 
C6orf226 19.478199 11.23227346 -1.7341279 
 
SEPP1 25.116469 15.1641566 -1.656305074 
 
C19orf44 41.826858 24.99474811 -1.673425879 
NDE1 382.21382 220.5314856 -1.733148536 
 
RDH14 45.46136 27.4551843 -1.65583882 
 
PTCHD1 7.7425401 4.627591924 -1.673125079 
MIR4472-1 5.8546242 3.379812593 -1.732233382 
 
KRTAP4-6 7.3737866 4.45416647 -1.655480691 
 
ASPHD1 23.698675 14.16524188 -1.673015934 
C1orf140 9.0456887 5.228296493 -1.730140724 
 
PVRIG 11.646677 7.04242223 -1.653788459 
 
USP29 5.6542535 3.380310345 -1.672702472 
NUDT17 29.294248 16.93336914 -1.729971635 
 
LOC100653005 8.2475975 4.99065439 -1.65260843 
 
ADH1C 17.75652 10.61799857 -1.672303892 
FAM92A1P2 6.4670072 3.738318714 -1.729923974 
 
ZBTB16 6.9431067 4.20130554 -1.652606941 
 
ZNF503-AS2 8.8183893 5.276899392 -1.671130836 
NCF1C 10.351222 5.984512963 -1.729668192 
 
SNORD114-14 39.890121 24.138504 -1.65255148 
 
SNAR-I 312.07131 186.8020577 -1.670598866 
SNORA37 70.881215 40.98696451 -1.729359955 
 
LOC101927721 6.78397 4.1059461 -1.652230659 
 
NA 14.997819 8.977527356 -1.670595738 
ZNF322 35.645737 20.6159386 -1.729037812 
 
ZNF300P1 14.804128 8.96523925 -1.651280846 
 
SAMD9L 188.65681 112.9500144 -1.670268128 
LOC100505592 21.423305 12.39105603 -1.728932966 
 
LOC101929719 6.8849874 4.17070375 -1.650797511 
 
NRG4 12.089954 7.242010002 -1.669419688 
SNORD114-4 17.276567 9.992702103 -1.728918411 
 
MIR4312 16.608596 10.0659235 -1.649982358 
 
FAM129A 120.07271 71.93369555 -1.669213699 
LOC101927888 13.782619 7.974675291 -1.728298435 
 
TLCD2 12.65901 7.67602807 -1.64916155 
 
NEU3 18.457097 11.06389776 -1.668227354 
IL17B 13.958291 8.076388546 -1.728283773 
 
RAB3IL1 79.178687 48.0216097 -1.64881368 
 
PLCD4 17.508022 10.50044474 -1.66736008 
MIR3116-2 12.181144 7.049565527 -1.727928359 
 
CCNC 99.178654 60.1827599 -1.647957896 
 
SLC30A3 29.874641 17.91839837 -1.66726068 
AMPH 158.19841 91.59063913 -1.727233412 
 
OLFML2A 9.0526005 5.49531043 -1.647331965 
 
LOC101927372 5.658053 3.397666416 -1.665276201 
OR2F2 5.4858077 3.177986958 -1.726189506 
 
TUBA4A 21.496473 13.0514334 -1.647058421 
 
ABCC6P2 7.5948634 4.561764429 -1.664896015 
PIDD1 44.947914 26.04516454 -1.72576808 
 
PACSIN1 10.04335 6.10281599 -1.64569113 
 
MAFG-AS1 27.287296 16.39537964 -1.664328402 
USP17L10 18.66616 10.8172811 -1.725587015 
 
NUDT22 22.897655 13.9226073 -1.644638438 
 
IGFBP3 54.011941 32.49363936 -1.66223118 
LOC101927757 5.76813 3.342962237 -1.72545472 
 
OR2L8 8.7438276 5.31675488 -1.644579794 
 
SNORD114-24 5.2956282 3.186485461 -1.661902529 
MIR4502 10.868588 6.303596522 -1.724188475 
 
FAM87B 8.4011562 5.11154709 -1.643564273 
 
PRPS1L1 9.2351294 5.560872557 -1.660733875 
RBBP9 148.43352 86.09323853 -1.724101975 
 
AKNA 24.907097 15.1592476 -1.643029867 
 
UBE2M 100.37973 60.45986773 -1.660270351 
RFTN2 40.588712 23.54660516 -1.723760669 
 
OR6B3 4.7989855 2.92103841 -1.642903947 
 
ZFAT-AS1 7.8062756 4.701980034 -1.660210286 
COLEC12 207.10106 120.2466225 -1.722302487 
 
CCNA1 28.222686 17.1838473 -1.642396253 
 
LINC01176 8.3843313 5.051307951 -1.659833721 
TAL2 6.8425905 3.975700628 -1.721103051 
 
IGFBP3 54.011941 32.8884164 -1.642278542 
 
MIR3191 19.708338 11.90070463 -1.656064811 
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ZMYND8 491.04813 285.4120911 -1.720488179 
 
OR52N2 7.1830612 4.37858607 -1.640497888 
 
DAPL1 5.3887783 3.25432877 -1.655880126 
ADAMTS12 6.9035997 4.017682286 -1.718304037 
 
IL34 13.722475 8.36883424 -1.63971167 
 
C17orf96 20.494088 12.37962121 -1.655469695 
IPO13 111.15944 64.69682236 -1.718159144 
 
PLEKHM1 134.99351 82.4093737 -1.638084456 
 
NPTX2 33.266315 20.09646316 -1.655331845 
LOC101929741 5.0268593 2.926981627 -1.717420864 
 
SCARNA20 32.691326 19.9762773 -1.636507398 
 
LOC101927720 10.514058 6.352611224 -1.655076537 
ATP5SL 296.24579 172.5245354 -1.717122683 
 
SNORA36B 6.631221 4.0523929 -1.636371688 
 
R3HDML 6.1861178 3.738381074 -1.654758483 
SUMO1 8.2937031 4.830409692 -1.716977155 
 
CD101 7.3373882 4.4867038 -1.635362737 
 
ZNRF2P1 14.446192 8.737451694 -1.653364423 
FAM127A 16.727008 9.74424816 -1.716603273 
 
IL6 236.85212 144.873494 -1.634889271 
 
TNF 19.45505 11.78020489 -1.651503496 
CORO1A 108.20789 63.08691823 -1.715219205 
 
SH3GL3 6.6196735 4.05200994 -1.633676512 
 
LINC01490 11.376261 6.889386482 -1.651273524 
CHRNG 9.9579896 5.808627028 -1.714344808 
 
ZBTB12 18.592708 11.3818306 -1.633542834 
 
URAHP 24.201609 14.66667739 -1.650108526 
GDF7 10.944486 6.387788484 -1.713345101 
 
FAM90A25P 18.293829 11.2051588 -1.632625614 
 
LINC00278 10.329464 6.264547227 -1.648876432 
ABHD14B 35.648352 20.82706681 -1.711635764 
 
LINC01476 6.4914345 3.97823824 -1.631735996 
 
TUBB2A 44.062647 26.73490388 -1.648131854 
MRPL48 61.48909 35.92558697 -1.711568137 
 
OXCT2 7.637276 4.68166933 -1.631314695 
 
LINC01347 14.576222 8.84449647 -1.64805564 
OR13C3 5.6206642 3.286434193 -1.710262202 
 
ZBTB44 218.74486 134.115828 -1.631014519 
 
FAM73B 46.596754 28.27792674 -1.647813672 
KATNAL1 101.03009 59.08622552 -1.709875541 
 
MIR520F 9.5227824 5.84001915 -1.630608084 
 
MIR4638 40.996316 24.88665032 -1.647321593 
MIR891A 30.873533 18.05897138 -1.709595321 
 
DKFZP434L187 5.5436777 3.40188785 -1.629588614 
 
C10orf53 6.6465188 4.035547333 -1.646993147 
CENPM 43.566046 25.50618005 -1.708058437 
 
EGLN3 8.4714566 5.20177644 -1.628569906 
 
JDP2 18.15658 11.02612658 -1.64668708 
HTN1 6.7728604 3.967078725 -1.707266445 
 
ALG10B 11.202913 6.87933714 -1.628487255 
 
SNORA44 69.617713 42.28367524 -1.646444217 
PDPK1 429.68333 251.6893561 -1.707197063 
 
MIR3130-1 11.434813 7.02174474 -1.628485947 
 
LOC101928227 5.8825058 3.575609743 -1.645175575 
ITGA11 25.126184 14.72695165 -1.706136132 
 
PCDHB14 14.096632 8.65707824 -1.628335947 
 
SURF2 98.954833 60.1713157 -1.64455159 
CYP1B1 15.955155 9.353472018 -1.705800285 
 
IGKV3-20 15.354057 9.43025099 -1.628170531 
 
RRP8 67.895801 41.29818951 -1.644038202 
HAPLN3 200.1042 117.3787396 -1.704773839 
 
LOC101927746 29.936544 18.3969138 -1.627259001 
 
ZNF705A 4.5406972 2.763536766 -1.643074639 
NUDT4 94.038512 55.17083655 -1.70449676 
 
MIR598 7.1384512 4.3887279 -1.626542209 
 
LOC101929463 9.9281657 6.042739886 -1.64299075 
LRRC71 12.965498 7.614009675 -1.70284765 
 
PTTG1 50.47561 31.0393279 -1.62618244 
 
CEBPA 12.663081 7.711476635 -1.642108425 
CYP2B7P 6.5890993 3.870325525 -1.702466441 
 
KRTAP19-3 5.6738898 3.49055378 -1.625498474 
 
PAQR5 27.273715 16.61394412 -1.641615897 
LOC100506100 38.353733 22.53149888 -1.70222734 
 
LOC101928004 18.023695 11.088755 -1.625402904 
 
VPS37C 121.95383 74.30625342 -1.641232331 
PBXIP1 88.967516 52.26662855 -1.702185862 
 
TNFAIP3 550.12826 338.636221 -1.624540506 
 
ARL11 8.7718139 5.346490377 -1.640667665 
PAPSS2 386.16525 227.0253608 -1.700978468 
 
LOC100289361 13.425916 8.26966698 -1.6235135 
 
CHRNG 9.9579896 6.071941443 -1.640000925 
LOC100130899 8.1781793 4.809766393 -1.700327752 
 
PNMAL2 10.589205 6.52268873 -1.62344179 
 
MVK 28.024697 17.09370742 -1.639474456 
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MAGEA12 5.8002235 3.412411847 -1.699743114 
 
ZNF708 14.987492 9.23400918 -1.623075313 
 
LOC283278 6.7006213 4.093947219 -1.636714149 
LOC100130673 6.2766898 3.693878466 -1.699213947 
 
AHSG 9.8967948 6.0981364 -1.622921193 
 
RNF217-AS1 7.8931247 4.825564284 -1.635689475 
CXorf31 10.865206 6.398642098 -1.698048793 
 
NR4A1 34.973506 21.5508749 -1.622834603 
 
ISL1 16.029168 9.802757332 -1.635169301 
TRAV13-2 14.772022 8.700603752 -1.697815743 
 
CYP2D7P 16.948262 10.4436531 -1.622828906 
 
TRIM3 60.696614 37.12948314 -1.634728213 
MCU 266.59468 157.0353804 -1.697672734 
 
CXCR5 7.7152904 4.7544018 -1.622767852 
 
C8orf31 12.22449 7.479196522 -1.634465731 
PCDHGA10 67.715964 39.89805269 -1.697224781 
 
MYL1 11.361871 7.00317532 -1.622388505 
 
LOC391722 10.79298 6.60394203 -1.634323908 
IRF6 139.27808 82.06660722 -1.697134674 
 
GATA6-AS1 10.662148 6.57215745 -1.6223209 
 
LOC100287010 5.7428701 3.51535959 -1.633650817 
ARHGAP28 178.90416 105.4217831 -1.697032241 
 
RNU6-68P 4.9573089 3.05630369 -1.621994878 
 
CD70 13.9535 8.544071462 -1.633120658 
ANKRD65 13.569421 8.000339501 -1.696105675 
 
C1QTNF9B-AS1 16.089715 9.92276832 -1.621494614 
 
ELAVL3 19.486017 11.94198572 -1.631723379 
OR4D1 6.2658496 3.69431475 -1.696078991 
 
FAM138C 3.6419245 2.24663254 -1.621059278 
 
LINC00475 4.7578362 2.916423518 -1.631394145 
GPR135 24.556708 14.47886282 -1.696038459 
 
TRMT61A 62.671316 38.704219 -1.619237317 
 
LLPH 132.61713 81.31410992 -1.630923899 
TIMP3 106.20902 62.63836673 -1.695590542 
 
LOC101928947 5.459051 3.37363739 -1.618149883 
 
TNFSF18 331.17676 203.1123757 -1.630510015 
OR7E14P 8.0804765 4.771126654 -1.693620213 
 
LOC643406 4.9301403 3.0468828 -1.618093198 
 
PRR13 48.626621 29.82782142 -1.6302438 
TTC9 16.415927 9.695527872 -1.693144249 
 
PRKY 20.001295 12.3688811 -1.617065825 
 
EXOSC4 38.975085 23.90826258 -1.630193101 
LOC101060400 8.6568048 5.115760431 -1.692183386 
 
NPY1R 9.5786254 5.92371006 -1.616997683 
 
LOC101928758 14.345728 8.801800687 -1.629862867 
SDC3 374.67076 221.4621718 -1.69180479 
 
LOC645513 21.94902 13.5780574 -1.616506622 
 
PWP2 170.46748 104.597962 -1.629739975 
KRTAP12-1 10.344794 6.115558908 -1.691553377 
 
GRM3 6.4278273 3.97715149 -1.616188705 
 
PGBD2 21.552058 13.22593267 -1.629530326 
LOC101928221 5.9291585 3.505554995 -1.691360857 
 
SFRP5 11.87166 7.34552508 -1.616175843 
 
SNORD63 324.90191 199.3939649 -1.629447072 
OR10A3 23.34467 13.80766273 -1.690703923 
 
OR10H4 8.5093634 5.2669779 -1.61560644 
 
DHX58 18.842387 11.56406745 -1.629390987 
ATL1 21.844982 12.93184058 -1.689239946 
 
MIR4492 32.158181 19.9061163 -1.615492492 
 
C9orf116 72.395943 44.43677943 -1.629189687 
SNN 303.29142 179.7431842 -1.687359786 
 
ZNF823 57.600836 35.6660412 -1.615005041 
 
LOC101927757 5.76813 3.540695203 -1.629095316 
SEMA6C 24.978045 14.80925994 -1.686650477 
 
AMELX 5.6646627 3.50843553 -1.614583664 
 
RPS15AP10 11.545018 7.087808848 -1.628855656 
CCNT1 254.70048 151.0826569 -1.685835349 
 
ZNF594 24.824052 15.3779833 -1.614259238 
 
ZNF33B 98.773824 60.67335101 -1.627960582 
LOC101927002 28.64437 16.99150883 -1.685804975 
 
AOC3 10.797622 6.69474295 -1.61285088 
 
ZNF300P1 14.804128 9.094090608 -1.627884358 
SYN2 24.969333 14.81491413 -1.685418649 
 
HHAT 19.280302 11.9682229 -1.610957794 
 
AMZ2P1 6.2614768 3.846412677 -1.627874418 
TRBV4-1 7.8426232 4.654129013 -1.685089337 
 
CDY2B 12.785609 7.93697798 -1.610891321 
 
DNM1P35 15.4841 9.513672923 -1.627562765 
ZNF552 8.462102 5.022435717 -1.684860188 
 
FOXL2NB 9.274111 5.75729798 -1.610844356 
 
CELP 8.7666139 5.387059067 -1.627346906 
NA 7.726902 4.587060262 -1.68449977 
 
LIG3 83.822854 52.0611713 -1.610083912 
 
ZNF132 16.919226 10.39712753 -1.627298144 
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GDPD5 57.180781 33.98631668 -1.682464786 
 
POM121L8P 69.141378 42.9656255 -1.609225458 
 
STAT5A 135.20514 83.11205072 -1.626781454 
LOC101929715 11.456978 6.810265173 -1.682310132 
 
LOC284344 8.4920666 5.27748698 -1.609111808 
 
FAM76A 29.249375 17.98634304 -1.626199123 
GIPC2 74.711408 44.41548255 -1.682102811 
 
LOC101927151 13.318803 8.28283848 -1.607999819 
 
PCDHGA8 11.531116 7.090993488 -1.626163641 
LOC101927685 13.020529 7.742142025 -1.68177348 
 
CELF4 10.005029 6.22366627 -1.607577989 
 
INPP5E 57.305745 35.26422957 -1.625038892 
NT5M 10.810853 6.428667114 -1.681663155 
 
SNORD58C 124.75338 77.6213165 -1.607205103 
 
LOC101928162 13.777018 8.478345791 -1.624965309 
PPP3CB-AS1 27.810221 16.53861262 -1.681532898 
 
SPATA24 18.067345 11.2484197 -1.606211834 
 
C9orf106 27.446344 16.89525005 -1.624500585 
RBP1 51.001862 30.33273842 -1.681413058 
 
CXorf31 10.865206 6.76537112 -1.606003026 
 
ZKSCAN5 43.034018 26.49311288 -1.624347348 
RPL13A 40.346315 24.00038845 -1.681069247 
 
CBX4 114.48654 71.289646 -1.605935056 
 
OR1L3 3.9433558 2.430677621 -1.622327762 
EPS15L1 405.55254 241.2708687 -1.680901382 
 
MYRF 10.370186 6.46179686 -1.604845569 
 
LOC100653133 21.809327 13.44388707 -1.6222486 
MAP2K6 88.806997 52.86197195 -1.679978893 
 
HMSD 8.04396 5.01263022 -1.604738362 
 
C17orf97 40.282383 24.84950196 -1.621053952 
DZIP1L 25.758688 15.33419319 -1.679820234 
 
GP9 10.49286 6.53875806 -1.604717612 
 
SH3RF2 40.846284 25.19798544 -1.621013885 
CREB3L2 610.38078 363.3957256 -1.67965867 
 
KCNK3 20.878303 13.0132652 -1.604386221 
 
HAAO 14.174662 8.744641171 -1.620954152 
PABPC3 7.0355708 4.189397498 -1.679375335 
 
ZNF573 14.286299 8.90558155 -1.604196134 
 
SCARNA21 100.32514 61.92972823 -1.619983478 
MIR27A 32.473905 19.34560562 -1.678619207 
 
IGHV1-24 7.4617661 4.6537379 -1.603391998 
 
EBF4 17.281177 10.66775208 -1.619945493 
LINC00906 5.9607095 3.551005614 -1.678597589 
 
ZNF468 258.28737 161.112841 -1.603145798 
 
NA 8.9715733 5.539233207 -1.619641741 
LOC100505478 7.1269451 4.245851381 -1.678566773 
 
TEX15 12.392753 7.73428946 -1.602313052 
 
LINC00536 8.0239181 4.954864159 -1.619402237 
AKT2 133.26008 79.39962128 -1.678346505 
 
CASP12 16.803484 10.4882625 -1.602122781 
 
MMP17 41.805452 25.81632546 -1.619341674 
SEMA6A 22.09301 13.16770165 -1.67781822 
 
ZNF204P 8.0758177 5.04177001 -1.601782245 
 
ZNF679 5.2305413 3.230168828 -1.619278008 
SNORD90 13.086034 7.802532796 -1.677152103 
 
KRTAP5-8 9.025871 5.634931 -1.601771347 
 
MIR1185-2 8.6446336 5.338592085 -1.619272169 
SPATA3-AS1 8.4756234 5.054445545 -1.676865112 
 
MIR103A2 15.848983 9.89512105 -1.601696699 
 
SNORD115-24 8.0006711 4.942028575 -1.61890426 
GDF6 119.55904 71.30852122 -1.676644475 
 
TUBGCP6 38.633378 24.1449046 -1.600063396 
 
HIST1H4H 39.300629 24.28116259 -1.618564549 
MIR550A1 7.891342 4.708098751 -1.676120756 
 
ZNF276 59.76321 37.3605938 -1.599632238 
 
HDHD2 136.94102 84.6487466 -1.617756068 
LOC284600 8.9790825 5.357119918 -1.676102576 
 
LOC101926940 9.4448958 5.90784029 -1.598705331 
 
RIIAD1 9.2316613 5.706857685 -1.617643519 
MIF4GD 72.232508 43.13487517 -1.674573256 
 
MIR27A 32.473905 20.3128711 -1.598686126 
 
LOC101927204 39.647449 24.51225302 -1.617454286 
SIRPA 489.1068 292.1291506 -1.674282771 
 
MTOR-AS1 6.508771 4.07268094 -1.598153925 
 
CXCL8 3013.9613 1863.646364 -1.617238825 
LGI3 7.4462784 4.447837299 -1.674134624 
 
LOC101060400 8.6568048 5.41700291 -1.598080149 
 
SNORD19 7.838496 4.852703008 -1.615284503 
CRHBP 10.600431 6.333432052 -1.673726114 
 
MIR4311 5.8984819 3.69217982 -1.597560839 
 
LOC101929445 9.3749672 5.804315223 -1.615171957 
LOC101927257 8.9728071 5.361537112 -1.673551241 
 
DIAPH3-AS1 11.643144 7.29278105 -1.596530054 
 
GRIN3B 14.259731 8.828882411 -1.615122958 
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G6PC3 836.29765 500.139057 -1.672130266 
 
CEBPA 12.663081 7.93199501 -1.596455966 
 
ANKRD53 34.739232 21.50970829 -1.615048962 
LRRN4 6.9525587 4.160021376 -1.671279549 
 
BAK1 155.04775 97.2117427 -1.594948805 
 
NOG 40.346315 24.99648234 -1.614079709 
MS4A6A 8.0245038 4.802305654 -1.670968991 
 
IL17B 13.958291 8.75240152 -1.594795582 
 
EGR3 14.718184 9.119490881 -1.613926093 
DOCK1 397.86394 238.1125276 -1.670907227 
 
PLBD1 11.904838 7.46543716 -1.594660485 
 
LARS2-AS1 6.89447 4.273850589 -1.613175243 
LOC101929340 19.210922 11.50068995 -1.670414773 
 
CCL18 19.072468 11.9653257 -1.593978186 
 
LOC100506538 6.7682885 4.195753393 -1.613128289 
C14orf178 9.4277121 5.647882538 -1.669247206 
 
CHKB-AS1 25.884725 16.249799 -1.592925828 
 
GKAP1 10.315636 6.395414083 -1.612973944 
CAMK4 62.153491 37.25517593 -1.668318272 
 
CMA1 10.484304 6.58450484 -1.592269103 
 
LOC101928399 13.422012 8.323276713 -1.612587511 
IL1F10 6.4887565 3.891538937 -1.667401161 
 
PRIM2B 130.33039 81.9240939 -1.590867588 
 
CACTIN 70.679695 43.84391872 -1.612075213 
ZNF599 10.493422 6.299458061 -1.665765898 
 
OR8B4 5.3961111 3.39355445 -1.59010595 
 
PRKCZ 13.177904 8.175832918 -1.611811856 
LINC00263 39.673154 23.82170848 -1.665420179 
 
MIR4472-1 5.8546242 3.6829745 -1.589645596 
 
PBOV1 7.026481 4.363113262 -1.61042828 
NFKBID 44.558207 26.76212774 -1.664972522 
 
ATP5L 37.741676 23.7467242 -1.589342436 
 
ZBTB12 18.592708 11.54585291 -1.610336454 
LOC100996286 10.563336 6.344588144 -1.664936507 
 
CDH20 6.9380169 4.36572604 -1.589201158 
 
LINC01470 5.927864 3.681962064 -1.609974223 
OR4A47 6.0046764 3.60681265 -1.664815155 
 
GBP5 10.43691 6.57019772 -1.588523008 
 
LOC101060264 30.681669 19.06100976 -1.609656014 
C1R 26.947574 16.18931173 -1.66452871 
 
IFT81 51.292512 32.3163412 -1.587200487 
 
MIR3074 5.2605729 3.270066601 -1.608705118 
MILR1 14.534222 8.732630808 -1.664357723 
 
IGKV1-8 5.6086441 3.53471868 -1.58672999 
 
LINC01476 6.4914345 4.037261695 -1.607880547 
PCGF3 378.56421 227.548354 -1.663664909 
 
MAL2 200.09982 126.112094 -1.586682232 
 
ATP6V1E2 16.398019 10.19978005 -1.607683549 
LRRC37B 28.8035 17.31341069 -1.663652535 
 
LOC339622 5.1025726 3.21723419 -1.586012172 
 
CYB561D1 30.52403 18.99030198 -1.607348308 
PITX2 8.3642325 5.028877424 -1.663240487 
 
NPL 18.449712 11.6345918 -1.585763607 
 
ZNF135 43.033387 26.80058828 -1.605688151 
LOC392196 8.4948031 5.109375933 -1.662591133 
 
KRT38 13.153941 8.29566167 -1.585640946 
 
AHI1 62.174339 38.72593639 -1.605496069 
KRTAP5-6 9.332258 5.616133312 -1.661687401 
 
PRSS21 9.4484871 5.96096209 -1.585060756 
 
GPNMB 12.868266 8.015937205 -1.605335133 
TRIM49 6.3862892 3.843292006 -1.661671594 
 
LINC00276 6.0537091 3.81983187 -1.584810356 
 
TMEM110 50.200965 31.29824464 -1.603954636 
PBX1 80.863841 48.6679948 -1.661540431 
 
SLC30A10 6.3791496 4.02737731 -1.583946358 
 
LOC100506476 7.9773034 4.974855495 -1.603524646 
CLIP2 133.58483 80.41625676 -1.661167014 
 
OR52M1 7.363391 4.64925568 -1.583778463 
 
ZNF707 27.110236 16.91372647 -1.602854092 
DCAF12L2 7.9383919 4.779206724 -1.661027097 
 
ALOX5AP 23.134325 14.6083281 -1.583639475 
 
IRF7 31.911893 19.91035864 -1.602778411 
BCL2 30.344731 18.26975021 -1.660927504 
 
MIR147A 16.589357 10.4787994 -1.583135236 
 
SPATA25 18.462481 11.52091201 -1.602519027 
C10orf55 11.348034 6.832353743 -1.660925965 
 
CXCL2 48.698467 30.7627942 -1.583031317 
 
LOC100506371 9.5468404 5.963659893 -1.600835819 
NBPF1 165.81751 99.87284495 -1.660286189 
 
HNF4A 14.313027 9.04537056 -1.582359394 
 
LOC101928762 8.8180294 5.512312279 -1.599696999 
VWA5A 60.030983 36.16553222 -1.659894924 
 
C3orf67 20.371689 12.8755145 -1.582203841 
 
LOC101927903 10.698698 6.689333405 -1.599366761 
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SEPT7 778.56766 469.2013046 -1.659346742 
 
GGT8P 6.8718348 4.34440026 -1.581768343 
 
S100A3 52.476568 32.815678 -1.599130991 
MN1 77.744121 46.85398887 -1.659285012 
 
PCDHA6 10.661301 6.74251094 -1.581206364 
 
TPI1P2 19.049673 11.9132142 -1.59903723 
JMJD8 238.79984 143.9297375 -1.659141743 
 
ANKRD29 12.662291 8.01331136 -1.580157151 
 
ANGPTL4 101.09385 63.2381245 -1.59862185 
LOC90246 19.510682 11.76355353 -1.658570406 
 
MIR219A2 12.300864 7.78521293 -1.580029261 
 
KIAA1804 15.405794 9.637268756 -1.598564305 
FAM205A 8.6669624 5.226717202 -1.658203814 
 
IRS1 13.456463 8.51753027 -1.57985502 
 
PNMT 9.0330631 5.650746651 -1.598560984 
RPS3A 17.800736 10.73556762 -1.65810852 
 
HES3 8.79323 5.56755567 -1.579369937 
 
MIR711 6.861034 4.296303749 -1.59696203 
OR10V2P 6.7128918 4.0503785 -1.657349257 
 
CSF2 24.659026 15.6151158 -1.579176645 
 
OTOR 5.4110058 3.38843389 -1.596904636 
NRN1 206.18782 124.4473018 -1.656828366 
 
LOC101927354 9.2274092 5.84426503 -1.578882735 
 
SIRT7 84.303815 52.79486567 -1.596818447 
FSTL5 13.349232 8.059053153 -1.656426802 
 
ZNF583 58.564464 37.1094969 -1.578153015 
 
KLHDC8B 63.046316 39.49359928 -1.596367939 
NA 5.6735258 3.42546119 -1.656280855 
 
ELN 10.205472 6.47882359 -1.575204441 
 
SNORA13 100.82098 63.19249198 -1.595458253 
SDPR 1178.2228 711.9317447 -1.654966026 
 
PRKCZ 13.177904 8.36801908 -1.574793784 
 
TLE6 9.1370933 5.727175877 -1.595392474 
ZNF772 35.834105 21.65768498 -1.65456766 
 
SAPCD2 30.406387 19.3104792 -1.574605534 
 
SNORA16B 20.142813 12.62748719 -1.595156046 
LILRA5 5.8217704 3.518794007 -1.65447888 
 
PSKH2 10.959474 6.96016455 -1.574599776 
 
ZNF136 60.827665 38.13375581 -1.595113413 
SLC9A1 445.32466 269.2024856 -1.654236793 
 
LOC100505478 7.1269451 4.52662886 -1.574448727 
 
MYOC 8.920889 5.598117478 -1.593551589 
MZF1-AS1 15.172461 9.173112337 -1.654014509 
 
LOC285043 7.2415987 4.60078546 -1.573991818 
 
USP9Y 26.426528 16.59017522 -1.592902304 
DPPA4 6.7677849 4.09870643 -1.651200203 
 
TECTA 10.226161 6.49915552 -1.573460036 
 
HS3ST1 32.231698 20.23989136 -1.592483737 
CD34 461.74238 279.6952564 -1.650876676 
 
C3orf80 7.4027457 4.70553906 -1.573198222 
 
LOC101927797 5.6095315 3.522590737 -1.592444842 
NHEJ1 178.85059 108.4004444 -1.649906466 
 
ASIP 9.3894691 5.96899099 -1.57304126 
 
LOC101928374 9.2296894 5.79910836 -1.591570429 
TEX15 12.392753 7.516990045 -1.648632348 
 
DRD3 8.2932979 5.27309445 -1.572757319 
 
ZNF296 69.77364 43.83984539 -1.591557628 
IL20RB 52.219605 31.67927718 -1.648383725 
 
DUOX2 6.653422 4.23154385 -1.57233914 
 
RAB33A 11.399986 7.165182413 -1.591025281 
MIR544B 6.3950783 3.880955888 -1.647810091 
 
ZFP69 28.145345 17.9154626 -1.571008529 
 
WNT4 16.200032 10.18290356 -1.590904945 
LOC101926966 15.67297 9.513754328 -1.647401127 
 
CLN8 76.484487 48.6878588 -1.570914989 
 
NA 8.5552278 5.380740871 -1.589972082 
MYH6 7.5979304 4.612764454 -1.647153349 
 
STAG3L4 36.71368 23.3758622 -1.570580785 
 
GNAS-AS1 6.7462124 4.24348102 -1.589782629 
ITGB3BP 77.389881 46.99631646 -1.646722273 
 
PDE1C 7.5748396 4.82593804 -1.569609787 
 
SNORD114-6 9.5226831 5.992389971 -1.5891294 
MYO5C 60.640766 36.82946387 -1.646528605 
 
CXCL5 175.23017 111.651134 -1.569443715 
 
LOC101929741 5.0268593 3.163325792 -1.589105784 
LOC101927144 11.880177 7.216249309 -1.646309178 
 
C1QTNF3 6.7129733 4.27753545 -1.569355395 
 
TPI1P3 7.5627276 4.760941169 -1.588494243 
CCDC97 371.42634 225.612126 -1.646304843 
 
LOC283693 7.8214227 4.98626168 -1.568594509 
 
ZNF324 23.956015 15.08340738 -1.58823631 
NOS1 24.134995 14.66652949 -1.645583241 
 
BAAT 6.0852048 3.87965328 -1.568491909 
 
KANSL1L 50.708204 31.95470584 -1.586877506 
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SNRPA1 50.360161 30.60886816 -1.645280065 
 
LAMP3 46.556801 29.701375 -1.567496501 
 
GEMIN8 41.716992 26.29087235 -1.586748103 
ACVR2B 36.354934 22.11919914 -1.643591771 
 
UTS2 6.8898436 4.39589627 -1.567335349 
 
RUSC1-AS1 14.371101 9.058338881 -1.586505134 
PRAP1 33.56208 20.42151111 -1.643467007 
 
SLC25A25 41.547509 26.5250489 -1.566349956 
 
OR13J1 10.900323 6.871008793 -1.586422507 
MGP 694.60513 422.6608802 -1.643410028 
 
SDC4P 8.6874234 5.54700936 -1.566145437 
 
ZNF276 59.76321 37.67266343 -1.586381341 
LOC101927497 37.474272 22.81349186 -1.642636379 
 
CELP 8.7666139 5.59777372 -1.566089367 
 
LOC101929637 6.4286302 4.052575506 -1.586307329 
KANK4 6.0866844 3.712853771 -1.639354741 
 
TMEM134 38.528261 24.60222 -1.566048151 
 
EFNA3 39.619017 24.97880182 -1.586105578 
SNORA7B 83.628612 51.02019449 -1.639127658 
 
PDF 95.571317 61.0359289 -1.565820639 
 
C15orf48 8.6895801 5.478847514 -1.586023352 
BEAN1 16.271324 9.92710827 -1.639079898 
 
SNHG7 57.041024 36.4351093 -1.565551053 
 
PRG2 11.113395 7.013059458 -1.584671507 
VILL 13.160789 8.030371119 -1.638876775 
 
RPS3A 17.800736 11.3785693 -1.564408995 
 
C19orf48 139.29632 87.91956788 -1.584360786 
LOC100506302 28.034177 17.11736309 -1.637762613 
 
FLJ38668 26.201538 16.7507506 -1.564200811 
 
LOC146880 66.648582 42.07995799 -1.583855727 
PRICKLE2-AS3 8.5089313 5.195941908 -1.637610934 
 
DUSP26 11.284021 7.21587485 -1.563777283 
 
NLGN4Y-AS1 6.5857947 4.158278846 -1.583778994 
IGKV1-27 5.8940027 3.600308771 -1.637082547 
 
BOLA3-AS1 42.085855 26.9178173 -1.563494343 
 
PSG1 4.9519256 3.128056516 -1.583067814 
EPN2-AS1 6.5168013 3.982919056 -1.636187234 
 
RILP 25.094748 16.0563805 -1.562914353 
 
MIR16-2 7.4351042 4.69665286 -1.583064445 
OR5AR1 12.000451 7.334907376 -1.636073926 
 
TKTL1 11.676815 7.47151589 -1.562844113 
 
LINC00326 5.3813967 3.400207983 -1.582666919 
PBX2 322.56598 197.1993826 -1.635735232 
 
KRTAP5-6 9.332258 5.97182989 -1.562713297 
 
NA 5.9609049 3.766699452 -1.58252734 
NA 11.416779 6.980226639 -1.635588564 
 
LOC101927341 6.1504502 3.938251 -1.56172123 
 
IQCF5 7.8129802 4.937687083 -1.582315775 
NA 10.814676 6.612196708 -1.635564701 
 
ZNF611 76.909912 49.2594089 -1.561324294 
 
LOC148696 8.8760578 5.611105855 -1.581873176 
REEP5 885.20649 541.3074196 -1.635311949 
 
ST3GAL5-AS1 10.855012 6.9528676 -1.561228118 
 
NA 5.6735258 3.587425751 -1.581503335 
PIK3IP1 42.489729 25.98848798 -1.634944244 
 
OARD1 150.42482 96.3909173 -1.560570475 
 
TRIB3 92.972289 58.81030906 -1.580884214 
LOC101929229 21.159847 12.94283805 -1.634869182 
 
INSRR 7.2677579 4.657263 -1.560521247 
 
USP27X 39.179744 24.78450595 -1.580816012 
ATP8B4 6.6273415 4.055585297 -1.63412701 
 
GATS 9.2196944 5.9081151 -1.560513677 
 
AADACP1 22.855167 14.45786148 -1.580812421 
PLCE1-AS2 18.655915 11.41747188 -1.633979525 
 
FABP6 6.3608247 4.07798704 -1.559795215 
 
CASC1 7.4049598 4.684873414 -1.58061044 
ABCB6 49.243066 30.18302044 -1.631482363 
 
ZNF136 60.827665 38.9975256 -1.559782689 
 
HRG 5.3827922 3.406980525 -1.579930421 
LOC101926901 10.828049 6.637495537 -1.631345555 
 
SBDSP1 23.506547 15.0923649 -1.55751247 
 
CLEC18A 7.9861523 5.055155275 -1.579803553 
TRAJ53 4.8602841 2.979635072 -1.631167566 
 
FAM131C 11.368438 7.30531352 -1.556187545 
 
MRGPRX3 5.2835252 3.348164159 -1.578036494 
ATP5L 37.741676 23.14747471 -1.630487858 
 
FAP 24.910904 16.020419 -1.554947067 
 
OR13C3 5.6206642 3.561844424 -1.578020685 
LOC100996404 7.8801547 4.833782622 -1.630225292 
 
ATP8B4 6.6273415 4.26256799 -1.554776719 
 
OR5T1 3.8610319 2.448460864 -1.576922047 
ZNF492 7.2204066 4.431944654 -1.629173462 
 
INAFM1 52.163686 33.5585105 -1.554410042 
 
LOC101927837 7.4135184 4.701954495 -1.576688677 
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FGD5P1 9.3435855 5.735479179 -1.629085415 
 
GSTM2 12.356682 7.94952826 -1.554391806 
 
ZNF624 55.186323 35.03224038 -1.575300992 
MYD88 390.68347 239.8624879 -1.62878103 
 
THBS4 8.0694481 5.19249912 -1.554058628 
 
OR2T35 10.087852 6.406246126 -1.574689967 
LTB4R 15.754141 9.673802515 -1.628536505 
 
LINC01341 6.2882809 4.04752121 -1.55361283 
 
MTMR8 16.885073 10.72896039 -1.573784633 
TLE6 9.1370933 5.610826264 -1.628475533 
 
NRG4 12.089954 7.78442276 -1.553095773 
 
LOC100288798 23.588847 14.9887461 -1.573770567 
UCP2 34.182737 20.99838101 -1.62787489 
 
SPINK1 6.9072396 4.45100504 -1.551838195 
 
ICAM1 2867.665 1822.951447 -1.573089093 
SNHG7 57.041024 35.04274885 -1.627755403 
 
ZNF19 11.913117 7.6808591 -1.551013608 
 
SNORD100 996.29554 633.539114 -1.572587254 
AGPAT4-IT1 14.568217 8.952072016 -1.62735701 
 
C11orf96 35.819422 23.0955336 -1.550924184 
 
KITLG 588.46447 374.3819566 -1.571829147 
GH2 8.2715606 5.088182556 -1.62564147 
 
MIR891A 30.873533 19.9169018 -1.550117246 
 
LOC344887 23.222836 14.77517035 -1.571747414 
LOC642934 5.8932063 3.628561841 -1.624116253 
 
LOC101927156 5.1359573 3.31329777 -1.550104353 
 
FLJ45743 6.4539028 4.106726734 -1.571544243 
CYP4X1 11.995216 7.386935002 -1.623842045 
 
ZNF154 30.789135 19.8640576 -1.549992226 
 
FLJ37505 7.4090032 4.716131565 -1.570991634 
SATB1 69.318551 42.69457279 -1.623591635 
 
HTR1F 6.9598382 4.49145529 -1.549573074 
 
LOC642846 12.251441 7.800576903 -1.57058135 
ZNF589 96.393422 59.3766029 -1.623424327 
 
TRIM6 22.12907 14.2838824 -1.549233558 
 
COL13A1 95.056383 60.53915904 -1.570163581 
RGPD4-AS1 6.7100241 4.133701486 -1.623248352 
 
LOC100996342 6.9769159 4.50348311 -1.549226609 
 
USP17L5 17.363098 11.06031167 -1.569856113 
C11orf40 10.528339 6.487659884 -1.622825343 
 
LINC00690 7.6899102 4.96397653 -1.54914315 
 
SUN5 9.1967811 5.858487309 -1.569821803 
RGCC 214.12649 131.949707 -1.622788683 
 
GPRIN2 12.00677 7.75406804 -1.548447806 
 
HRH1 30.919114 19.70173846 -1.56935968 
RAB5B 200.68912 123.6811793 -1.622632689 
 
NLGN4X 7.0342302 4.54516572 -1.547628993 
 
HERC6 143.12542 91.20980384 -1.569188973 
SNORD114-13 7.7633674 4.785676961 -1.622208818 
 
FAM157A 6.5448995 4.22911142 -1.547582653 
 
MIR3144 4.5927344 2.927721475 -1.568706066 
IGHV4-34 12.42459 7.659940937 -1.622021693 
 
LOC100996286 10.563336 6.82577525 -1.547565812 
 
LOC100506123 24.377362 15.54624211 -1.56805494 
LOC644656 17.728187 10.93831567 -1.620741899 
 
ECEL1 9.3097982 6.01788881 -1.547020637 
 
ARHGEF25 34.176077 21.80024118 -1.567692611 
TLR1 59.800952 36.91404599 -1.620005341 
 
FAM107A 24.972586 16.1470048 -1.546576999 
 
LINC00467 19.909468 12.70148345 -1.56749155 
LINC00595 8.195592 5.059017518 -1.619996754 
 
TAC4 10.229883 6.61596159 -1.546242769 
 
IGBP1P1 11.212708 7.15369216 -1.5674015 
PTGFR 12.765811 7.885116668 -1.618975518 
 
ABTB1 14.090278 9.11666972 -1.545550977 
 
NHLRC1 23.402276 14.93091039 -1.567370997 
C1RL-AS1 11.418282 7.053003895 -1.618924672 
 
ZNF844 46.541586 30.114768 -1.545473845 
 
THAP3 32.610594 20.80649475 -1.567327622 
VPS36 144.56627 89.31118036 -1.618680522 
 
C15orf43 6.3887427 4.13391401 -1.545446447 
 
MIR134 15.089772 9.628034476 -1.567274383 
HDAC8 54.971946 33.98747655 -1.617417701 
 
MIR614 68.999794 44.6875962 -1.54404802 
 
FAM104A 50.811901 32.42760644 -1.56693345 
LUC7L2 97.361092 60.19888234 -1.617323909 
 
MIR30B 4.8483045 3.14083075 -1.543637634 
 
LOC101929726 10.449781 6.671162975 -1.566410663 
LAMC2 245.05584 151.5368275 -1.617137224 
 
AQP3 10.523336 6.82384133 -1.542142582 
 
HLA-B 1082.5287 691.2707987 -1.565998064 
IGHV1-2 14.146971 8.748657619 -1.617044797 
 
WI2-2373I1.2 15.197573 9.85624641 -1.541923045 
 
KIAA0513 43.988029 28.10635992 -1.565056057 
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CDH12 10.579262 6.544071864 -1.616617628 
 
PRRX2 31.033179 20.1298237 -1.541651806 
 
BEGAIN 6.168804 3.94304312 -1.564477948 
OR7G3 5.3420884 3.306317508 -1.615721522 
 
LIPE 27.30093 17.7096158 -1.541587923 
 
CD3EAP 149.04319 95.2716548 -1.564402264 
LOC101929058 9.0359666 5.593566117 -1.615421433 
 
CKLF 64.724861 41.9963165 -1.541203276 
 
TMEM187 45.98227 29.40168852 -1.563932978 
EPOR 74.187456 45.94047197 -1.614860563 
 
CRYGB 8.0428725 5.21900512 -1.541073885 
 
TSACC 12.236244 7.828698001 -1.562998659 
NID1 685.77986 424.9604793 -1.613749738 
 
LCE3B 29.609679 19.2188407 -1.540658948 
 
RNU6-78P 5.227773 3.345450365 -1.562651493 
LOC101929224 10.432801 6.465431193 -1.613628069 
 
RAB2B 161.0935 104.616979 -1.539840834 
 
IGLV5-45 4.4866936 2.873032996 -1.561657512 
MGARP 126.60233 78.46365393 -1.613515542 
 
SLC12A7 447.34108 290.626443 -1.53923048 
 
ZSCAN30 33.099794 21.19586268 -1.561615807 
LINC00707 8.2371416 5.106926067 -1.612935346 
 
REG1A 7.1451142 4.64418826 -1.538506573 
 
MAP2 37.074355 23.74993314 -1.561029861 
C17orf58 23.045195 14.29261718 -1.612384575 
 
LOC101928548 8.2900073 5.39125568 -1.537676525 
 
FRMPD1 5.8554014 3.751331371 -1.560886217 
LOC101929462 6.1252967 3.801928104 -1.61110271 
 
LINC01490 11.376261 7.39850029 -1.537644259 
 
MFSD4 10.80009 6.920317153 -1.560635164 
SLFN12L 5.1662313 3.209608942 -1.609613957 
 
TAF1A 10.867297 7.0679651 -1.537542528 
 
ZRANB3 41.99037 26.94635673 -1.558294904 
NA 23.946665 14.89143236 -1.608083355 
 
TRAF1 220.12821 143.178865 -1.53743507 
 
ALOX5AP 23.134325 14.84791029 -1.55808626 
DBIL5P 9.5130634 5.91598726 -1.608026344 
 
CACNA1C 6.189799 4.02806484 -1.536668165 
 
RAB11FIP4 10.051359 6.451456774 -1.557998295 
RIPK3 15.659196 9.738650643 -1.60794308 
 
NUDT13 9.0955856 5.92015973 -1.536375036 
 
RARRES2 13.769802 8.839238384 -1.557804131 
DHCR24 411.231 255.7713461 -1.607807139 
 
SLC23A3 17.222448 11.2129387 -1.53594417 
 
DEFB4B 9.423337 6.049830836 -1.557619917 
PTPN4 54.65228 34.02638144 -1.60617372 
 
MMP19 14.66931 9.55089844 -1.535908947 
 
LCE5A 5.5561869 3.567482143 -1.55745331 
ZNF350-AS1 9.5619989 5.955372745 -1.605608808 
 
S100A3 52.476568 34.1727596 -1.535625692 
 
LOC100996681 7.5359135 4.840341887 -1.556896942 
SLC22A31 14.002733 8.72472494 -1.604948365 
 
MIR3144 4.5927344 2.99084378 -1.535598235 
 
RDH14 45.46136 29.21419934 -1.556139174 
NA 14.760277 9.200103417 -1.604359946 
 
FAM83C 6.6598712 4.33728824 -1.535491948 
 
LOC151174 8.2692449 5.315041957 -1.555819301 
ZCWPW2 4.9792988 3.103624203 -1.604349764 
 
ATP5L2 7.3300679 4.77387197 -1.53545548 
 
ARRDC4 50.643078 32.5520058 -1.555759065 
MIR4292 16.460554 10.2622321 -1.603993579 
 
ZNF598 129.98172 84.7018812 -1.534578851 
 
PLA2G2F 6.8687358 4.416080424 -1.555391924 
NBR2 17.654719 11.00957013 -1.603579336 
 
ZNF667 37.301925 24.3106227 -1.534387885 
 
SYNDIG1 6.8355775 4.395653645 -1.555076453 
HTR1F 6.9598382 4.340518859 -1.603457652 
 
HIF1A-AS2 72.609086 47.3239464 -1.534299056 
 
MIR27A 32.473905 20.88601319 -1.554815889 
TRIM2 54.289684 33.88986246 -1.601944663 
 
FAM200A 40.320303 26.2830426 -1.5340805 
 
RSPH3 49.996413 32.15951122 -1.554638464 
SLC3A1 5.844265 3.648617695 -1.601775115 
 
CCDC88B 6.9456125 4.52759516 -1.534062177 
 
SLC22A24 6.3262098 4.072502612 -1.553396124 
CTU1 40.877987 25.52324573 -1.60159832 
 
SOHLH1 8.1448349 5.30944172 -1.534028498 
 
MIR325HG 14.560617 9.373688292 -1.55334982 
SLC16A9 50.715064 31.66600838 -1.601561619 
 
TNNC1 10.773936 7.02651919 -1.533324761 
 
MYL5 30.096693 19.38166266 -1.552843718 
PTK7 87.434054 54.63053086 -1.600461373 
 
MIR885 7.1879777 4.69117652 -1.532233476 
 
CEACAM19 69.519363 44.77338626 -1.552693893 
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LINC00640 6.1504502 3.844822666 -1.599670709 
 
TRIM16L 36.684866 23.9430816 -1.532169775 
 
SLC20A2 88.264279 56.85150841 -1.552540671 
RGS7BP 26.909153 16.82973234 -1.598905568 
 
TM4SF1-AS1 7.5655382 4.94004297 -1.531472147 
 
IGLL1 8.8644458 5.710941529 -1.552186402 
NPNT 10.034536 6.276454825 -1.598758559 
 
MIR330 12.36471 8.07414008 -1.531396488 
 
TRIM45 10.461673 6.742163173 -1.551679027 
CKLF 64.724861 40.49631646 -1.598290071 
 
LOC101927216 6.3830426 4.16817893 -1.531374433 
 
FAM220BP 21.674971 13.9730048 -1.551203283 
SNORD114-28 15.607655 9.765434261 -1.598255063 
 
BCL2L12 58.677852 38.3289551 -1.530901414 
 
CBX4 114.48654 73.84110303 -1.55044463 
LOC100507065 9.4680539 5.924461899 -1.598128922 
 
PABPC3 7.0355708 4.59587304 -1.530845339 
 
DDIT4L 50.892764 32.84327187 -1.549564376 
BUB1 317.6349 198.7754518 -1.597958402 
 
LOC101928360 9.1218145 5.96260956 -1.52983595 
 
LYRM2 48.923857 31.57342849 -1.54952627 
OR10H2 9.7622519 6.109943127 -1.597764766 
 
LOC101927636 4.1886463 2.73802244 -1.529807159 
 
ZFP3 52.773315 34.06053916 -1.549397522 
KRTAP16-1 7.3870263 4.625081917 -1.597166587 
 
MIR4502 10.868588 7.10854348 -1.528947317 
 
BHLHE40-AS1 7.8336264 5.058226864 -1.548690196 
FDPSP2 11.420594 7.152059237 -1.596826017 
 
ADAMTSL5 8.7465909 5.7207572 -1.528921892 
 
NA 9.4541114 6.106909549 -1.548100778 
SLC37A1 238.65705 149.516213 -1.596195118 
 
TMEM176B 15.360378 10.0468139 -1.528880566 
 
LOC100506098 7.7586796 5.011946539 -1.54803718 
KCNG4 5.560825 3.48595124 -1.595210194 
 
MIR4470 9.0155052 5.89727016 -1.528759064 
 
PRKCQ-AS1 18.682672 12.0708409 -1.547752319 
DHRS4-AS1 94.112613 59.00696257 -1.594940818 
 
LOC101929741 5.0268593 3.28866443 -1.528541275 
 
LOC100507599 14.869213 9.608659771 -1.547480476 
LYVE1 114.36157 71.70618858 -1.594863325 
 
MIR4314 9.3976315 6.15156988 -1.527680199 
 
MATN1 8.5831027 5.552821968 -1.545719057 
AMDHD1 6.6699161 4.183843366 -1.5942079 
 
LINC00515 4.9400682 3.23382803 -1.527622412 
 
TRAV38-1 32.499471 21.02564765 -1.545706052 
LOC101927759 14.263708 8.948696638 -1.593942514 
 
OXTR 20.529738 13.4397041 -1.527543886 
 
FCGR3B 6.4286302 4.159795295 -1.545419851 
LOC101929767 29.364096 18.42730884 -1.593509733 
 
LOC100506538 6.7682885 4.43085185 -1.527536629 
 
IRX5 6.3455074 4.109945188 -1.543939655 
ADAMTSL5 8.7465909 5.488891037 -1.593507845 
 
LOC101929261 9.0525054 5.92788929 -1.527104334 
 
SUDS3 122.25874 79.19240842 -1.543818977 
DMGDH 6.556427 4.114635401 -1.593440575 
 
LHX1 9.9770347 6.53383296 -1.526980382 
 
TUBB2B 33.827314 21.91175006 -1.543797919 
NFIC 950.95881 597.0064951 -1.5928785 
 
LSM14B 102.97938 67.4440667 -1.52688571 
 
LCE1E 3.4679067 2.246846486 -1.543455136 
ZER1 125.71699 78.92720136 -1.592822116 
 
LOC101929441 6.103881 3.999185 -1.526281222 
 
RIMS1 7.6402371 4.951236343 -1.543096832 
MAP3K2 119.61858 75.11051607 -1.592567737 
 
KIF27 34.246602 22.4473079 -1.525644048 
 
LINC00973 23.066715 14.95560715 -1.542345617 
LOC101928658 5.5818446 3.505554995 -1.592285554 
 
LOC101928220 12.810443 8.39694327 -1.525607874 
 
OR11H1 6.3411019 4.112264504 -1.541997587 
TMEM132B 7.5913839 4.767896075 -1.592187368 
 
SCOC-AS1 7.9276347 5.19671454 -1.525508975 
 
ZNF488 10.326595 6.700228381 -1.541230297 
LINC01476 6.4914345 4.077225284 -1.592120643 
 
CBR3 47.929402 31.4223976 -1.52532608 
 
LOC100505570 13.634208 8.846920247 -1.541124785 
LINC01194 12.772876 8.022977653 -1.592036879 
 
CA12 32.345835 21.2064833 -1.525280474 
 
SNORD115-15 4.9562122 3.21632184 -1.540956547 
ABCG8 7.7969545 4.897657774 -1.591976169 
 
HRH2 6.8454196 4.48953737 -1.524749454 
 
CAMK1D 118.00529 76.59833294 -1.540572611 
PATL1 759.68258 477.4307636 -1.591188992 
 
BARX2 6.9224827 4.5404218 -1.524634271 
 
PAG1 9.0811731 5.895683652 -1.54030874 
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ENTPD1 207.00558 130.1274163 -1.590791441 
 
ATE1-AS1 32.211449 21.1275888 -1.524615468 
 
BAK1 155.04775 100.6641359 -1.540248189 
SLC24A3 6.6232422 4.164493446 -1.590407644 
 
WWTR1-AS1 9.338135 6.12508884 -1.524571362 
 
TMEM147-AS1 16.928648 10.99132447 -1.54018274 
MIR4520-2 4.984266 3.134297369 -1.590233923 
 
CIB2 39.897261 26.173849 -1.524317681 
 
MIR4522 15.198889 9.868659863 -1.540116778 
C1orf86 57.835902 36.40158291 -1.588829304 
 
NA 4.7772744 3.13471606 -1.523989522 
 
BSX 8.8044602 5.716966275 -1.540058103 
LOC101929762 10.189832 6.415152739 -1.588400489 
 
ZNF807 5.5599416 3.64879758 -1.523773642 
 
PPP1R32 23.187463 15.05624255 -1.540056408 
ZNF300P1 14.804128 9.320605368 -1.588322568 
 
RCSD1 17.906593 11.7549523 -1.523323354 
 
RPUSD1 262.60097 170.5271165 -1.53993674 
HSPB9 8.0047751 5.042119701 -1.58758133 
 
ASB16 19.519411 12.8139203 -1.523297377 
 
GPT2 65.360302 42.45304111 -1.539590565 
ZNF70 99.129903 62.4732715 -1.58675703 
 
LOC728739 12.868266 8.4478453 -1.523260092 
 
KRTAP6-3 12.028831 7.813135229 -1.539565245 
GPR124 151.87983 95.72131494 -1.586687635 
 
LOC101927770 8.1037423 5.32002289 -1.523253269 
 
IGLV2-18 8.936589 5.805722521 -1.539272504 
MCTP2 20.801869 13.11180349 -1.586499419 
 
ZNF627 37.214069 24.4432258 -1.522469638 
 
IRF1 306.79781 199.3567099 -1.538938978 
TRAPPC12 127.79477 80.59144336 -1.585711346 
 
ZGRF1 29.818801 19.591656 -1.522015361 
 
RPL39L 83.371316 54.17662964 -1.538879716 
LOC100130872 7.8031601 4.921677933 -1.585467441 
 
ATP2A3 17.713774 11.6387654 -1.521963328 
 
C17orf105 7.1301746 4.634707492 -1.53843033 
GCSH 3.962746 2.49971561 -1.585278739 
 
SYPL2 9.4971843 6.24039396 -1.521888585 
 
PAQR8 26.804659 17.42856036 -1.537973217 
GNS 1724.4375 1087.873299 -1.585145527 
 
SIRT7 84.303815 55.4018922 -1.521677548 
 
ZNF333 40.837832 26.56448061 -1.537309651 
HORMAD2-AS1 8.3896769 5.293703632 -1.584840692 
 
LOC101929762 10.189832 6.69772831 -1.521386249 
 
DTHD1 5.0838874 3.308986004 -1.536388316 
AGFG2 168.82786 106.5477467 -1.584527718 
 
XAF1 278.50109 183.06632 -1.521312521 
 
ZNF823 57.600836 37.49713938 -1.536139483 
DTWD2 61.323437 38.70686546 -1.584303874 
 
ULK1 59.491502 39.108531 -1.521189886 
 
HAPLN1 132.11544 86.02491972 -1.535781 
LOC645752 6.6948989 4.225901421 -1.584253452 
 
CYP1A2 12.127897 7.97659136 -1.520436004 
 
HIST1H2BC 18.051874 11.75548841 -1.535612378 
SPINK6 5.1738845 3.267426359 -1.583473957 
 
STARD7-AS1 41.202311 27.101726 -1.520283667 
 
PPP1R14D 6.6276733 4.31632733 -1.535489042 
MIR4312 16.608596 10.49295655 -1.582832845 
 
INPP5E 57.305745 37.7180368 -1.519319387 
 
PP13 16.169077 10.53094051 -1.535387752 
TRAV8-6 7.4879175 4.73295601 -1.582080524 
 
ZNHIT3 119.52279 78.6701549 -1.519290189 
 
SLC24A3 6.6232422 4.314683806 -1.535046949 
PLEKHA8 51.284564 32.42209542 -1.58177822 
 
SNORA26 46.0822 30.3324374 -1.519238276 
 
ZNF334 11.72788 7.640247424 -1.535013093 
LINC00690 7.6899102 4.861804973 -1.581698624 
 
SHROOM1 16.591952 10.9213124 -1.519226983 
 
ZFP14 10.7578 7.011419219 -1.534325627 
ZNF396 6.1963535 3.91808244 -1.581476035 
 
GBP1 306.90235 202.055016 -1.518904876 
 
HHATL 6.6406516 4.329513687 -1.53381004 
OR2L8 8.7438276 5.530270372 -1.581085021 
 
LOC442028 7.1096508 4.68197249 -1.518516143 
 
TGFB3 18.726271 12.20915219 -1.533789616 
CDHR3 7.0299389 4.446458214 -1.581019888 
 
OR14A16 5.5492011 3.65488792 -1.518295823 
 
LOC93463 7.9878425 5.208515438 -1.53361213 
AMN1 79.819675 50.48679222 -1.581001116 
 
LOXL4 11.52442 7.59114274 -1.518140375 
 
GADD45B 274.90903 179.2662254 -1.533523824 
NA 8.2091373 5.193238318 -1.580735708 
 
LINC01237 17.647302 11.6246186 -1.518097301 
 
ADAM28 8.4714608 5.5254026 -1.533184346 
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ATP9B 74.457518 47.1088731 -1.580541278 
 
LINC00883 36.448005 24.0117037 -1.51792665 
 
AQP4-AS1 5.8767973 3.834315542 -1.532684838 
CYP2A7 31.482246 19.9228418 -1.580208607 
 
USP29 5.6542535 3.72610891 -1.517468654 
 
PRAMEF7 13.846143 9.03596659 -1.532336709 
CTNNA3 7.4650716 4.728502346 -1.578739104 
 
BRE-AS1 9.0230632 5.94613498 -1.517466928 
 
LOC93622 41.398129 27.0406604 -1.530958495 
PHF19 213.91526 135.5230446 -1.578441973 
 
MIR4748 31.311802 20.6368556 -1.517275798 
 
SNORD116-13 7.0645466 4.615788212 -1.530517917 
SRGAP2 356.41246 225.8815353 -1.577873391 
 
CSAD 34.141008 22.5097402 -1.516721556 
 
NARFL 80.232998 52.43617233 -1.530107836 
LOC101928162 13.777018 8.733412483 -1.577506824 
 
PRKCQ-AS1 18.682672 12.3223095 -1.516166426 
 
VEGFA 99.577118 65.10426735 -1.529502166 
PNMAL2 10.589205 6.71275819 -1.577474589 
 
MAFG-AS1 27.287296 18.009793 -1.515136567 
 
LOC339622 5.1025726 3.336161245 -1.529474209 
LOC101928800 5.2658414 3.33868707 -1.577219217 
 
MEG8 31.040073 20.4920997 -1.514733666 
 
AKAP7 20.886218 13.65590133 -1.529464646 
HCRTR1 15.346346 9.73003696 -1.57721354 
 
IGLV10-54 22.41892 14.8025112 -1.51453494 
 
AJUBA 94.311506 61.66776057 -1.529348648 
ZNF660 6.8051503 4.314996393 -1.577092929 
 
LINC00592 7.1353437 4.71619305 -1.512945647 
 
UPF3A 137.7567 90.07772038 -1.529309405 
MGC72080 81.176003 51.47818327 -1.576901077 
 
RPL34 261.86508 173.158682 -1.512283869 
 
GPR133 9.6862989 6.336684385 -1.528606803 
SLC32A1 13.883544 8.807619539 -1.576310555 
 
LOC101928461 8.8181096 5.83280258 -1.511813488 
 
TMEM116 22.50551 14.72290823 -1.52860493 
HIST1H2AK 53.125797 33.71174284 -1.575884035 
 
RWDD2B 96.594744 63.9330787 -1.51087272 
 
DCAF8L1 4.9233919 3.221850497 -1.528125505 
VIPR1 24.411765 15.49310713 -1.575653307 
 
ATP6V0A4 10.626668 7.03581653 -1.510367354 
 
ADAMTS9-AS2 9.306212 6.091238835 -1.527802837 
ATMIN 598.76379 380.0312165 -1.575564741 
 
CDSN 8.0148512 5.30677612 -1.51030513 
 
SCIMP 7.4080464 4.850728751 -1.527202781 
POTEF 4.7549989 3.018000803 -1.575545949 
 
LOC101928737 10.097695 6.6862404 -1.510220209 
 
CYTH3 37.03605 24.25111888 -1.527189312 
EXTL1 7.0685368 4.488577241 -1.574783367 
 
SPATA31A6 9.0196907 5.97301374 -1.510073653 
 
PLEKHA8 51.284564 33.58438808 -1.527035843 
LOC100129046 8.918356 5.668543867 -1.573306347 
 
TMEM170A 134.83287 89.2989916 -1.509903605 
 
RPE 30.732179 20.14333326 -1.52567497 
ZNF248 17.83672 11.34402043 -1.572345556 
 
OR8A1 9.1542338 6.06344078 -1.509742422 
 
LOC100132731 10.057052 6.592383155 -1.525556363 
TMBIM4 413.07806 262.7286003 -1.5722615 
 
ZFP36 97.860872 64.820353 -1.50972445 
 
TTC32 14.021298 9.197568103 -1.524457061 
GBAP1 26.174715 16.65030014 -1.572026607 
 
SOGA3 9.2232002 6.10996852 -1.509533172 
 
CXCL16 101.05723 66.30569944 -1.524110825 
MCHR2-AS1 8.9811667 5.714976639 -1.571514162 
 
SLC24A3 6.6232422 4.38769941 -1.50950227 
 
NAT9 175.84494 115.3889649 -1.523932071 
MDFIC 46.56503 29.64331029 -1.570844469 
 
LOC101927837 7.4135184 4.9133421 -1.508854516 
 
MIR4532 8.2429232 5.410513013 -1.523501219 
FAM43A 564.38897 359.2924479 -1.570834487 
 
ZNF257 9.2639583 6.14004636 -1.508776596 
 
SLC35G1 18.492569 12.14441666 -1.522721872 
C14orf1 569.26501 362.4846974 -1.570452518 
 
OR10G4 5.8896489 3.90397219 -1.508629826 
 
SLC22A31 14.002733 9.197952578 -1.522374997 
KIF4A 278.72559 177.653583 -1.568927498 
 
MTO1 157.63559 104.499732 -1.508478454 
 
TRAJ28 10.590994 6.958285713 -1.522069442 
FAHD2CP 36.300657 23.13935465 -1.56878432 
 
MIR655 4.0717376 2.6994844 -1.508338995 
 
STC2 390.75803 256.7444725 -1.521972522 
PF4V1 7.6001207 4.848588622 -1.567491351 
 
SLC25A51 88.171316 58.462045 -1.508180491 
 
TRPM2-AS 13.169877 8.65680481 -1.52133227 
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PACSIN1 10.04335 6.407528199 -1.567429722 
 
TOB2P1 18.19535 12.0676212 -1.507782648 
 
OSBPL6 35.895585 23.60269804 -1.520825515 
RETNLB 7.3809216 4.709088251 -1.567378054 
 
RFPL2 10.748326 7.12934504 -1.507617528 
 
DNAJB9 59.493049 39.12176156 -1.520714995 
SOGA3 9.2232002 5.885416332 -1.567127904 
 
LOC101928859 10.40721 6.90359969 -1.507504886 
 
APOL6 58.967745 38.78209683 -1.52048884 
IPO5P1 24.559373 15.67439641 -1.566846484 
 
LOC100287175 17.252808 11.4450469 -1.50744758 
 
FAM184A 23.698537 15.58952086 -1.52015816 
ZNF14 13.135545 8.383626504 -1.566809367 
 
CD3EAP 149.04319 98.8995238 -1.50701628 
 
ZNF627 37.214069 24.49032 -1.519541969 
LINC00702 36.317201 23.18108077 -1.566674194 
 
DNAJA4 119.82076 79.5091311 -1.507006237 
 
LOC101928947 5.459051 3.593780923 -1.519027194 
VEGFA 99.577118 63.56144174 -1.566627742 
 
XRCC3 54.854267 36.4070924 -1.506691778 
 
TMSB4Y 6.4359201 4.237751353 -1.518711119 
PYHIN1 5.8114473 3.710005044 -1.566425703 
 
PINLYP 10.108154 6.71024396 -1.506376568 
 
ZNF671 21.946761 14.45934154 -1.517825742 
SPATA6 42.621934 27.21135222 -1.566329139 
 
XKR6 25.032055 16.6186905 -1.506259146 
 
FAM86HP 34.509355 22.73750858 -1.517728061 
ERP27 18.815325 12.01365714 -1.566161341 
 
KIF21B 20.903314 13.8783524 -1.506181242 
 
AGMAT 16.41605 10.81750839 -1.517544458 
MCTP1 577.13372 368.5241464 -1.566067585 
 
RPS15AP10 11.545018 7.66654895 -1.505894975 
 
LOC254896 51.921316 34.22206536 -1.517188257 
BOLA1 37.29838 23.82170848 -1.565730687 
 
WBP11P1 7.8084095 5.18595581 -1.505683762 
 
FAM19A5 12.576935 8.290007295 -1.517119847 
IFI27L1 63.499362 40.56120334 -1.565519668 
 
CCDC85C 29.398273 19.527281 -1.505497508 
 
HDAC10 62.26814 41.04959857 -1.516900105 
ECM1 63.869389 40.80051336 -1.565406512 
 
GUCY2EP 9.9348274 6.5996235 -1.505362757 
 
KLRC4 7.2162493 4.757493376 -1.516817521 
C10orf54 19.827085 12.6662543 -1.565347161 
 
DANCR 631.39087 419.472399 -1.505202414 
 
C19orf38 9.6608318 6.371289029 -1.516307255 
KIF18B 90.288157 57.69631723 -1.56488596 
 
DHX58 18.842387 12.5183698 -1.505179001 
 
C1RL-AS1 11.418282 7.534999491 -1.515365998 
MRAP2 23.924328 15.28878175 -1.564828902 
 
UNC5D 6.4648681 4.29667438 -1.504621362 
 
SNORD116-26 24.756867 16.34668094 -1.514488928 
LOC643072 61.058149 39.01943534 -1.564813759 
 
TRBV5-7 7.0332472 4.6759843 -1.504121227 
 
RASGRF2 88.511718 58.44985635 -1.514318834 
ARRB1 760.59495 486.1447416 -1.564544234 
 
P2RX6P 6.0267449 4.00702547 -1.504044569 
 
DSCR10 9.1352676 6.033531184 -1.514083108 
LOXL4 11.52442 7.366210411 -1.564497841 
 
SNORA44 69.617713 46.3213172 -1.50293033 
 
FAM195A 29.503512 19.48919708 -1.513839267 
COL4A6 9.1911727 5.875927174 -1.564208073 
 
LINC01208 6.4286302 4.27932679 -1.502252699 
 
MIR874 5.983161 3.953410627 -1.513417543 
MTMR9LP 17.80459 11.38250515 -1.564206648 
 
HES7 13.320368 8.86707082 -1.502228637 
 
IFI44 133.41588 88.16262847 -1.513292876 
C16orf86 5.5596866 3.55503349 -1.563891473 
 
APOL6 58.967745 39.2536503 -1.502223231 
 
MIR222 30.777858 20.34765121 -1.51260006 
LY86 7.1508531 4.572479973 -1.56388943 
 
KIF1A 38.73679 25.7872337 -1.50216926 
 
ALDH1A3 81.157277 53.66469868 -1.512302849 
NKAIN4 8.1549654 5.214552518 -1.563885947 
 
EHHADH-AS1 7.6156899 5.06997248 -1.502116605 
 
SNORD12B 238.29891 157.622235 -1.511835615 
WASH3P 36.421316 23.29341532 -1.563588474 
 
MIR3657 8.1914568 5.45337177 -1.502090301 
 
MDGA1 18.568745 12.28303262 -1.511739491 
LXN 152.76321 97.72632071 -1.563173618 
 
NOX5 9.0679554 6.03751011 -1.501936271 
 
ALDH1L1-AS2 8.6840477 5.746559034 -1.511173503 
TACC1 1070.4212 685.131529 -1.562358741 
 
LOC101929380 12.992967 8.65765878 -1.500748323 
 
LOC101926901 10.828049 7.165697354 -1.511094916 
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NBEAL2 137.79518 88.23371317 -1.561706655 
 
LINC00671 14.051091 9.36332442 -1.500651922 
 
DENND2C 9.6779938 6.406985849 -1.510537726 
SLC52A2 257.38075 164.8743714 -1.561071914 
 
USP17L10 18.66616 12.4394186 -1.500565298 
 
HIST1H2BE 22.4107 14.83720899 -1.510439064 
NA 29.788762 19.08278512 -1.561028022 
 
DPF1 20.484293 13.6524459 -1.500411983 
 
SEMA4B 60.021762 39.73937041 -1.510385319 
RNU105B 8.2712818 5.299101283 -1.560883882 
 
NSUN5 71.939982 47.9497415 -1.500320531 
 
OR56B4 9.7229856 6.439835055 -1.509819045 
LOC101927617 5.077336 3.254265263 -1.560209634 
 
NCR3LG1 172.78962 115.169319 -1.500309476 
 
CST8 6.2747927 4.158653129 -1.508852156 
HAPLN2 8.8312478 5.661242886 -1.55994858 
      
FAT1 65.031288 43.13926209 -1.507473359 
MIR320D2 4.8950297 3.138538023 -1.559652836 
      
SNHG20 42.503124 28.201604 -1.50711724 
LOC283683 5.9040635 3.786009139 -1.559442473 
      
TRBV5-7 7.0332472 4.667080983 -1.506990615 
DBF4B 37.531115 24.06951893 -1.559279819 
      
CFAP44 10.499763 6.96945111 -1.50654086 
CCDC106 34.198748 21.93703971 -1.558949987 
      
ZNF585A 36.317585 24.11446719 -1.506049673 
FAM200A 40.320303 25.86914457 -1.558625294 
      
LUC7L2 97.361092 64.65016497 -1.505968187 
TACC3 220.69691 141.6579654 -1.557956247 
      
PGAM1 16.892125 11.21704009 -1.505934264 
REG3G 7.9164914 5.081690715 -1.557845965 
      
FCN2 7.0788299 4.70072915 -1.505900408 
ZNF558 24.188611 15.52818994 -1.557722529 
      
LOC101928239 8.4620651 5.619908352 -1.505730092 
SCN4B 11.730127 7.530926786 -1.557594124 
      
FAM92A1P2 6.4670072 4.295001541 -1.505705435 
PTPRG-AS1 5.6170118 3.60700539 -1.557250735 
      
BAG2 61.856752 41.08494088 -1.505582108 
ASRGL1 132.63008 85.23668467 -1.556021106 
      
BREA2 9.0489016 6.010561146 -1.505500296 
MIR3944 23.828224 15.31824208 -1.555545609 
      
NOX5 9.0679554 6.024036759 -1.505295499 
LOC101927751 38.62771 24.84038323 -1.555036804 
      
CDR2L 166.12077 110.3927503 -1.504815932 
LRRK2 6.3593877 4.089709164 -1.554973099 
      
PDF 95.571317 63.5463157 -1.503963151 
SOCS3 104.60162 67.27272788 -1.554888932 
      
LINC00398 8.4715304 5.633267247 -1.5038396 
CLEC17A 7.0649879 4.546480421 -1.553946629 
      
PPBPP2 5.7475875 3.823603337 -1.503186126 
PPP1R3G 9.9707953 6.417524656 -1.553682423 
      
CA13 72.115779 47.98766391 -1.502798277 
IGF2 11.065759 7.123953725 -1.553317098 
      
CLCNKB 6.3613243 4.233704236 -1.502543388 
LOC101929261 9.0525054 5.830522171 -1.552606296 
      
MIB2 39.356409 26.19767884 -1.502286115 
MARVELD1 217.01257 139.8254935 -1.552024349 
      
FSTL3 95.728978 63.72990257 -1.502104564 
CRYBB2P1 87.836309 56.59824962 -1.551926248 
      
PINLYP 10.108154 6.730003967 -1.501953686 
DLEU2 18.909318 12.1850353 -1.551847609 
      
EYA4 6.2626233 4.170974237 -1.501477348 
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C3orf35 19.468547 12.54782078 -1.551548066 
      
SH3RF1 258.91782 172.4839248 -1.501112739 
KRTAP19-3 5.6738898 3.657207118 -1.551426994 
      
SDHAF1 29.672038 19.76969005 -1.500885342 
PCAT7 10.352334 6.673153082 -1.551340669 
      
LOC101928809 6.8479926 4.562789365 -1.500834698 
LOC101927372 5.658053 3.64745694 -1.551232301 
      
GCNT4 9.2819481 6.184524111 -1.500834661 
SNORD91A 16.108199 10.38460263 -1.5511618 
      
CNIH2 8.545971 5.695106558 -1.500581414 
LOC101927886 46.293567 29.85020777 -1.550862458 
          
C17orf105 7.1301746 4.600217483 -1.549964671 
          
PDGFRL 179.43865 115.7897069 -1.549694332 
          
RPE 30.732179 19.83409889 -1.54946184 
          
ZNF182 43.991376 28.39800369 -1.549100997 
          
LPAR4 34.699389 22.40769831 -1.548547677 
          
LOC284344 8.4920666 5.485807739 -1.548006607 
          
MIR4674HG 17.479948 11.29409325 -1.547707049 
          
ACKR3 324.43656 209.6450947 -1.547551411 
          
SLIT3 93.920064 60.70487232 -1.547158583 
          
LINC00276 6.0537091 3.913478067 -1.546887194 
          
LINC00226 9.0623846 5.858711874 -1.54682203 
          
LOC101926893 8.6738539 5.608472671 -1.546562561 
          
LRIG3 409.88836 265.0646316 -1.546371363 
          
SMR3A 4.9354038 3.191795103 -1.546278395 
          
CHST7 42.901494 27.74921832 -1.546043332 
          
ZNF503-AS2 8.8183893 5.703918953 -1.546022895 
          
TMEM242 173.57581 112.2829213 -1.545878965 
          
CATSPER2P1 13.060394 8.448930192 -1.54580442 
          
UTS2 6.8898436 4.457208025 -1.545775644 
          
ITGB4 27.704181 17.92686242 -1.545400431 
          
CBX7 21.728446 14.06131429 -1.545264263 
          
ZNF337 49.469843 32.01683811 -1.545119576 
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C6orf195 6.7948175 4.397602776 -1.545118531 
          
RPL23A 480.72805 311.1741691 -1.544884184 
          
NA 4.7772744 3.092783164 -1.544652234 
          
HOXA6 65.782768 42.60933752 -1.543858025 
          
TBC1D26 13.75616 8.910534465 -1.543808603 
          
ZNF30 24.107179 15.61855402 -1.543496214 
          
ATOH8 58.220523 37.72412509 -1.543323336 
          
GAGE12J 8.4077755 5.447994519 -1.543278995 
          
SIGLEC7 6.4465555 4.177737365 -1.543073427 
          
LOC101928026 5.6446309 3.658334901 -1.542950849 
          
CRYAA 12.109796 7.850389201 -1.542572686 
          
SGIP1 119.65641 77.6147916 -1.541670123 
          
SNORA74A 28.062581 18.20354205 -1.541600057 
          
NA 8.6392683 5.606746209 -1.540870235 
          
CPXM1 26.17139 16.98558012 -1.540800477 
          
TRAV12-1 8.7949952 5.709002289 -1.540548543 
          
LPHN3-AS1 7.1244157 4.625027581 -1.54040503 
          
LOC101927391 4.895287 3.177986958 -1.540373533 
          
KCTD12 533.39504 346.4170618 -1.539748188 
          
TMOD1 55.14979 35.8249017 -1.539426126 
          
MYH13 6.2869968 4.086449893 -1.538498435 
          
CCDC115 71.020973 46.16953553 -1.538264842 
          
LOC101928794 14.206231 9.235904267 -1.53815266 
          
LMNTD2 18.279897 11.88577127 -1.53796473 
          
CGNL1 219.60331 142.7892236 -1.537954363 
          
LOC653786 5.6338239 3.663198644 -1.537952053 
          
SNORD114-9 14.247744 9.265479559 -1.537723281 
          
GMPR 160.75197 104.5489042 -1.537576762 
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TTC30A 54.644541 35.54585743 -1.537297042 
          
GPR146 18.76388 12.20734965 -1.537096959 
          
CEACAM1 104.53817 68.04031513 -1.536415161 
          
NCAM1-AS1 8.2587365 5.376714647 -1.536019117 
          
HOXC10 9.5553368 6.221147349 -1.535944456 
          
PRSS27 10.767736 7.011725723 -1.535675652 
          
IGFBP6 12.201261 7.945467833 -1.535625206 
          
IGKV1-8 5.6086441 3.652510342 -1.535558727 
          
LOC100506538 6.7682885 4.409255638 -1.53501839 
          
B3GNT1 54.699955 35.64770271 -1.534459461 
          
GTSF1 12.747757 8.308378354 -1.534325509 
          
NDUFAF5 59.917823 39.05286602 -1.534274667 
          
KDELR3 302.1096 196.9213157 -1.534164024 
          
ZNF513 119.54124 77.93780902 -1.533802897 
          
TGFB3 18.726271 12.20915219 -1.533789616 
          
MYOM1 6.774186 4.420851941 -1.532325917 
          
MMP28 9.9739543 6.509820985 -1.53213957 
          
TREX2 9.5569505 6.237927041 -1.532071541 
          
TSPAN15 389.70511 254.3794715 -1.53198333 
          
PIK3C2A 687.30851 448.7220496 -1.531702109 
          
SNORA79 15.12281 9.879661352 -1.530701288 
          
KIAA0930 482.93253 315.5290271 -1.530548676 
          
BRWD3 143.33386 93.65485092 -1.530447816 
          
MIR3667 19.230177 12.56507551 -1.530446632 
          
ZNF572 6.7783237 4.430252841 -1.530008326 
          
COL3A1 57.227029 37.4053716 -1.529914732 
          
ZNF568 21.05087 13.75955959 -1.52990872 
          
SLC25A51 88.171316 57.63395017 -1.529850296 
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SPSB4 6.4707897 4.229727004 -1.529836252 
          
LOC101928201 5.1035457 3.337754942 -1.529035475 
          
FAM114A1 746.67304 488.371062 -1.52890516 
          
LOC101928248 7.1639156 4.685682129 -1.528894916 
          
RBCK1 301.87331 197.5130237 -1.528371682 
          
HS3ST1 32.231698 21.0933594 -1.528049525 
          
TRBV11-2 4.3946466 2.876794259 -1.527619346 
          
OCM 6.2032138 4.061116721 -1.527465036 
          
SKP1P2 5.3633781 3.511390197 -1.527422997 
          
KRT14 6.480772 4.243373431 -1.527268825 
          
DLX5 7.6189546 4.989084214 -1.527124867 
          
FGD6 111.9254 73.29224538 -1.527111139 
          
TBX6 9.9385975 6.509880035 -1.52669442 
          
RASAL1 11.075094 7.25627082 -1.526279003 
          
LOC646522 8.19025 5.367213085 -1.525978165 
          
MIR9-1 13.776751 9.029386229 -1.525768294 
          
KRTAP10-5 6.1442765 4.027336747 -1.525642587 
          
PKD1L2 7.2693816 4.764924636 -1.525602643 
          
CACNA1C 6.189799 4.058544224 -1.525127894 
          
ADAM7 5.8441928 3.832931698 -1.524731787 
          
LOC283693 7.8214227 5.132969498 -1.523761772 
          
NDUFA5 12.261111 8.048102777 -1.523478397 
          
LOC101929412 8.1744295 5.366415513 -1.523256899 
          
GOLGA1 113.57277 74.56829074 -1.523070622 
          
NA 11.137455 7.313569269 -1.522848113 
          
SLC27A3 68.991621 45.32375397 -1.52219565 
          
LOC730101 11.686308 7.680899802 -1.521476376 
          
MIR377 10.419383 6.848217397 -1.521473789 
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FLJ37505 7.4090032 4.870494397 -1.52120147 
          
CTGLF12P 128.61244 84.5608541 -1.520945419 
          
FUK 23.044978 15.15285165 -1.520834369 
          
KAT6A 337.22008 221.7667986 -1.520606686 
          
RNU6-57P 7.0835444 4.658601084 -1.520530372 
          
OR2T35 10.087852 6.63652202 -1.520050935 
          
ZFAT-AS1 7.8062756 5.136330722 -1.519815611 
          
RGS21 5.3269622 3.505664357 -1.519530018 
          
S100A3 52.476568 34.53896804 -1.519343821 
          
NUDT13 9.0955856 5.989220257 -1.518659397 
          
C2orf69 70.792144 46.62717371 -1.518259387 
          
SELP 66.8662 44.04197655 -1.518237953 
          
HRH2 6.8454196 4.514309561 -1.516382418 
          
TRAJ58 5.6882874 3.751847212 -1.516129801 
          
ACKR4 8.9036246 5.873757886 -1.515831047 
          
LINC00314 7.2696764 4.796647408 -1.515574472 
          
CCL7 9.0266805 5.958414078 -1.514946823 
          
ARHGEF3 83.930842 55.40219549 -1.514937104 
          
MEGF8 45.437363 29.99682215 -1.514739222 
          
MKI67 792.22702 523.1463027 -1.514350803 
          
BLACAT1 4.9279266 3.254265263 -1.514297754 
          
EMB 6.5369248 4.317062198 -1.514206759 
          
TRAJ61 5.7347238 3.788893097 -1.513561797 
          
HMSD 8.04396 5.314881969 -1.513478578 
          
HPR 4.5867579 3.031045825 -1.513259183 
          
PCDH10 620.84701 410.4937684 -1.512439553 
          
LRRC23 13.604741 8.9966914 -1.512193825 
          
TTTY22 8.1246469 5.373366105 -1.512021835 
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HIST1H3G 201.42277 133.2170507 -1.511989427 
          
SDCBP2-AS1 14.140548 9.356700506 -1.511275051 
          
HIST1H4A 42.93981 28.41757112 -1.511030248 
          
SEMA4G 25.595941 16.94202031 -1.510796244 
          
CGB8 13.07791 8.65680481 -1.510708606 
          
KBTBD6 64.181428 42.48938209 -1.510528618 
          
SESN3 110.95623 73.46139498 -1.510401843 
          
OR2T11 5.730977 3.795296176 -1.510021027 
          
RABL6 131.02082 86.77147018 -1.50995279 
          
DSCR10 9.1352676 6.050329715 -1.509879308 
          
GBP4 300.15886 198.8413493 -1.509539431 
          
FNBP1 307.30962 203.6978243 -1.508654402 
          
CA12 32.345835 21.4409369 -1.508601751 
          
RERE 399.78838 265.0341074 -1.508441246 
          
RNF43 7.0761979 4.691339735 -1.508353323 
          
GNAS-AS1 6.7462124 4.472649551 -1.508325733 
          
ADAM30 6.9067487 4.579418115 -1.508215355 
          
TCF15 13.881516 9.205393159 -1.507976443 
          
LOC100129215 14.215139 9.426852167 -1.507941192 
          
FLJ13224 19.363927 12.84240297 -1.507811837 
          
LOC101927752 195.94617 129.9595123 -1.507747799 
          
TNS1 98.561735 65.37393838 -1.50766096 
          
OR7A10 6.829997 4.531188684 -1.507330074 
          
UACA 525.69806 348.799884 -1.507162371 
          
F13A1 5.2262498 3.467915706 -1.507029087 
          
FCGR2A 7.3911952 4.904968211 -1.506879335 
          
TMEM42 34.046316 22.59793315 -1.506611935 
          
LOC101927274 6.2801999 4.168535815 -1.506572127 
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CSRP2BP 17.688123 11.74159113 -1.506450268 
          
C10orf71 7.8683602 5.223124947 -1.506446868 
          
GUSBP2 7.7402178 5.138412124 -1.506344293 
          
MIR4691 17.690165 11.74413972 -1.50629725 
          
CPQ 108.37397 71.96455764 -1.505935335 
          
DIO1 6.7677849 4.494201963 -1.505892468 
          
GPHB5 7.4172668 4.928285408 -1.505040035 
          
VCX2 24.73997 16.44069287 -1.50480092 
          
OR2F1 8.6910449 5.777607731 -1.504263587 
          
LOC101927560 4.9278377 3.276016291 -1.504216485 
          
LOC100287175 17.252808 11.47324852 -1.503742225 
          
LOC101927282 5.6502401 3.75829847 -1.503403778 
          
CHI3L1 6.5078584 4.329708451 -1.503070818 
          
NR2F2-AS1 18.231533 12.12971011 -1.503047675 
          
SRD5A1P1 5.112533 3.401722237 -1.502924895 
          
LOC101928472 14.193275 9.444593434 -1.502793646 
          
CRHR1-IT1 20.089424 13.36924399 -1.502659691 
          
LOC101928909 6.1564692 4.097400698 -1.502530417 
          
DENND1C 9.5676557 6.369402923 -1.50212756 
          
LOC101929484 11.232121 7.47793725 -1.502034677 
          
TMCO5A 6.1617217 4.102585859 -1.501911704 
          
SPIN2B 122.95207 81.87131646 -1.501772212 
          
SSH3 82.278096 54.79717961 -1.501502382 
          
FOXD4L3 74.310829 49.49631646 -1.501340596 
          
DIAPH3-AS1 11.643144 7.755515301 -1.501272793 
          
SH2D6 13.544248 9.023036654 -1.501074269 
          
BTBD17 10.717407 7.141742486 -1.50067121 
          
MIR433 6.323033 4.214097458 -1.50044773 
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NEUROG2 7.2685342 4.844325675 -1.500422291 
          
RSPO1 10.472297 6.980557448 -1.500209266 
          
LINC00202-2 5.6801387 3.786562555 -1.500077867 
           
